TW201217433A - Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element - Google Patents

Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element Download PDF

Info

Publication number
TW201217433A
TW201217433A TW100124790A TW100124790A TW201217433A TW 201217433 A TW201217433 A TW 201217433A TW 100124790 A TW100124790 A TW 100124790A TW 100124790 A TW100124790 A TW 100124790A TW 201217433 A TW201217433 A TW 201217433A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
ring
single bond
group
carbon atoms
Prior art date
Application number
TW100124790A
Other languages
Chinese (zh)
Other versions
TWI520984B (en
Inventor
Kazuyoshi Hosaka
Kohei Goto
Noritoshi Miki
Masaaki Katayama
Koji Sonoyama
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of TW201217433A publication Critical patent/TW201217433A/en
Application granted granted Critical
Publication of TWI520984B publication Critical patent/TWI520984B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1075—Partially aromatic polyimides
    • C08G73/1078—Partially aromatic polyimides wholly aromatic in the diamino moiety
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1075—Partially aromatic polyimides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/17—Amines; Quaternary ammonium compounds
    • C08K5/175—Amines; Quaternary ammonium compounds containing COOH-groups; Esters or salts thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/34—Heterocyclic compounds having nitrogen in the ring
    • C08K5/3412—Heterocyclic compounds having nitrogen in the ring having one nitrogen atom in the ring
    • C08K5/3415—Five-membered rings
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333—Constructional arrangements; Manufacturing methods
    • G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723—Polyimide, polyamide-imide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Liquid Crystal (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

Provided are: a liquid crystal aligning agent which is capable of providing a liquid crystal alignment film that does not easily produce scraping dust of a polymer coating film or scratches on the polymer coating film during a rubbing treatment and is suppressed in decrease of the voltage holding ratio after light irradiation of long time; a liquid crystal alignment film which is obtained from the liquid crystal aligning agent; and a liquid crystal display element. The liquid crystal aligning agent contains a compound represented by formula [1] (component (A)) and at least one polymer (component (B)) that is selected from the group consisting of polyimide precursors and polyimides. (In formula [1], X1 represents a divalent organic group that is composed of an aliphatic hydrocarbon group or a non-aromatic cyclic hydrocarbon group; X2 represents a single bond, -O-, -NH-, -S-, -SO2-, -COO-, -OCO-, -CONH-, -NHCO-, -CO-, a benzene ring or a cyclohexane ring; and X3 represents at least one group that is selected from among the groups represented by formulae [1-1] to [1-6].) (In formulae [1-1] to [1-6], W1 represents a hydrogen atom or a benzene ring; W2 represents a cyclic ring that is selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring; and W3 represents an alkyl group, a fluorine-containing alkyl group, an alkoxyl group or a fluorine-containing alkoxyl group, each having 1-18 carbon atoms.)

Description

201217433 六、發明說明： 【發明所屬之技術領域】 本發明係有關製作液晶配向膜時所用的液晶配向處理 劑、及使用其之液晶配向膜及液晶顯示元件》 v 【先前技術】 液晶顯示元件係作爲實現薄型•質輕的顯示裝置，現 在被廣泛地使用。通常此液晶顯示元件爲了決定液晶之配 向狀態，而使用液晶配向膜。又，除了一部份之垂直配向 型的液晶顯示元件等，其液晶配向膜之大部分係將形成於 電極基板上之聚合物被膜的表面施予某種的配向處理來製 作。 聚合物被膜的配向處理方法，例如現在一般使用的方 法係將其聚合物被膜表面藉由生絲等作爲素材的布施加壓 力摩擦’即施加所謂的摩擦處理的方法。對於解決因這種 摩擦處理造成之聚合物被膜之切削屑問題的方法，例如提 案除了聚醯胺酸或聚醯亞胺之至少：[種之聚合物外，使用 含有特定熱交聯性化合物之液晶配向處理劑的方法（參照 例如專利文獻1 )或使用含有含環氧基化合物之液晶配向 h· 處理劑的方法（參照例如專利文獻2 )等，藉由使用硬化 ^ 劑提·高摩擦耐性的方法。 〔先前技術文獻〕 〔專利文獻〕 〔專利文獻1〕日本特開平9_ 1 8 5065號公報 201217433 〔專利文獻2〕日本特開平9-146100號公報 【發明內容】 〔發明開示〕 〔發明欲解決的課題〕 爲了縮短液晶顯示元件之製造步驟時間，因此摩擦處 理係以短時間，且強摩擦條件下進行。因此相較於以往， 較常發生伴隨摩擦處理之聚合物被膜之切削屑或摩擦處理 所造成之傷痕的問題》此等異常使液晶顯示元件之特性降 低，更造成良率降低之原因之一。 此外，隨著近年之液晶顯示元件之高性能化，液晶顯 示元件被使用於大畫面且高精細之液晶電視、裝設於車上 的用途，例如有汽車導航系統或儀奉面板等的用途。此等 用途，爲了得到高亮度時，有時使用發熱量大的背光。因 此，液晶配向膜被要求從另外的觀點之高可靠性，即要求 對於背光之光的高安定性。特別是液晶顯示元件之電特性 之一的電壓保持率，因背光的光照射而降低時，容易產生 液晶顯示元件之顯示不良之一的殘影不良（也稱爲線燒焦 )，而無法得到可靠性高的液晶顯示元件。因此，液晶配 向膜除了初期特性良好外，例如也被要求即使長時間光照 射後，電壓保持率仍不易降低的特性。 本發明之目的係提供兼具上述特性的液晶配向膜。換 言之’本發明之目的係提供不易產生在液晶顯示元件製造 步驟中伴隨摩擦處理之聚合物被膜之切削屑或伴隨摩擦處 -6- 201217433 理所造成之傷痕，且即使長時間、光照射後，也瓦 壓保持率降低的液晶配向膜、可提供該液晶配向脂 配向處理劑及由此液晶配向處理劑所得之液晶顯示 〔解決課題的手段〕 本發明人等精心硏究的結果，發現含有具有特 之化合物的液晶配向處理劑可達成上述目的，遂完 明。 換言之，本發明係具有以下技術要件。 (1 ) 一種液晶配向處理劑，其特徵係含有下 (A)及成分（B)。 成分（A):下述式[1]表示之化合物（以下也 定胺化合物） 成分（B):選自聚醯亞胺前驅物及聚醯亞胺 之至少一種聚合物（以下也稱爲特定聚合物）。 [化1] [1] (X1係由脂肪族烴基或非芳香族系環式烴基戶歹 2 價有機基，X2 係單鍵、-〇-、-]^11-、-5-、-302-、-OCO-、-CONH-、-NHCO-、-CO-、苯環或環己 X3係選自下述式[1-1]〜[1-6]之至少1種的基團） 「抑制電 [的液晶 元件。 定結構 成本發 述成分 稱爲特 所成群 f構成之 ' -COO-烷環， 201217433[Technical Field] The present invention relates to a liquid crystal alignment treatment agent used for producing a liquid crystal alignment film, and a liquid crystal alignment film and liquid crystal display element using the same. [Prior Art] Liquid crystal display element system As a thin type and light weight display device, it is now widely used. Usually, the liquid crystal display element uses a liquid crystal alignment film in order to determine the alignment state of the liquid crystal. Further, in addition to a part of the vertical alignment type liquid crystal display element or the like, most of the liquid crystal alignment film is formed by applying a certain alignment treatment to the surface of the polymer film formed on the electrode substrate. The alignment treatment method of the polymer film, for example, a method generally used in the present invention, is a method in which a pressure rubbing is applied to a cloth whose surface is a polymer film by a raw material such as a raw yarn, that is, a so-called rubbing treatment is applied. For the method of solving the problem of chipping of the polymer film caused by such rubbing treatment, for example, it is proposed to use at least a polyamine or a polyamidiamine to use a specific thermally crosslinkable compound. A method of using a liquid crystal alignment agent (see, for example, Patent Document 1) or a method of using a liquid crystal alignment h-containing treatment agent containing an epoxy group-containing compound (see, for example, Patent Document 2), etc., and high friction resistance by using a curing agent Methods. [PRIOR ART DOCUMENT] [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei 9-14650-A Publication No. Hei 9-146100 [Patent Document 2] [Invention] [Invention] Problem] In order to shorten the manufacturing step time of the liquid crystal display element, the rubbing treatment is performed in a short time and under strong friction conditions. Therefore, compared with the prior art, the problem of the chips caused by the rubbing treatment or the scratches caused by the rubbing treatment is often caused. These abnormalities cause the characteristics of the liquid crystal display element to be lowered, which causes one of the reasons for the decrease in the yield. Further, with the improvement of the performance of liquid crystal display elements in recent years, liquid crystal display elements have been used for large-screen, high-definition liquid crystal televisions, and for use in vehicles, such as car navigation systems or instrument panels. For such applications, in order to obtain high brightness, a backlight having a large amount of heat may be used. Therefore, the liquid crystal alignment film is required to have high reliability from another viewpoint, that is, high stability for backlight light is required. In particular, when the voltage holding ratio of one of the electrical characteristics of the liquid crystal display element is lowered by the light irradiation of the backlight, it is likely to cause image sticking failure (also referred to as line burn) which is one of display defects of the liquid crystal display element, and is not obtained. Highly reliable liquid crystal display elements. Therefore, in addition to the initial characteristics of the liquid crystal alignment film, for example, it is required that the voltage retention ratio is not easily lowered even after a long period of light irradiation. SUMMARY OF THE INVENTION An object of the present invention is to provide a liquid crystal alignment film having the above characteristics. In other words, the object of the present invention is to provide a chip which is less likely to cause chipping of the polymer film accompanying the rubbing treatment in the manufacturing step of the liquid crystal display element or a flaw caused by the friction, and even after a long period of time, after light irradiation, A liquid crystal alignment film having a reduced pressure-retaining ratio, and a liquid crystal display obtained by providing the liquid crystal alignment grease alignment treatment agent and the liquid crystal alignment treatment agent. [Means for Solving the Problem] The inventors of the present invention have found that they have The liquid crystal alignment treatment agent of the specific compound can achieve the above object and is completed. In other words, the present invention has the following technical requirements. (1) A liquid crystal alignment treatment agent characterized by containing the lower (A) and the component (B). Component (A): a compound represented by the following formula [1] (hereinafter also an amine compound) Component (B): at least one polymer selected from the group consisting of a polyimine precursor and a polyimine (hereinafter also referred to as a specific one) polymer). [1] (1) is an aliphatic hydrocarbon group or a non-aromatic cyclic hydrocarbon group, a 2-valent organic group, an X2 system single bond, -〇-, -]^11-, -5-, -302 -, -OCO-, -CONH-, -NHCO-, -CO-, benzene ring or cyclohexene X3 is selected from at least one of the following formulas [1-1] to [1-6]" A liquid crystal element that suppresses electricity. The structure of the structure is called a composition of a special group f. -COO-alkane ring, 201217433

[化2] ，0γΝ：Η2 [1-1][Chemical 2], 0γΝ:Η2 [1-1]

[1 —5] (W 1係表示氫, 環及雜環所成群之ϊ 卜18之含氟烷基、® 氧基）。 (2 )如上述（ χΐ爲未與前述2價有 〇- ' -COO- ' -OCO-(〇) 2-、-CF2-、-( )2- > -OSi ( CH3 ) 、環狀烴基或雜環Φ 碳數1〜20之直鏈狀ί 3~20之環狀烴基、碳 羥基取代。 (3 )如上述（ 〔子或苯環。W2係選自苯環、環己烷 狀基，W3係碳數1~18之烷基、碳數 數1~18之烷氧基或碳數卜18之含氟烷 1 )項之液晶配向處理劑，其中式Π ]之 機基之胺基鄰接之任意的—^^-可被· 、-C0NH-、-NHCO-、-CO-、-S-、-S ：(CF3 ) 2- ' -C ( ch3 ) 2- ' -Si ( ch3 2-、-Si ( CH3 ) 2〇- ' -OSi ( CH3 ) 2〇-[代，與任意碳原子鍵結之氫原子可被 完基、碳數3〜2〇之支鏈狀烷基、碳數 丨數1〜10之含氟烷基、雜環、氟原子或 1 )或（2 )項之液晶配向處理劑，其 2 -8- 201217433 中式[1]之X2爲單鍵、-〇c〇-、-NHCO-、苯環或環己院環 〇 (4 )如上述（1 )〜（3 )項中任一項之液晶配向處理 劑，其中式[1]之X3爲式[1-2]、式[1-4]、式Π-5]或式[1-6] 表示之結構的基團。 (5 )如上述（1 ) ~ ( 4 )項中任一項之液晶配向處理 劑，其中成分（B)爲選自使二胺成分與四羧酸二酐成分 反應所得之聚醯胺酸及使該聚醯胺酸進行脫水閉環所得之 聚醯亞胺所成群之至少一種聚合物。 (6 )如上述（5 )項之液晶配向處理劑，其中二胺成 分爲下述式[2]表示之二胺化合物。[1 - 5] (W 1 is a group of a fluorine-containing alkyl group or a oxy group which is a group of hydrogen, a ring and a heterocyclic ring). (2) as described above ( χΐ is not 与 with the above two 〇 - ' -COO- ' -OCO-(〇) 2-, -CF2-, -( )2- > -OSi ( CH3 ), cyclic hydrocarbon group Or a heterocyclic ring Φ, a linear hydrocarbon group having a carbon number of 1 to 20, a cyclic hydrocarbon group of 3 to 20, or a hydroxy group. (3) as described above ([ or a benzene ring. W2 is selected from a benzene ring or a cyclohexane group). , W3 is a liquid crystal alignment treatment agent having an alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkane having a carbon number of 1), wherein the amine group of the formula is Any adjacent -^^- can be ·, -C0NH-, -NHCO-, -CO-, -S-, -S :(CF3 ) 2- ' -C ( ch3 ) 2- ' -Si ( ch3 2 -, -Si ( CH3 ) 2〇- ' -OSi ( CH3 ) 2〇-[, a hydrogen atom bonded to any carbon atom can be completed, a branched alkyl group having a carbon number of 3 to 2 Å, carbon a liquid crystal alignment treatment agent having a number of fluorenyl groups of 1 to 10 or a fluorine atom or a liquid crystal alignment treatment agent of 1) or (2), wherein 2 to 8 to 201217433, X2 of the formula [1] is a single bond, -〇c The liquid crystal alignment treatment agent of any one of the above items (1) to (3), wherein X3 of the formula [1] is a formula [1- 2], formula [1-4], formula Π-5] or formula [1-6] The liquid crystal alignment treatment agent according to any one of the above items (1), wherein the component (B) is selected from the group consisting of reacting a diamine component with a tetracarboxylic dianhydride component. And the at least one polymer of the obtained polyaminic acid and the polyimine obtained by subjecting the polyamic acid to dehydration ring closure. (6) The liquid crystal alignment treatment agent according to (5) above, wherein the diamine component It is a diamine compound represented by the following formula [2].

γ1_γ2_γ3_γ4_/_γ5\ _γ6 ] [2] (Y1係單鍵、選自-(CH2 ) a- ( a係1〜15之整數）、-0-、 -CH20-、 -COO-或 OCO-， Y2 係 單鍵或 (CH2) b-(b係 1〜15之整數），Y3係單鍵、- (CDe-Cc係1~15之整數 )、-0-、-CH20-、-C00-及 OCO-，Y4 係選自苯環、環己 烷環及雜環所成群之環狀基（此等之環狀基上之任意的氫 原子可被碳數1〜3之烷基、碳數1〜3之烷氧基、碳數1~3之 含氟烷基、碳數1〜3之含氟烷氧基或氟原子取代）、或具 有類固醇骨架之碳數12〜25之有機基之2價有機基，Y5係選 自苯環、環己烷環及雜環所成群之環狀基（此等之環狀基 上之任意的氫原子可被碳數1〜3之烷基、碳數^之烷氧基 -9 - 201217433 、碳數1~3之含氟烷基、碳數1〜3之含氟烷氧基或氟原子取 代），η係0〜4之整數，Y6係碳數1〜18之烷基、碳數1~18之 含氟烷基、碳數1〜18之烷氧基或碳數1〜18之含氟烷氧基， m係1〜4之整數）。 (7 )如上述（6 )項之液晶配向處理劑，其中式[2]表 示之二胺化合物爲二胺成分中之5~ 80莫耳％。 (8) 如上述（5) ~(7)項中任一項之液晶配向處理 劑，其中四羧酸二酐爲下述式[3]表示之四羧酸二酐》 [化4]Γ1_γ2_γ3_γ4_/_γ5\ _γ6 ] [2] (Y1 single bond, selected from -(CH2) a- (a is an integer from 1 to 15), -0-, -CH20-, -COO- or OCO-, Y2 system Single bond or (CH2) b- (b is an integer from 1 to 15), Y3 is a single bond, - (CDe-Cc is an integer from 1 to 15), -0-, -CH20-, -C00-, and OCO- Y4 is a cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring, and a heterocyclic ring (any hydrogen atom on the cyclic group may be an alkyl group having 1 to 3 carbon atoms, and a carbon number of 1 to 2 valence of an alkoxy group of 3, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom), or an organic group having a carbon number of 12 to 25 having a steroid skeleton The organic group, Y5 is a cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring (any hydrogen atom on the cyclic group may be an alkyl group having 1 to 3 carbon atoms, carbon number ^ alkoxy-9 - 201217433, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom), an integer of η-system 0 to 4, and a carbon number of Y6 An alkyl group of 1 to 18, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkoxy group having 1 to 18 carbon atoms, m is an integer of 1 to 4). (7) The liquid crystal alignment treatment agent according to the above (6), wherein the diamine compound represented by the formula [2] is 5 to 80 mol% of the diamine component. (8) The liquid crystal alignment treatment agent according to any one of the above items (5) to (7), wherein the tetracarboxylic dianhydride is a tetracarboxylic dianhydride represented by the following formula [3].

[3] (Z1係碳數4〜13之4價有機基，且含有碳數4〜1〇之非 芳香族環狀烴基）。 (9) 如上述（8)項之液晶配向處理劑，其中式[3]中 之Z1爲下述式[3a]〜式[3j]表示之結構。[3] (Z1 is a 4-valent organic group having 4 to 13 carbon atoms and a non-aromatic cyclic hydrocarbon group having 4 to 1 carbon atoms). (9) The liquid crystal alignment treatment agent according to the above item (8), wherein Z1 in the formula [3] is a structure represented by the following formula [3a] to formula [3j].

-10- 201217433 [化5] z2 z4 文允XX z3 z5-10- 201217433 [化5] z2 z4 Wen Yun XX z3 z5

[3a] [3b] [3C] [3d][3a] [3b] [3C] [3d]

(z2〜z5係氫原子、甲基、氯原子或苯環，各自可相 同或相異。Z6及Z7係氫原子或甲基’各自可相同或相異） * (10)如上述（1)〜（9)項中任一項之液晶配向處 w 理劑，其中成分（B)之聚合物爲使聚醯胺酸進行脫水閉 胃所得的聚醯亞胺。 (1 1 )如上述（1 )〜（1 0 )項中任—項之液晶配向處 理劑，其中相對於成分（B) 100質量份，成分（A)爲〇1 -11 - 201217433 質量份〜50質量份。 (1 2 )如上述（1 )〜（1 1 )項中任一項之液晶配向處 理劑，其中液晶配向處理劑含有有機溶劑，且含有有機溶 劑全體之5〜8 0質量％的弱溶劑。 (1 3 )—種液晶配向膜，其特徵係使用如上述（1 )〜 (1 2 )項中任一項之液晶配向處理劑所得。 (14)—種液晶顯示元件，其特徵係具有如上述（13 )項之液晶配向膜。 (1 5 )如上述（1 3 )項之液晶配向膜，其係用於下述 液晶顯示元件，該液晶顯示元件係在具備電極之一對基板 間具有液晶層所成，且經由前述一對基板間配置含有藉由 活性能量線及熱之至少其一進行聚合之聚合性化合物的液 晶組成物，對前述電極間外加電壓，使前述聚合性化合物 聚合的步驟所製造。 (1 6 )—種液晶顯示元件，其係具有上述（1 5 )項之 液晶配向膜。 (17)如上述（16)項之液晶顯示元件，其係在具備 電極與上述（1 3 )或（1 5 )項之液晶配向膜之一對基板間 具有液晶層所成，且經由前述一對基板間配置含有藉由活 性能量線及熱之至少其一進行聚合之聚合性化合物的液晶 組成物，對前述電極間外加電壓，使前述聚合性化合物聚 合的步驟所製造。 (1 8 )如上述（1 3 )項之液晶配向膜，其係用於下述 液晶顯示元件，該液晶顯示元件係在具備電極之一對基板 • 12 - 201217433 間具有液晶層所成，且經由前述一對基板間配置 能量線及熱之至少其一進行聚合之含有聚合性基 向膜，對前述電極間外加電壓，使前述聚合性基 驟所製造。 (1 9 ) 一種液晶顯示元件，其係具有上述（ 液晶配向膜。 (20 )如上述（1 9 )項之液晶顯示元件，其 電極之一對基板間具有液晶層所成，且經由前述 間配置藉由活性能量線及熱之至少其一進行聚合 合性基之液晶配向膜，對前述電極間外加電壓， 合性基聚合的步驟所製造。 發明效果 本發明之液晶配向處理劑可得到不易伴隨液 件之製造步驟中之摩擦處理產生聚合物被膜之切 隨摩擦處理產生傷痕，即使長時間受光照射，也 壓保持率降低的液晶配向膜。具有由本發明之液 理劑所得之液晶配向膜的液晶顯示元件係可靠性 用於大畫面、高精細的液晶電視等。 本發明之液晶配向處理劑爲何具有上述優異 其原因雖不明確，可能係因以下的緣故。 換言之，本發明之液晶配向處理劑中’特定 中之一級胺基係與特定聚合物中之羧基形成鹽’ 定聚合物中之羧基或羧酯基，隨著水或醇之脫離 藉由活性 的液晶配 聚合的步 1 8 )項之 係在具備 —對基板 之含有聚 使前述聚 晶顯示元 削屑或伴 可抑制電 晶配向處 優異，適 的特性， 胺化合物 或對於特 形成醯胺 -13- 201217433 鍵’或對於特定聚合物中之醯亞胺基，隨著醯亞胺基之開 環反應形成鍵結。此外，因製作液晶配向膜時之燒成步驟 ’與特定聚合物中之羧基形成鹽之一級胺基係藉由水之脫 離形成醯胺鍵。結果本發明之液晶配向處理劑即使在有機 溶劑中混合之簡便的手段，所得之液晶配向膜中，特定胺 化合物與特定聚合物有效率地鍵結著。 又’特定胺化合物中之X2之式[1-1]〜式[1-6]的雙鍵部 分係藉由熱或紫外線照射而反應已爲人知。因此，如上述 ’由本發明之液晶配向處理劑所得的液晶配向膜係因特定 胺化合物與特定聚合物鍵結，因此，製作液晶配向膜時之 燒結步驟或製作液晶顯示元件時之密封劑的硬化步驟，換 言之’藉由燒成步驟或紫外線照射步驟，產生聚合物相互 之交聯反應’提高物理安定性，此外，對熱或光的耐性較 高。 如此，由發明之液晶配向處理劑所得的液晶配向膜， 相較於不含特定胺化合物的液晶配向膜時，不易伴隨液晶 顯示元件之製造步驟中之摩擦處理產生聚合物被膜之切削 屑或伴隨摩擦處理產生傷痕，即使長時間受背光照射，也 可抑制電壓保持率降低。 本發明之特定胺化合物係僅有1個在分子內所含有的 一級胺基，因此調製液晶配向處理劑時或液晶配向處理劑 之保管中’可便免產生聚合物析出或凝膠化的問題。 〔實施發明的形態〕(z2 to z5 are a hydrogen atom, a methyl group, a chlorine atom or a benzene ring, and each may be the same or different. The Z6 and Z7 hydrogen atoms or the methyl group 'each may be the same or different) * (10) as described above (1) The liquid crystal alignment agent according to any one of (9), wherein the polymer of the component (B) is a polyimine obtained by subjecting polylysine to dehydration and gastric closing. (1) The liquid crystal alignment treatment agent according to any one of the above items (1) to (10), wherein the component (A) is 〇1 -11 - 201217433 parts by mass relative to 100 parts by mass of the component (B). 50 parts by mass. The liquid crystal alignment treatment agent according to any one of the above aspects, wherein the liquid crystal alignment treatment agent contains an organic solvent and contains 5 to 80% by mass of a weak solvent of the entire organic solvent. (1 3 ) A liquid crystal alignment film obtained by using the liquid crystal alignment treatment agent according to any one of the above items (1) to (1 2). (14) A liquid crystal display element characterized by having the liquid crystal alignment film of the above (13). (1) The liquid crystal alignment film according to the above (1), which is used in a liquid crystal display device having a liquid crystal layer between a pair of electrodes and a pair of electrodes, and via the aforementioned pair A liquid crystal composition containing a polymerizable compound polymerized by at least one of an active energy ray and heat is disposed between the substrates, and a step of applying a voltage between the electrodes to polymerize the polymerizable compound is produced. (1) A liquid crystal display element comprising the liquid crystal alignment film of the above (1). (17) The liquid crystal display element according to the above (16), wherein the liquid crystal layer is provided between the substrate and the one of the liquid crystal alignment film of the above (1 3 ) or (1 5), and the A liquid crystal composition containing a polymerizable compound polymerized by at least one of an active energy ray and heat is disposed between the substrates, and a step of applying a voltage between the electrodes to polymerize the polymerizable compound is produced. (1) The liquid crystal alignment film according to the above (1), which is used for a liquid crystal display element having a liquid crystal layer between a pair of electrodes and a substrate, 12 - 201217433, and A polymerizable base film is formed by disposing at least one of energy rays and heat between the pair of substrates, and a voltage is applied between the electrodes to prepare the polymerizable group. (1) A liquid crystal display element comprising the above (liquid crystal alignment film. (20) The liquid crystal display element according to (1) above, wherein one of the electrodes has a liquid crystal layer between the substrates, and the A liquid crystal alignment film which is subjected to a polymerizable group by at least one of an active energy ray and a heat is disposed, and a step of applying a voltage between the electrodes and a polymerizable group is carried out. Advantageous Effects of Invention The liquid crystal alignment treatment agent of the present invention can be easily obtained. In the rubbing treatment in the manufacturing step of the liquid member, the liquid crystal alignment film having a reduction in the pressure retention ratio even if it is irradiated with light for a long period of time due to the rubbing treatment of the polymer film, and the liquid crystal alignment film obtained by the liquid working agent of the present invention. The liquid crystal display element is used for a large-screen, high-definition liquid crystal television, etc. The reason why the liquid crystal alignment agent of the present invention has the above-described excellentness is not clear, and may be due to the following. In other words, the liquid crystal alignment of the present invention The specific amine in the treatment agent forms a salt with a carboxyl group in a specific polymer. The step of removing the water or the alcohol by the active liquid crystal polymerization step 1 8) is excellent in that the inclusion of the substrate is such that the polycrystalline display element shavings or the electron crystal alignment can be suppressed. A suitable property, the amine compound or for the formation of the indole-13-201217433 bond' or for the quinone imine group in a particular polymer, forms a bond with the ring opening reaction of the quinone imine group. Further, the calcination step in the production of the liquid crystal alignment film 'supplements with the carboxyl group in the specific polymer is a one-stage amine group which forms a guanamine bond by the separation of water. As a result, in the liquid crystal alignment film obtained by the liquid crystal alignment agent of the present invention, even if it is mixed in an organic solvent, the specific amine compound is efficiently bonded to the specific polymer. Further, it has been known that the double bond moiety of the formula [1-1] to the formula [1-6] of X2 in the specific amine compound is reacted by heat or ultraviolet irradiation. Therefore, as described above, the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention is bonded to a specific polymer by a specific amine compound, so that the sintering step in the production of the liquid crystal alignment film or the hardening of the sealant when the liquid crystal display element is produced The step, in other words, 'the crosslinking reaction of the polymers by the firing step or the ultraviolet irradiation step' improves physical stability and, in addition, has high resistance to heat or light. When the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the invention is compared with the liquid crystal alignment film containing no specific amine compound, it is difficult to cause chipping of the polymer film or accompanying the rubbing treatment in the manufacturing process of the liquid crystal display element. The rubbing treatment produces scratches, and the voltage holding ratio can be suppressed from being lowered even if it is irradiated by the backlight for a long period of time. Since the specific amine compound of the present invention has only one primary amine group contained in the molecule, the liquid crystal alignment treatment agent or the liquid crystal alignment treatment agent can be prepared to avoid the problem of polymer precipitation or gelation. . [Formation of the Invention]

S -14- 201217433 <特定胺化合物> 本發明之特定胺化合物係下述式[1]表示之化合物。 [化6] \χ’Χ ⑴ (X1係由脂肪族烴基或非芳香族系環式烴基所構成之 2價有機基，X2係單鍵、-0-、-：^11-、-8-、-302-、-(：00-、_OCO-、-CONH·、·ΝΗΟΟ_、-CO ·、苯環或環己烷環， X3係選自下述式[1-1]〜[1-6]之至少1種的基團） [化7]S -14-201217433 <Specific amine compound> The specific amine compound of the present invention is a compound represented by the following formula [1]. (化6) \χ'Χ (1) (X1 is a divalent organic group composed of an aliphatic hydrocarbon group or a non-aromatic cyclic hydrocarbon group, X2 is a single bond, -0-, -:^11-, -8- , -302-, -(:00-, _OCO-, -CONH·, ·ΝΗΟΟ_, -CO ·, benzene ring or cyclohexane ring, X3 is selected from the following formula [1-1]~[1-6 At least one of the groups] [Chemical 7]

[1-4][1-4]

[1—5][1—5]

式Π ]中，X1係特定胺化合物所含之一級胺基與特定 聚合物形成鹽或進行反應，容易鍵結，因此係由脂肪族烴 基或非芳香族系環式烴基所構成之2價有機基。具體而言 爲碳數1~20之脂肪族烴基或非芳香族系環式烴基，且未與 胺基鄰接之任意的-CH2-可被-0-、-COO-、-OCO-、- -15- 201217433 CONH-、-NHCO-、-CO-、-S-、-S ( Ο) i- ' -CF2- ' -C ( C F 3 ) 2- ' -C ( CH3) 2- ' -Si ( CH3) 2-' -OSi ( CH3) 2 - ' -Si ( CH3 ) 2〇-、-0Si(CH3) 2〇-、環狀烴基或雜環取代， 與任意碳原子鍵結之氫原子可被碳數1〜2 0之直鏈狀烷基、 碳數3〜2 0之支鏈狀烷基、碳數3〜2 0之環狀烴基、碳數1〜10 之含氟烷基、雜環、氟原子或羥基取代。 脂肪族烴基之具體例，例如有直鏈狀烷基、具有支鏈 結構之烷基或具有不飽和鍵之烴基等。其中較佳爲碳數爲 1~2 0的烷基》更佳爲碳數爲1〜15之烷基，更佳爲碳數爲 1〜1 〇之烷基。 非芳香族環式烴基之具體例有環丙烷環、環丁烷環、 環戊烷環、環己烷環、環庚烷環、環辛烷環、環壬烷環、 環癸烷環、環十一烷環、環十二烷環、環十三烷環、環十 四烷環、環十五烷環、環十六烷環、環十七烷環、環十八 烷環、環十九烷環、環二十烷環、三環二十烷環、三環癸 烷環、雙環己基環、雙環庚烷環、十氫萘環、降莰烯環或 金剛烷環等。其中較佳爲碳數爲3〜20之環。更佳爲碳數爲 3~15之環’更佳爲碳數爲6〜12之環的非芳香族環式烴基。 具體而言’例如有環己烷環或雙環己基環。 式 Π]中，X2 係單鍵、-0-、-1^11-、-5-、-3 02-、-(：00-、-OCO_、_c〇NH-、_NHc〇·、-CO·、苯環或環己烷環。 其中較佳爲單鍵、_〇·、-NH-、-COO-、-OCO-、-CONH-、-NHCO-、苯環或環己烷環。更佳爲單鍵、-OC〇-、_ NHCO-、苯環或環己烷環。 201217433 式Π]中，X3係選自式[1-1]〜式[1-6]表示之結構之基團 之至少1種。 式[1-3]中，w1係表示氫原子或苯環。 式[1-6]中，W2係選自由苯環、環己環及雜環所成群 之環狀基。其中較佳爲苯環、環己烷環或聯苯環。 式[1-6]中，W3係碳數1〜18之烷基、碳數1〜18之含氟 烷基、碳數1〜18之烷氧基或碳數卜18之含氟烷氧基。其中 較佳爲碳數1〜9之烷基或碳數1~9之烷氧基。 式[1]中，X3較佳爲式[1-2]、式[1-4]、式[1-5]或式[1-6]表示之結構的基團。 式[1 ]中之X 1、X2及X3之較佳組合係如表1及表2所示 -17- 201217433 〔表1〕 XI X2 X3 1-1 碳數1〜1〇之烷基 單鍵 式[1-2] 1-2 碳數1~1〇之烷基 苯環 式[1-2] 1-3 碳數1〜10之烷基 環己基環 式[1-2] 1-4 碳數1〜10之院基 單鍵 式[1-4] 1-5 碳數1〜10之院基 -OCO- 式[1-4] 1-6 碳數1~1〇之院基 -NHCO- 式[1-4] 1-7 碳數1〜10之院基 苯環 式[1-4] 1-8 碳數1〜1〇之烷基 環己基環 式[1-4] 1-9 碳數1~1〇之院基 單鍵 式[1-5] 1-10 碳數1〜10之烷基 -OCO- 式[1-5] 1-11 碳數1~1〇之院基 -NHCO- 式[1-5] 1-12 碳數1〜1〇之烷基 苯環 式[1-5] 1-13 碳數1〜10之烷基 環己基環 式[1-5] 1-14 碳數1〜10之院基 單鍵 式[1-6] 1-15 碳數1〜1〇之院基 苯環 式[1-6] 1-16 碳數1〜1〇之院基 rm—t -M*rsa 環CS壞 式[1-6] 1-17 環己基環 單鍵 式[1-2J 1-18 環己基環 苯環 式[1-2] 1-19 環己基環 環己基環 式[1-2] 1-20 環己基環 單鍵 式 Π-4] 1-21 環己基環 -OCO- 式[1-4] 1-22 環己基環 -NHCO- 式[1-4] 1-23 環己基環 苯環 式[1-4] 1-24 環己基環 環己基環 式[1_4] 201217433 〔表2〕 XI X2 X3 1-25 環己基環 單鍵 式[1-5] 1-26 環己基環 -OCO- 式[1-5] 1-27 環己基環 -NHCO- 式[1-5] 1-28 環己基環 苯環 式[1-5] 1-29 環己基環 環己基環 式[1-5] 1-30 環己基環 單鍵 式[1-6] 1-31 環己基環 苯環 式[1-6] 1-32 環己基環 環己基環 式[1-6] 1-33 雙環己基環 單鍵 式[1-2] 1-34 雙環己基環 苯環 式[1-2] 1-35 雙環己基環 環己基環 式[1-2] 1-36 雙環己基環 單鍵 式[1-4] 1-37 雙環己基環 -OCO- 式[1-4] 1-38 雙環己基環 -NHCO- 式 Π-4] 1-39 雙環己基環 苯環 式[1-4] 1-40 雙環己基環 環己基環 式[1-4] 1-41 雙環己基環 單鍵 式[1-5] 1-42 雙環己基環 -OCO- 式[1-5] 1-43 雙環己基環 -NHCO- 式[1-5] 1-44 雙環己基環 苯環 式[1-5] 1-45 雙環己基環 環己基環 式[1-5] 1-46 雙環己基環 單鍵 式[1-6] 1-47 雙環己基環 苯環 式[1-6] 1-48 雙環己基環 環己基環 式[1_6] 24、1 - 特別是 其中特定胺化合物較佳爲由1-1~1-7、1-14〜1-33~1-40、或1-46〜1-48所構成之組合的胺化合物。 由或1-1 4〜1-1 6所構成之組合的胺化合物爲佳 <特定聚合物> •19· 201217433 本發明之特定聚合物係選自具有下述式[A]表示之糸士 構之聚醯亞胺前驅物及使該聚醯亞胺前驅物進行釀亞胺化 後的聚醯亞胺所成群之至少1種的聚合物。In the formula Π], a certain amine group contained in a specific amine compound of X1 is formed into a salt or a reaction with a specific polymer, and is easily bonded, and thus is a divalent organic compound composed of an aliphatic hydrocarbon group or a non-aromatic cyclic hydrocarbon group. base. Specifically, it is an aliphatic hydrocarbon group having 1 to 20 carbon atoms or a non-aromatic cyclic hydrocarbon group, and any -CH2- which is not adjacent to the amine group may be -0-, -COO-, -OCO-, - 15- 201217433 CONH-, -NHCO-, -CO-, -S-, -S ( Ο) i- ' -CF2- ' -C ( CF 3 ) 2- ' -C ( CH3) 2- ' -Si ( CH3) 2-'-OSi(CH3) 2 - '-Si(CH3) 2〇-, -0Si(CH3) 2〇-, cyclic hydrocarbyl or heterocyclic ring, hydrogen atom bonded to any carbon atom can be a linear alkyl group having 1 to 2 carbon atoms, a branched alkyl group having 3 to 20 carbon atoms, a cyclic hydrocarbon group having 3 to 20 carbon atoms, a fluorine-containing alkyl group having 1 to 10 carbon atoms, and a heterocyclic ring , fluorine atom or hydroxyl substitution. Specific examples of the aliphatic hydrocarbon group include a linear alkyl group, an alkyl group having a branched structure, or a hydrocarbon group having an unsaturated bond. Among them, an alkyl group having a carbon number of from 1 to 20 is more preferably an alkyl group having a carbon number of from 1 to 15, more preferably an alkyl group having a carbon number of from 1 to 1 Torr. Specific examples of the non-aromatic cyclic hydrocarbon group are a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, a cyclohexane ring, a cycloheptane ring, a cyclooctane ring, a cyclodecane ring, a cyclodecane ring, and a ring. Undecane ring, cyclododecane ring, cyclotridecane ring, cyclotetradecane ring, cyclopentadecane ring, cyclohexadecane ring, cycloheptadecane ring, cyclooctadecane ring, ring nineteen An alkane ring, a cyclohexadecane ring, a tricyclohexadecane ring, a tricyclodecane ring, a bicyclohexyl ring, a bicycloheptane ring, a decahydronaphthalene ring, a norbornene ring or an adamantane ring. Among them, a ring having a carbon number of 3 to 20 is preferred. More preferably, the ring having a carbon number of 3 to 15 is more preferably a non-aromatic cyclic hydrocarbon group having a ring number of 6 to 12 carbon atoms. Specifically, for example, there is a cyclohexane ring or a bicyclohexyl ring. In the formula ,], X2 is a single bond, -0-, -1^11-, -5-, -3 02-, -(:00-, -OCO_, _c〇NH-, _NHc〇·, -CO· a benzene ring or a cyclohexane ring. Among them, a single bond, _〇·, -NH-, -COO-, -OCO-, -CONH-, -NHCO-, a benzene ring or a cyclohexane ring is preferred. Is a single bond, -OC〇-, _NHCO-, benzene ring or cyclohexane ring. In 201217433, X3 is selected from the group of the structure represented by the formula [1-1] to the formula [1-6]. In the formula [1-3], w1 represents a hydrogen atom or a benzene ring. In the formula [1-6], W2 is a cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring. Preferably, it is a benzene ring, a cyclohexane ring or a biphenyl ring. In the formula [1-6], W3 is an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, and a carbon number of 1. The alkoxy group of -18 or the fluoroalkoxy group of carbon number 18. Among them, an alkyl group having 1 to 9 carbon atoms or an alkoxy group having 1 to 9 carbon atoms is preferable. In the formula [1], X3 is preferred. A group represented by the formula [1-2], the formula [1-4], the formula [1-5] or the formula [1-6]. Preferably, X 1 , X 2 and X 3 in the formula [1 ] The combination is shown in Table 1 and Table 2-17-201217433 [Table 1] XI X2 X3 1-1 Carbon number 1~1〇 alkyl single bond type [1 -2] 1-2 Alkylbenzene ring with a carbon number of 1 to 1 [ [1-2] 1-3 Alkylcyclohexyl ring of a carbon number of 1 to 10 [1-2] 1-4 Carbon number 1~ 10 yard base single-key type [1-4] 1-5 carbon number 1~10 yard base-OCO- type [1-4] 1-6 carbon number 1~1〇 yard base-NHCO- type [1 -4] 1-7 phenyl ring with a carbon number of 1 to 10 [1-4] 1-8 Alkylcyclohexyl ring of carbon number 1 to 1 [ [1-4] 1-9 Carbon number 1~ 1〇的院单单式[1-5] 1-10 Carbon number 1~10 alkyl-OCO- [1-5] 1-11 Carbon number 1~1〇院基-NHCO- [ 1-5] 1-12 Alkylbenzene ring having a carbon number of 1 to 1 [ [1-5] 1-13 Alkylcyclohexyl ring having a carbon number of 1 to 10 [1-5] 1-14 Carbon number 1 ～10的院基单键式 [1-6] 1-15 Carbon number 1~1〇的院基苯式 [1-6] 1-16 Carbon number 1~1〇的院基 rm-t -M *rsa ring CS bad formula [1-6] 1-17 cyclohexyl ring single bond type [1-2J 1-18 cyclohexyl ring benzene ring [1-2] 1-19 cyclohexylcyclocyclohexyl ring type [1] -2] 1-20 cyclohexyl ring single bond Π-4] 1-21 cyclohexyl ring-OCO- formula [1-4] 1-22 cyclohexyl ring-NHCO- formula [1-4] 1-23 ring Hexylcyclophenyl ring [1-4] 1-24 cyclohexylcyclocyclohexyl ring[1_4] 201217433 Table 2] XI X2 X3 1-25 cyclohexyl ring single bond [1-5] 1-26 cyclohexyl ring-OCO- formula [1-5] 1-27 cyclohexyl ring-NHCO- formula [1-5] 1-28 Cyclohexylcyclophenyl ring [1-5] 1-29 Cyclohexylcyclocyclohexyl ring [1-5] 1-30 Cyclohexyl ring single bond [1-6] 1-31 Cyclohexylcyclobenzene Ring [1-6] 1-32 cyclohexylcyclocyclohexyl ring [1-6] 1-33 bicyclohexyl ring single bond [1-2] 1-34 bicyclohexyl ring benzene ring [1-2] 1-35 Dicyclohexylcyclocyclohexyl ring [1-2] 1-36 Dicyclohexyl ring single bond [1-4] 1-37 Dicyclohexyl ring-OCO- Formula [1-4] 1-38 Dicyclohexyl ring -NHCO- Π-4] 1-39 Dicyclohexylcyclophenyl ring [1-4] 1-40 Dicyclohexylcyclocyclohexyl ring [1-4] 1-41 Dicyclohexyl ring single bond [1-5] 1-42 Bicyclohexyl ring-OCO- Formula [1-5] 1-43 Bicyclohexyl ring-NHCO- [1-5] 1-44 Dicyclohexylcyclophenyl ring [1-5] 1-45 Dicyclohexyl Cyclohexylcyclo[1-5] 1-46 bicyclohexyl ring single bond [1-6] 1-47 dicyclohexylcyclophenyl ring [1-6] 1-48 dicyclohexylcyclocyclohexyl ring [1_6 24, 1 - especially wherein the specific amine compound is preferably from 1-1 to 1 An amine compound of -7, 1-14 to 1-33 to 1-40, or a combination of 1-46 to 1-48. The amine compound of the combination of 1-1 4 to 1-1 6 is preferable <specific polymer> • 19·201217433 The specific polymer of the present invention is selected from the group consisting of the following formula [A]. A polymer of at least one of a polyimine precursor of the composition and a polyimine obtained by subjecting the polyimine precursor to the imidization.

(R1係4價有機基’ R2係2價有機基，R3及R4係氫原子 或碳數1〜8之烷基，各自可相同或相異，n係表示正整數） 本發明之特定聚合物係以下述式[Β]表示之二胺成分 與下述式[C]表示之四羧酸二酐成分爲原料，從比較簡便 可得到的理由，較佳爲由下述式[D]表示之重複單位之結 構式所構成之聚醯胺酸或使該聚醯胺酸進行醯亞胺化後的 聚醯亞胺。 [化9](R1 is a tetravalent organic group 'R2 is a divalent organic group, R3 and R4 are a hydrogen atom or an alkyl group having 1 to 8 carbon atoms, each of which may be the same or different, and n is a positive integer) Specific polymer of the present invention The diamine component represented by the following formula [Β] and the tetracarboxylic dianhydride component represented by the following formula [C] are preferably used as a raw material, and are preferably represented by the following formula [D]. The polyaminic acid composed of the structural formula of the repeating unit or the polyimine obtained by subjecting the polyamic acid to ruthenium. [Chemistry 9]

Hzti— R1 —叫[B]Hzti — R1 — called [B]

[C] (R1及R2係與式[A]所定義者相同意義）。 201217433 [化 10][C] (R1 and R2 have the same meaning as those defined in formula [A]). 201217433 [化10]

[D] (R1、R2及η係與式[A]所定義者相同意義）。 式[A]及式[D]中，R1及R2係可爲各自1種，或具有各 自不同之R1及R2，作爲重複單位，組合不同之複數種者。 二胺成分較佳爲使用下述式[2]表示之二胺化合物（以 下也稱爲特定側鏈型二胺化合物）。 [化11][D] (R1, R2 and η are the same as those defined in the formula [A]). In the formula [A] and the formula [D], each of R1 and R2 may be one of them, or each of R1 and R2 may be used as a repeating unit, and a plurality of different types may be combined. The diamine component is preferably a diamine compound (hereinafter also referred to as a specific side chain type diamine compound) represented by the following formula [2]. [11]

一Y6 ) [2] in }m 式[2]中，Y1係單鍵、-(CH2 ) a- ( a係1〜15之整數） 、-0-、-CH20-、-COO -或 OCO-。其中單鍵、-(CH2) a-( a係1〜15之整數）、-Ο-、-CH20-或COO-係容易合成側鏈 結構，故較佳。更佳爲單鍵、-(CH2 ) a- ( a係1~10之整數 )、-〇-、-CH20-或 COO-。 式[2]中，Y2係單鍵或（CH2)b-(b係1〜15之整數）。 其中較佳爲單鍵或（CH2) b- ( b係1〜1〇之整數）。 式[2]中，Y3係單鍵、-(CH2) c- ( c係卜15之整數） 、-〇-、-CH20·、-COO -或 OCO-。其中單鍵、-(CH2)。-( c係1〜15之整數）、-〇-、-ch2〇-、-COO -或OCO-較容易合 -21 - 201217433 成，故較佳。更佳爲單鍵、-(CH2) e-(c係1〜10之整數） 、-0-、-CH20-、-COO-或 OCO-0 式[2]中，Y4係選自苯環、環己烷環及雜環所成群之 環狀基，此等之環狀基上之任意的氫原子’可被碳數1〜3 之烷基、碳數1~3之烷氧基、碳數1〜3之含氟烷基、碳數 1~3之含氟烷氧基或氟原子取代。此外，γ4係具有類固醇 骨架之碳數12 ~2 5之有機基。其中較佳爲苯環、環己環或 具有類固醇骨架之碳數12~25之有機基。 式[2]中，Y5係選自苯環、環己烷環及雜環所成群之 環狀基，此等環狀基上之任意的氫原子可被碳數丨~3之院 基、碳數1〜3之烷氧基、碳數1~3之含氟烷基、碳數1~3之 含氟烷氧基或氟原子取代。 式[2]中，η係0~4之整數。較佳爲〇〜2之整數。 式[2]中，Υ6係碳數1〜18之烷基、碳數1~18之含氟烷 基、碳數1〜18之烷氧基或碳數卜18之含氟烷氧基。其中較 佳爲碳數1〜18之烷基、碳數1〇之含氟烷基、碳數卜18之 烷氧基或碳數1〜1〇之含氟烷氧基。更佳爲碳數1〜12之烷基 或碳數1〜12之烷氧基。更佳爲碳數1〜9之烷基或碳數1〜9之 烷氧基。 式[2]中，m係1〜4之整數。較佳爲1之整數。 式[2]中之Υ1、Υ2、Υ3、Υ4、Υ5、Υ6、η及m之較佳的 組合係如表3 ~ 3 2所示。 201217433 〔表3〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-1 單鍵 單鍵 單鍵 ^5+：τ& 洋:¾ 碳數1〜9之烷基 0 1 2-2 單鍵 單鍵 單鍵 苯環 苯環 碳數1~9之烷基 1 1 2-3 單鍵 單鍵 單鍵 苯環 苯環 碳數1~9之烷基 2 1 2-4 單鍵 單鍵 單鍵 苯環 碳數1〜9之烷氧基 0 1 2-5 單鍵 單鍵 單鍵 苯環 苯環 碳數卜9之烷氧基 1 1 2-6 單鍵 單鍵 單鍵 苯環 苯環 碳數1〜9之烷氧基 2 1 2-7 單鍵 單鍵 單鍵 苯環 碳數1〜9之烷基 0 1 2-8 單鍵 單鍵 單鍵 苯環 環己基環 碳數1〜9之烷基 1 1 2-9 單鍵 單鍵 單鍵 苯環 環己基環 碳數1〜9之烷基 2 1 2-10 單鍵 單鍵 單鍵 举壞 碳數1〜9之烷氧基 0 1 2-11 單鍵 單鍵 單鍵 本環 環己基環 碳數1〜9之院氧基 1 1 2-12 單鍵 單鍵 單鍵 率壞 環己基環 碳數1〜9之烷氧基 2 1 2-13 單鍵 單鍵 單鍵 環己基環 碳數1~9之烷基 0 1 2-14 單鍵 單鍵 單鍵 環己基環 苯環 碳數1〜9之烷基 1 1 2-15 單鍵 單鍵 單鍵 環己基環 苯環 碳數1〜9之烷基 2 1 2-16 單鍵 單鍵 單鍵 環己基環 碳數1〜9之烷氧基 0 1 2-17 單鍵 單鍵 單鍵 環己基環 苯環 碳數1〜9之烷氧基 1 1 2-18 單鍵 單鍵 單鍵 環己基環 苯環 碳數1〜9之烷氧基 2 1 2-19 單鍵 單鍵 單鍵 環己基環 碳數1〜9之烷基 0 1 2-20 單鍵 單鍵 單鍵 環己基環 環己基環 碳數1〜9之烷基 1 1 2-21 單鍵 單鍵 單鍵 環己基環 環己基環 碳數1~9之烷基 2 1 -23- 201217433 〔表4〕 Y1 Y2 Y3 Y4 Υ5 Υ6 η m 2-22 單鍵 單鍵 單鍵 環己基環 碳數1〜9之烷氧基 0 1 2-23 單鍵 單鍵 單鍵 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-24 單鍵 單鍵 單鍵 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-25 單鍵 單鍵 -(CH2)c- 苯環 碳數1〜9之烷基 0 1 2-26 單鍵 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9之烷基 1 1 2-27 單鍵 單鍵 -(CH2)c- 苯環 苯環 碳數1~9之烷基 2 1 2-28 單鍵 單鍵 -(CH2)c- 苯環 碳數1~9之烷氧基 0 1 2-29 單鍵 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9之烷氧基 1 1 2-30 單鍵 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-31 單鍵 單鍵 -(CH2)c- 苯環 碳數1〜9之烷基 0 1 2-32 單鍵 單鍵 -(CH2)c- 渾^環 環己基環 碳數1〜9之烷基 1 1 2-33 單鍵 單鍵 -(CH2)c- 苯環 環己基環 碳數1〜9之烷基 2 1 2-34 單鍵 單鍵 -(CH2)c- 苯環 碳數1〜9之烷氧基 0 1 2-35 單鍵 單鍵 -(CH2)c- 苯環 環己基環 碳數1〜9之烷氧基 1 1 2-36 單鍵 單鍵 -(CH2)c- 苯環 環己基環 碳數1~9之烷氧基 2 1 2-37 單鍵 單鍵 -(CH2)c- 環己基環 碳數1〜9之烷基 0 1 2-38 單鍵 單鍵 -(CH2)c- 環己基環 苯環 碳數1~9之烷基 1 1 2-39 單鍵 單鍵 -(CH2)c- 環己基環 苯環 碳數1~9之烷基 2 1 2-40 單鍵 單鍵 -(CH2)c- 環己基環 碳數1〜9之烷氧基 0 1 2-41 單鍵 單鍵 -(CH2)c- 環己基環 苯環 碳數1〜9之烷氧基 1 1 2-42 單鍵 單鍵 _(CH2)c- 環己基環 苯環 碳數1〜9之烷氧基 2 1 c爲1〜10之整數 201217433 〔表5〕 Y1 Y2 Y3 Y4 Y5 Υ6 η m 2-43 單鍵 單鍵 -(CH2)c- 環己基環 碳數1〜9之烷基 0 1 2-44 單鍵 單鍵 -(CH2)c- 環己基環 環己基環 碳數1〜9之烷基 1 1 2-45 單鍵 單鍵 -(CH2)c- 環己基環 環己基環 碳數1~9之烷基 2 1 2-46 單鍵 單鍵 -(CH2)c- 環己基環 碳數1〜9之烷氧基 0 1 2-47 單鍵 單鍵 -(CH2)c- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-48 單鍵 單鍵 -(CH2)c- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-49 單鍵 單鍵 -0- 苯環 碳數1〜9之烷基 0 1 2-50 單鍵 單鍵 -0- 苯環 苯環 碳數1〜9之烷基 1 1 2-51 單鍵 單鍵 -o- 苯環 苯環 碳數1〜9之烷基 2 1 2-52 單鍵 單鍵 -0- 苯環 碳數1~9之烷氧基 0 1 2-53 單鍵 單鍵 -0- 苯環 苯環 碳數1〜9之烷氧基 1 1 2-54 單鍵 單鍵 -0- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-55 單鍵 單鍵 -0- 苯環 碳數1〜9之烷基 0 1 2-56 單鍵 單鍵 -0- 苯環 環己基環 碳數1〜9之烷基 1 1 2-57 單鍵 單鍵 苯環 環己基環 碳數1〜9之烷基 2 1 2-58 單鍵 單鍵 -0- 苯環 碳數1〜9之院氧基 0 1 2-59 單鍵 單鍵 -0- 苯環 環己基環 碳數1〜9之烷氧基 1 1 2-60 單鍵 單鍵 -o- 苯環 τεβ-Π 甘 基場 碳數1〜9之烷氧基 2 1 2-61 單鍵 單鍵 -0- 環己基環 碳數1〜9之烷基 0 1 2-62 單鍵 單鍵 -o- 環己基環 茶環 碳數1〜9之烷基 1 1 2-63 單鍵 單鍵 -0- 環己基環 苯環 碳數1〜9之烷基 2 1 c爲1〜1 0之整數 -25- 201217433 〔表6〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-64 單鍵 單鍵 -0- 環己基環 碳數1〜9之烷氧基 0 1 2-65 單鍵 單鍵 -0- 環己基環 苯環 碳數1〜9之烷氧基 1 1 2-66 單鍵 單鍵 環己基環 苯環 碳數1〜9之烷氧基 2 1 2-67 單鍵 單鍵 -0- 環己基環 碳數1〜9之烷基 0 1 2-68 單鍵 單鍵 -0- 環己基環 環己基環 碳數1〜9之烷基 1 1 2-69 單鍵 單鍵 -0- 環己基環 環己基環 碳數1〜9之烷基 2 1 2-70 單鍵 單鍵 -0- 環己基環 碳數1〜9之烷氧基 0 1 2-71 單鍵 單鍵 -0- 環己基環 環己基環 碳數1~9之烷氧基 1 1 2-72 單鍵 單鍵 -0- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-73 單鍵 單鍵 -CH20- 苯環 碳數1〜9之烷基 0 1 2-74 單鍵 單鍵 -CH20- 苯環 苯環 碳數1〜9之烷基 1 1 2-75 單鍵 單鍵 -CH20- 苯環 苯環 碳數1〜9之烷基 2 1 2-76 單鍵 單鍵 -CH20- 苯環 碳數1〜9之烷氧基 0 1 2-77 單鍵 單鍵 -CH20- 苯環 苯環 碳數1〜9之烷氧基 1 1 2-78 單鍵 單鍵 -CH20- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-79 單鍵 單鍵 -CH20- 苯環 碳數1〜9之烷基 0 1 2-80 單鍵 單鍵 -CH20- 苯環 環己基環 碳數1〜9之烷基 1 1 2-81 單鍵 單鍵 -CH20- 苯環 環己基環 碳數1〜9之烷基 2 1 2-82 單鍵 單鍵 -CH20- 苯環 碳數1~9之烷氧基 0 1 2-83 單鍵 單鍵 -CH20- 苯環 環己基環 碳數1〜9之烷氧基 1 1 2-84 單鍵 單鍵 -CH20- 苯環 環己基環 碳數1〜9之烷氧基 2 1 -26 201217433 〔表7〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-85 單鍵 單鍵 -CH20- 環己基環 碳數1〜9之烷基 0 1 2-86 單鍵 單鍵 -CH20- 環己基環 苯環 碳數卜9之烷基 1 1 2-87 單鍵 單鍵 -CH20- 環己基環 苯環 碳數1~9之院基 2 1 2-88 單鍵 單鍵 -CH20- 環己基環 碳數1〜9之烷氧基. 0 1 2-89 單鍵 單鍵 -CH20- 環己基環 苯環 碳數1~9之烷氧基 1 1 2-90 單鍵 單鍵 -CH20- 環己基環 苯環 碳數卜9之烷氧基 2 1 2-91 單鍵 單鍵 -CH20- 環己基環 碳數1〜9之烷基 0 1 2-92 單鍵 單鍵 -CH20- 環己基環 環己基環 碳數1〜9之烷基 1 1 2-93 單鍵 單鍵 -CH20- 環己基環 環己基環 碳數卜9之烷基 2 1 2-94 單鍵 單鍵 -CH20- 環己基環 碳數1〜9之烷氧基 0 1 2-95 單鍵 單鍵 -CH20- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-96 單鍵 單鍵 -CH20- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-97 單鍵 單鍵 -COO- 举壞 碳數1~9之烷基 0 1 2-98 單鍵 單鍵 -COO- 苯環 苯環 碳數1〜9之烷基 1 1 2-99 單鍵 單鍵 -COO- 苯環 苯環 碳數卜9之烷基 2 1 2-100 單鍵 單鍵 -COO- 苯環 碳數1~9之烷氧基 0 1 2-101 單鍵 單鍵 -COO- 苯環 苯環 碳數1〜9之烷氧基 1 1 2-102 單鍵 單鍵 -COO- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-103 單鍵 單鍵 -COO- 本場 碳數1〜9之烷基 0 1 2-104 單鍵 單鍵 -COO- 苯環 環己基環 碳數1~9之烷基 1 1 2-105 單鍵 單鍵 -coo- 苯環 isa—1 甘 壞匕垂壞 碳數1~9之烷基 2 1 -27- 201217433 〔表8〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-106 單鍵 單鍵 -COO- 苯環 碳數1〜9之烷氧基 0 1 2-107 單鍵 單鍵 -COO- 苯環 環己基環 碳數1〜9之烷氧基 1 1 2-108 單鍵 單鍵 -COO- 苯環 環己基環 碳數1〜9之烷氧基 2 1 2-109 單鍵 單鍵 -coo- 環己基環 碳數1〜9之烷基 0 1 2-110 單鍵 單鍵 -coo- 環己基環 苯環 碳數1〜9之烷基 1 1 2-111 單鍵 單鍵 -coo- 環己基環 苯環 碳數1〜9之烷基 2 1 2-112 單鍵 單鍵 -coo- 環己基環 碳數1〜9之烷氧基 0 1 2-113 單鍵 單鍵 -coo- 環己基環 苯環 碳數1〜9之烷氧基 1 1 2-114 單鍵 單鍵 -coo- 環己基環 苯環 碳數1〜9之烷氧基 2 1 2-115 單鍵 單鍵 -coo- 環己基環 碳數1〜9之烷基 0 1 2-116 單鍵 單鍵 -coo- 環己基環 環己基環 碳數1〜9之院基 1 1 2-117 單鍵 單鍵 -coo- 環己基環 環己基環 碳數1〜9之烷基 2 1 2-118 單鍵 單鍵 -coo- 環己基環 碳數1〜9之烷氧基 0 1 2-119 單鍵 單鍵 -coo- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-120 單鍵 單鍵 -coo- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-121 單鍵 單鍵 -OCO- 苯環 碳數1~9之烷基 0 1 2-122 單鍵 單鍵 -OCO- 苯環 苯環 碳數1~9之烷基 1 1 2-123 單鍵 單鍵 -OCO- 苯環 苯環 碳數1〜9之烷基 2 1 2-124 單鍵 單鍵 -OCO- 苯環 碳數1〜9之烷氧基 0 1 2-125 單鍵 單鍵 -OCO- 苯環 苯環 碳數1〜9之烷氧基 1 1 2-126 單鍵 單鍵 -OCO- 苯環 苯環 碳數1〜9之烷氧基 2 1 s -28- 201217433 〔表9〕 Y1 Y2 Υ3 Υ4 Y5 Y6 η m 2-127 單鍵 單鍵 -OCO- 苯環 碳數1〜9之烷基 0 1 2-128 單鍵 單鍵 -OCO- 苯環 環己基環 碳數1〜9之烷基 1 1 2-129 單鍵 單鍵 -OCO- 本壞 環己基環 碳數1~9之烷基 2 1 2-130 單鍵 單鍵 -OCO- 苯環 碳數1〜9之烷氧基 0 1 2-131 單鍵 單鍵 -OCO- 苯環 環己基環 碳數1〜9之院氧基 1 1 2-132 單鍵 單鍵 -OCO- 苯環 環己基環 碳數1〜9之烷氧基 2 1 2-133 單鍵 單鍵 -OCO- 環己基環 碳數1〜9之烷基 0 1 2-134 單鍵 單鍵 -OCO- 環己基環 苯環 碳數1〜9之烷基 1 1 2-135 單鍵 單鍵 -OCO- 環己基環 苯環 碳數1〜9之烷基 2 1 2-136 單鍵 單鍵 -OCO- 環己基環 碳數卜9之烷氧基 0 1 2-137 單鍵 單鍵 -OCO- 環己基環 苯環 碳數1〜9之烷氧基 1 1 2-138 單鍵 單鍵 -OCO- 環己基環 rMrisa 本壞 碳數1〜9之烷氧基 2 1 2-139 單鍵 單鍵 -OCO- 環己基環 碳數1〜9之烷基 0 1 2-140 單鍵 單鍵 -OCO- 環己基環 環己基環 碳數1〜9之烷基 1 1 2-141 單鍵 單鍵 -OCO- 環己基環 環己基環 碳數1~9之烷基 2 1 2-142 單鍵 單鍵 -OCO- 環己基環 碳數1〜9之烷氧基 0 1 2-143 單鍵 單鍵 -OCO- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-144 單鍵 單鍵 -OCO- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-145 _(CH2)a- 單鍵 -0- 苯環 碳數1〜9之烷基 0 1 2-146 -(CH2)a- 單鍵 -0- 苯環 茶場 碳數1〜9之烷基 1 1 2-147 _(CH2)a- 單鍵 -0- 苯環 苯環 碳數1〜9之烷基 2 1 a爲1〜1 0之整數 -29 - 201217433 〔表 ι〇〕 Y1 Y2 Y3 Y4 Υ5 Υ6 η m 2-148 -(CH2)a- 單鍵 -0- 苯環 碳數1~9之烷氧基 0 1 2-149 -(CH2)a- 單鍵 -0- 苯環 苯環 碳數1〜9之烷氧基 1 1 2-150 -(CH2)a- 單鍵 -0- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-151 -(CH2)a- 單鍵 -0- 苯環 碳數1〜9之院基 0 1 2-152 -(CH2)a- 單鍵 -0- 苯環 環己基環 碳數1〜9之烷基 1 1 2-153 -(CH2)a- 單鍵 -0- 苯環 環己基環 碳數1〜9之院基 2 1 2-154 -(CH2)a- 單鍵 -0- 苯環 碳數1~9之烷氧基 0 1 2-155 -(CH2)a- 單鍵 -0- 苯環 環己基環 碳數1〜9之烷氧基 1 1 2-156 -(CH2)a- 單鍵 -0- 苯環 環己基環 碳數1〜9之烷氧基 2 1 2-157 -(CH2)a- 單鍵 -0- 環己基環 碳數1〜9之烷基 0 1 2-158 -(CH2)a- 單鍵 -0- 環己基環 苯環 碳數1〜9之烷基 1 1 2-159 -(CH2)a- 單鍵 -0- 環己基環 苯環 碳數1〜9之烷基 2 1 2-160 -(CH2)a- 單鍵 -0- 環己基環 碳數1〜9之烷氧基 0 1 2-161 -(CH2)a- 單鍵 -0- 環己基環 苯環 碳數1〜9之烷氧基 1 1 2-162 -(CH2)a- 單鍵 -0- -1 甘 ΐρΩ· 壞匕卷壞 苯環 碳數1〜9之烷氧基 2 1 2-163 -(CH2)a- 單鍵 -0- 環己基環 碳數1〜9之烷基 0 1 2-164 -(CH2)a- 單鍵 -0- 環己基環 環己基環 碳數1〜9之烷基 1 1 2-165 -(CH2)a- 單鍵 -0- 環己基環 環己基環 碳數1〜9之烷基 2 1 2-166 -(CH2)a- 單鍵 -0- 環己基環 碳數1〜9之烷氧基 0 1 2-167 -(CH2)a- 單鍵 -0- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-168 -(CH2)a- 單鍵 -0- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 a爲1〜10之整數 -30- 201217433 〔表 11〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-169 -(CH2)a- 單鍵 -COO- 苯環 碳數1~9之院基 0 1 2-170 -(CH2)a- 單鍵 -COO- 苯環 苯環 碳數1~9之烷基 1 1 2-171 -(CH2)a- 單鍵 -COO- 苯環 苯環 碳數1〜9之烷基 2 1 2-172 -(CH2)a- 單鍵 -COO- 苯環 碳數1〜9之烷氧基 0 1 2-173 -(CH2)a- 單鍵 -COO- 苯環 苯環 碳數1〜9之烷氧基 1 1 2-174 -(CH2)a- 單鍵 -coo- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-175 -(CH2)a- 單鍵 -COO- 苯環 碳數1〜9之烷基 0 1 2-176 -(CH2)a- 單鍵 -COO- 苯環 環己基環 碳數1〜9之烷基 1 1 2-177 -(CH2)a- 單鍵 -coo- 苯環 環己基環 碳數1〜9之烷基 2 1 2-178 -(CH2)a- 單鍵 -coo- 茶環 碳數1〜9之烷氧基 0 1 2-179 -(CH2)a- 單鍵 -coo- 苯環 環己基環 碳數1〜9之院氧基 1 1 2-180 -(CH2)a- 單鍵 -coo- 苯環 環己基環 碳數1〜9之烷氧基 2 1 2-181 -(CH2)a- 單鍵 -coo- 環己基環 碳數1〜9之院基 0 1 2-182 -(CH2)a- 單鍵 -COO- 環己基環 zfefcTsa. 本壞 碳數1~9之烷基 1 1 2-183 -(CH2)a- 單鍵 -COO- 環己基環 苯環 碳數1〜9之烷基 2 1 2-184 -(CH2)a- 單鍵 -coo- 環己基環 碳數1〜9之烷氧基 0 1 2-185 -(CH2)a- 單鍵 -coo- 環己基環 苯環 碳數1〜9之院氧基 1 1 2-186 -(CH2)a- 單鍵 -coo- 環己基環 苯環 碳數1~9之烷氧基 2 1 2-187 -(CH2)a- 單鍵 -coo- 環己基環 碳數1〜9之院基 0 1 2-188 -(CH2)a- 單鍵 -coo- 環己基環 環己基環 碳數1〜9之烷基 1 1 2-189 -(CH2)a- 單鍵 -COO- 環己基環 環己基環 碳數1〜9之烷基 2 1 a爲1〜10之整數 -31 - 201217433 〔表 12〕 Y1 Y2 Y3 Y4 Υ5 Υ6 η m 2-190 -(CH2)a- 單鍵 -COO- 環己基環 碳數1〜9之烷氧基 0 1 2-191 -(CH2)a- 單鍵 -COO- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-192 -(CH2)a- 單鍵 -COO- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-193 -(CH2)a- 單鍵 -OCO- 苯環 碳數1〜9之院基 0 1 2-194 -(CH2)a- 單鍵 -OCO- 苯壞 苯環 碳數1〜9之烷基 1 1 2-195 -(CH2)a- 單鍵 -OCO- 苯環 苯環 碳數1〜9之烷基 2 1 2-196 -(CH2)a- 單鍵 -OCO- 苯環 碳數1〜9之烷氧基 0 1 2-197 -(CH2)a- 單鍵 -OCO- 苯環 苯環 碳數1〜9之烷氧基 1 1 2-198 -(CH2)a- 單鍵 -OCO- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-199 -(CH2)a- 單鍵 -OCO- 苯環 碳數1〜9之烷基 0 1 2-200 -(CH2)a- 單鍵 -OCO- 苯環 環己基環 碳數1〜9之烷基 1 1 2-201 -(CH2)a- 單鍵 -OCO- 苯環 環己基環 碳數1〜9之烷基 2 1 2-202 -(CH2)a- 單鍵 -OCO- 苯環 碳數1〜9之烷氧基 0 1 2-203 -(CH2)a- 單鍵 -OCO- 苯環 環己基環 碳數1~9之烷氧基 1 1 2-204 -(CH2)a- 單鍵 -OCO- 苯環 環己基環 碳數1〜9之烷氧基 2 1 2-205 -(CH2)a- 單鍵 -OCO- 環己基環 碳數1〜9之烷基 0 1 2-206 -(CH2)a- 單鍵 -OCO- 環己基環 苯環 碳數1~9之烷基 1 1 2-207 -(CH2)a- 單鍵 -OCO- 環己基環 苯環 碳數1〜9之烷基 2 1 2-208 -(CH2)a- 單鍵 -OCO- 環己基環 碳數1〜9之烷氧基 0 1 2-209 -(CH2)a- 單鍵 -OCO- 環己基環 苯環 碳數1〜9之烷氧基 1 1 2-210 -(CH2)a- 單鍵 -OCO- 環己基環 苯環 碳數1〜9之烷氧基 2 1 a爲1〜1 0之整數 -32- 201217433 〔表 13〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-211 -(CH2)a- 單鍵 -0C0- 環己基環 碳數1〜9之烷基 0 1 2-212 -(CH2)a- 單鍵 -0C0- 環己基環 環己基環 碳數1〜9之烷基 1 1 2-213 -(CH2)a- 單鍵 -0C0- 環己基環 環己基環 碳數1〜9之烷基 2 1 2-214 -(CH2)a- 單鍵 -0C0- 環己基環 碳數1~9之烷氧基 0 1 2-215 -(CH2)a- 單鍵 -0C0- 環己基環 環己基環 碳數1〜9之院氧基 1 1 2-216 -(CH2)a- 單鍵 -0C0- 環己基環 環己基環 碳數1~9之烷氧基 2 1 2-217 -0- 單鍵 -(CH2)c- 苯環 碳數1〜9之烷基 0 1 2-218 -0- 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9之烷基 1 1 2-219 -0- 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9之烷基 2 1 2-220 -0- 單鍵 -(CH2)c- 苯環 碳數1〜9之烷氧基 0 1 2-221 -0- 單鍵 -(CH2)c- 苯環 苯環 碳數1~9之烷氧基 1 1 2-222 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9之院氧基 2 1 2-223 -0- 單鍵 -(CH2)c- 苯環 碳數1〜9之烷基 0 1 2-224 -0- 單鍵 -(CH2)c- 苯環 環己基環 碳數1〜9之烷基 1 1 2-225 -0- 單鍵 -(CH2)c- 苯環 環己基環 碳數1〜9之烷基 2 1 2-226 -0- 單鍵 -(CH2)c- 苯環 碳數1〜9之烷氧基 0 1 2-227 -0- 單鍵 -(CH2)c- 本壞 環己基環 碳數1〜9之烷氧基 1 1 2-228 -0- 單鍵 -(CH2)c- 苯環 環己基環 碳數1〜9之烷氧基 2 1 2-229 -0- 單鍵 -(CH2)c- 環己基環 碳數1〜9之院基 0 1 2-230 -0- 單鍵 -(CH2)c- 環己基環 苯環 碳數1〜9之烷基 1 1 2-231 -0- 單鍵 -(CH2)c- 環己基環 苯環 碳數1〜9之烷基 2 1 a，c係各獨立爲1〜10之整數 -33- 201217433 〔表 14〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-232 -0- 單鍵 -(CH2)c- 環己基環 碳數1〜9之院氧基 0 1 2-233 -0- 單鍵 -(CH2)c- 環己基環 苯環 碳數1〜9之烷氧基 1 1 2-234 -0- 單鍵 -(CH2)c- 環己基環 苯環 碳數1〜9之烷氧基 2 1 2-235 -0- 單鍵 -(CH2)c- 環己基環 碳數1〜9之烷基 0 1 2-236 -0- 單鍵 -(CH2)c- 環己基環 環己基環 碳數1〜9之烷基 1 1 2-237 -0- 單鍵 -(CH2)c- 環己基環 環己基環 碳數1〜9之院基 2 1 2-238 -0- 單鍵 -(CH2)c- 環己基環 碳數1〜9之烷氧基 0 1 2-239 -0- 單鍵 -(CH2)c- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-240 -0- 單鍵 -(CH2)c- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-241 -0- 單鍵 -CH20- 苯環 碳數1~9之烷氧基 0 1 2-242 -0- 單鍵 -CH20- 苯環 苯環 碳數1〜9之烷氧基 1 1 2-243 -0- 單鍵 -CH20- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-244 -0- 單鍵 -CH20- 苯環 碳數1〜9之烷基 0 1 2-245 -0- 單鍵 -CH20- 苯環 苯環 碳數1〜9之烷基 1 1 2-246 -0- 單鍵 -CH20- 苯環 苯環 碳數1〜9之烷基 2 1 2-247 -0- 單鍵 -CH20- 苯環 碳數1~9之烷氧基 0 1 2-248 -0- 單鍵 -CH20- 苯環 環己基環 碳數1~9之烷氧基 1 1 2-249 -0- 單鍵 -CH20- 苯環 環己基環 碳數1〜9之烷氧基 2 1 2-250 -0- 單鍵 -CH20- 苯環 碳數1~9之烷基 0 1 2-251 -0- 單鍵 -CH20- 苯環 環己基環 碳數1〜9之烷基 1 1 2-252 -0- 單鍵 -CH20- 苯環 環己基環 碳數1〜9之烷基 2 1 c爲1〜10之整數 -34 201217433 〔表 15〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-253 -0- 單鍵 -CH20- 苯環 碳數1〜9之烷氧基 0 1 2-254 -0- 單鍵 -CH20- 苯環 環己基環 碳數1〜9之烷氧基 1 1 2-255 -0- 單鍵 -CH20- 苯環 環己基環 碳數1〜9之烷氧基 2 1 2-256 -0- 單鍵 -CH20- 環己基環 碳數1~9之烷基 0 1 2-257 -0- 單鍵 -CH20- 環己基環 苯環 碳數1~9之烷基 1 1 2-258 -0- 單鍵 -CH20- 環己基環 苯環 碳數1~9之烷基 2 1 2-259 -0- 單鍵 -CH20- 環己基環 碳數1〜9之烷氧基 0 1 2-260 -0- 單鍵 -CH20- 環己基環 苯環 碳數1~9之烷氧基 1 1 2-261 -0- 單鍵 -CH20- 環己基環 苯環 碳數1〜9之烷氧基 2 1 2-262 -0- 單鍵 -CH20- 環己基環 碳數1~9之烷基 0 1 2-263 單鍵 -CH20- 環己基環 環己基環 碳數1~9之烷基 1 1 2-264 -0- 單鍵 -CH20- 環己基環 環己基環 碳數1〜9之院基 2 1 2-265 -0- 單鍵 -CH20- 環己基環 碳數1〜9之烷氧基 0 1 2-266 -0- 單鍵 -CH20- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-267 單鍵 -CH20- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-268 -CH20- 單鍵 -(CH2)c- 苯環 碳數1~9之烷基 0 1 2-269 -CH20- 單鍵 -(CH2)c- 苯環 苯環 碳數卜9之院基 1 1 2-270 -CH20- 單鍵 -(CH2)c- 苯環 苯環 碳數1~9之烷基 2 1 2-271 -CH20- 單鍵 -(CH2)c- 苯環 碳數1〜9之烷氧基 0 1 2-272 -CH20- 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9之烷氧基 1 1 2-273 -CH20- 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9之烷氧基 2 1 c爲1〜1 0之整數 -35- 201217433 〔表 16〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-274 -CH20- 單鍵 -(CH2)c- 苯環 碳數1〜9之烷基 0 1 2-275 -CH20- 單鍵 -(CH2)c- 苯環 環己基環 碳數1〜9之烷基 1 1 2-276 -CH20- 單鍵 -(CH2)c- 苯環 環己基環 碳數1〜9之烷基 2 1 2-277 -CH20- 單鍵 -(CH2)c- 苯環 碳數1〜9之烷氧基 0 1 2-278 -CH20- 單鍵 -(CH2)c- 苯環 環己基環 碳數1〜9之烷氧基 1 1 2-279 -CH20- 單鍵 -(CH2)c- 苯環 環己基環 碳數1〜9之烷氧基 2 1 2-280 -CH20- 單鍵 -(CH2)c- 環己基環 碳數1〜9之烷基 0 1 2-281 -CH20- 單鍵 -(CH2)c- 環己基環 苯環 碳數1〜9之烷基 1 1 2-282 -CH20- 單鍵 -(CH2)c- 環己基環 苯環 碳數1〜9之烷基 2 1 2-283 -CH20- 單鍵 -(CH2)c- 環己基環 碳數1〜9之烷氧基 0 1 2-284 -CH20- 單鍵 -(CH2)c- 環己基環 苯環 碳數1〜9之烷氧基 1 1 2-285 -CH20- 單鍵 -(CH2)c- 環己基環 苯環 碳數1〜9之烷氧基 2 1 2-286 -CH20- 單鍵 -(CH2)c- 環己基環 碳數1〜9之烷基 0 1 2-287 -CH20- 單鍵 -(CH2)c- 環己基環 環己基環 碳數1〜9之烷基 1 1 2-288 -CH20- 單鍵 -(CH2)c- 環己基環 環己基環 碳數1~9之烷基 2 1 2-289 -CH20- 單鍵 -(CH2)c- 環己基環 碳數1〜9之烷氧基 0 1 2-290 -CH20- 單鍵 -(CH2)c- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-291 -CH20- 單鍵 -(CH2)c- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-292 -CH20- 單鍵 -CH20- 苯環 碳數1〜9之烷基 0 1 2-293 -CH20- 單鍵 -CH20- 苯環 苯環 碳數1〜9之烷基 1 1 2-294 -CH20- 單鍵 -CH20- 苯環 苯環 碳數1〜9之烷基 2 1 c爲1〜10之整數 -36- 201217433 〔表 17〕 Y1 Y2 Υ3 Υ4 Υ5 Υ6 η m 2-295 -CH20- 單鍵 -CH20- 苯環 碳數1〜9之烷氧基 0 1 2-296 -CH20- 單鍵 -CH20- 苯環 苯環 碳數1〜9之烷氧基 1 1 2-297 -CH20- 單鍵 -CH20- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-298 -CH20- 單鍵 -CH20- 苯環 碳數卜9之烷基 0 1 2-299 -CH20- 單鍵 -CH20- 苯環 環己基環 碳數1〜9之烷基 1 1 2-300 -CH20- 單鍵 -CH20- 苯環 環己基環 碳數1~9之烷基 2 1 2-301 -CH20- 單鍵 -CH20- 苯環 碳數1〜9之院氧基 0 1 2-302 -CH20- 單鍵 -CH20- 苯環 環己基環 碳數1〜9之烷氧基 1 1 2-303 -CH20- 單鍵 -CH20- 苯環 環己基環 碳數1〜9之烷氧基 2 1 2-304 -CH20- 單鍵 -CH20- 環己基環 碳數1~9之烷基 0 1 2-305 -CH20- 單鍵 -CH20- 環己基環 苯環 碳數1~9之烷基 1 1 2-306 -CH20- 單鍵 -CH20- 環己基環 苯環 碳數1~9之烷基 2 1 2-307 -CH20- 單鍵 -CH20- 環己基環 碳數1~9之烷氧基 0 1 2-308 -CH20- 單鍵 -CH20- 環己基環 苯環 碳數1〜9之烷氧基 1 1 2-309 -CH20- 單鍵 -CH20- 環己基環 苯環 碳數1〜9之烷氧基 2 1 2-310 -CH20- 單鍵 -CH20- 環己基環 碳數1 之院基 0 1 2-311 -CH20- 單鍵 -CH20- 環己基環 環己基環 碳數卜9之烷基 1 1 2-312 -CH20- 單鍵 -CH20- 環己基環 環己基環 碳數1~9之院基 2 1 2-313 -CH20- 單鍵 -CH20- 環己基環 碳數1〜9之烷氧基 0 1 2-314 -CH20- 單鍵 -CH20- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-315 -CH20- 單鍵 -CH20- 環己基環 IS—I 甘χθ· 壞C卷環 碳數1〜9之烷氧基 2 1 -37- 201217433 〔表 18〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-316 -COO- 單鍵 -(CH2)c- 苯環 碳數1〜9之烷基 0 1 2-317 -COO- 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9之烷基 1 1 2-318 -COO- 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9之烷基 2 1 2-319 -COO- 單鍵 -(CH2)c- 苯環 碳數1〜9之烷氧基 0 1 2-320 -COO- 單鍵 -(CH2)c- 苯環 苯環 碳數1~9之烷氧基 1 1 2-321 -COO- 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-322 -COO- 單鍵 -(CH2)c- 苯環 碳數1〜9之烷基 0 1 2-323 -coo- 單鍵 -(CH2)c- 苯環 環己基環 碳數1〜9之烷基 1 1 2-324 -coo- 單鍵 -(CH2)c- 苯環 環己基環 碳數1〜9之烷基 2 1 2-325 -coo- 單鍵 -(CH2)c- 苯環 碳數1〜9之烷氧基 0 1 2-326 -coo- 單鍵 -(CH2)c- 苯環 環己基環 碳數1〜9之烷氧基 1 1 2-327 -coo- 單鍵 -(CH2)c- 苯環 環己基環 碳數1〜9之烷氧基 2 1 2-328 -coo- 單鍵 -(CH2)c- 環己基環 碳數1〜9之烷基 0 1 2-329 -coo- 單鍵 -(CH2)c- 環己基環 苯環 碳數1〜9之烷基 1 1 2-330 -coo- 單鍵 -(CH2)c- 環己基環 苯環 碳數1〜9之烷基 2 1 2-331 -coo- 單鍵 -(CH2)c- 環己基環 碳數1〜9之烷氧基 0 1 2-332 -coo- 單鍵 -(CH2)c- 環己基環 茶壞 碳數1〜9之烷氧基 1 1 2-333 -coo- 單鍵 -(CH2)c- 環己基環 苯環 碳數1〜9之烷氧基 2 1 2-334 -coo- 單鍵 -(CH2)c- 環己基環 碳數1〜9之烷基 0 1 2-335 -coo- 單鍵 -(CH2)c- 環己基環 環己基環 碳數1〜9之烷基 1 1 2-336 -coo- 單鍵 -(CH2)c- 環己基環 環己基環 碳數1〜9之烷基 2 1 c爲1 ~1 0之整數 -38- 201217433 〔表 19〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-337 -COO- 單鍵 -(CH2)c- 環己基環 碳數1~9之烷氧基 0 1 2-338 -coo- 單鍵 -(CH2)c- rm—t 甘 壞O基環 環己基環 碳數1〜9之烷氧基 1 1 2-339 -coo- 單鍵 -(CH2)c- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-340 -coo- 單鍵 -CH20- 苯環 碳數1〜9之烷基 0 1 2-341 -coo- 單鍵 -CH20- 苯環 苯環 碳數1〜9之烷基 1 1 2-342 -coo- 單鍵 -CH20- 苯環 苯環 碳數1〜9之院基 2 1 2-343 -COO- 單鍵 -CH20- 苯環 碳數1〜9之烷氧基 0 1 2-344 -COO- 單鍵 -CH20- 苯環 苯環 碳數1~9之烷氧基 1 1 2-345 -coo- 單鍵 -CH20- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-346 -coo- 單鍵 -CH20- 苯環 碳數1~9之烷基 0 1 2-347 -coo- 單鍵 -CH20- 苯環 環己基環 碳數1〜9之烷基 1 1 2-348 -coo- 單鍵 -CH20- 苯環 環己基環 碳數1〜9之烷基 2 1 2-349 -COO- 單鍵 -CH20- 薄:壞 碳數1~9之烷氧基 0 1 2-350 -coo- 單鍵 -CH20- 苯環 環己基環 碳數1~9之烷氧基 1 1 2-351 -COO- 單鍵 -CH20- 本壞 環己基環 碳數1~9之烷氧基 2 1 2-352 -coo- 單鍵 -CH20- 環己基環 碳數1〜9之院基 0 1 2-353 -COO- 單鍵 -CH20- 環己基環 苯環 碳數1〜9之烷基 1 1 2-354 -COO- 單鍵 -CH20- 環己基環 苯環 碳數1〜9之烷基 2 1 2-355 -coo- 單鍵 -CH20- 環己基環 碳數1~9之烷氧基 0 1 2-356 -coo- 單鍵 -CH20- 環己基環 苯環 碳數1〜9之烷氧基 1 1 2-357 -coo- 單鍵 -CH20- 環己基環 苯環 碳數1〜9之烷氧基 2 1 c爲1~10之整數 -39- 201217433 〔表 20〕 Y1 Y2 Y3 Y4 Y5 Υ6 η m 2-358 -COO- 單鍵 -CH20- 環己基環 碳數1〜9之烷基 0 1 2-359 -coo- 單鍵 -CH20- 環己基環 環己基環 碳數1〜9之烷基 1 1 2-360 -coo- 單鍵 -CH20- 環己基環 環己基環 碳數1〜9之烷基 2 1 2-361 -coo- 單鍵 -CH20- 環己基環 碳數1〜9之院氧基 0 1 2-362 -coo- 單鍵 -CH20- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-363 -coo- 單鍵 -CH20- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-364 -0- -(CH2)b- -0- 苯環 碳數1〜9之烷基 0 1 2-365 -0- -(CH2)b- -0- 苯環 苯環 碳數1〜9之烷基 1 1 2-366 -0- -(CH2)b- -0- 苯環 苯環 碳數1〜9之烷基 2 1 2-367 -0- -(CH2)b- -0- 苯環 碳數1〜9之院氧基 0 1 2-368 -0- -(CH2)b- -0- 苯環 莽壞 碳數1〜9之烷氧基 1 1 2-369 -0- -(CH2)b- -0- 苯環 苯環 碳數1~9之烷氧基 2 1 2-370 -0- -(CH2)b- -0- 苯環 碳數1〜9之烷基 0 1 2-371 -0- -(CH2)b- -0- 苯環 環己基環 碳數之院基 1 1 2-372 -0- -(CH2)b- -0- 苯環 環己基環 碳數1〜9之烷基 2 1 2-373 -0- -(CH2)b- -0- 苯環 碳數1〜9之烷氧基 0 1 2-374 -0- -(CH2)b- -0- 苯環 環己基環 碳數1〜9之烷氧基 1 1 2-375 -0- -(CH2)b- -0- 苯環 環己基環 碳數1〜9之烷氧基 2 1 2-376 -0- -(CH2)b- -0- 環己基環 碳數1〜9之烷基 0 1 2-377 -0- -(CH2)b- -0- 環己基環 苯環 碳數1〜9之烷基 1 1 2-378 -0- -(CH2)b- -0- 環己基環 苯環 碳數1〜9之院基 2 1 b爲1〜10之整數 -40 - 201217433 〔表 21〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-379 -0- -(CH2)b- -0- 環己基環 碳數1〜9之烷氧基 0 1 2-380 -0- -(CH2)b- -0- 環己基環 本％ 碳數1〜9之烷氧基 1 1 2-381 -0- -(CH2)b- -0- 環己基環 苯環 碳數1〜9之烷氧基 2 1 2-382 -0- -(CH2)b- -0- 環己基環 碳數1〜9之烷基 0 1 2-383 -(CH2)b- -0- 環己基環 環己基環 碳數1〜9之院基 1 1 2-384 -(CH2)b- -0- 環己基環 環己基環 碳數1〜9之烷基 2 1 2-385 -0- -(CH2)b- -0- 環己基環 碳數1〜9之烷氧基 0 1 2-386 -(CH2)b- -0- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-387 -(CH2)b- -0- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-388 -(CH2)b- -coo- 苯環 碳數1〜9之院基 0 1 2-389 -(CH2)b- -coo- 苯環 本壞 碳數1〜9之烷基 1 1 2-390 -0- -(CH2)b- -coo- 苯環 碳數1~9之烷基 2 1 2-391 -0- -(CH2)b- -coo- 苯環 碳數1〜9之烷氧基 0 1 2-392 -(CH2)b- -coo- 苯環 苯環 碳數1〜9之烷氧基 1 1 2-393 -(CH2)b- -coo- 苯環 苯環 碳數1〜9之院氧基 2 1 2-394 -(CH2)b- -coo- 苯環 碳數1〜9之院基 0 1 2-395 -(CH2)b- -coo- 苯環 環己基環 碳數1〜9之院基 1 1 2-396 -(CH2)b- -coo- 苯環 環己基環 碳數1〜9之院基 2 1 2-397 -0- -(CH2)b- -coo- 苯環 碳數1〜9之烷氧基 0 1 2-398 -(CH2)b- -coo- 苯環 環己基環 碳數卜9之烷氧基 1 1 2-399 -(CH2)b- -coo- 苯環 環己基環 碳數1〜9之烷氧基 2 1 b爲1〜10之整數 -41 - 201217433 〔表 22〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-400 -(CH2)b- -COO- 環己基環 碳數1〜9之烷基 0 1 2-401 -(CH2)b- -coo- 環己基環 苯環 碳數1~9之烷基 1 1 2-402 -0- -(CH2)b- -coo- 環己基環 苯環 碳數1〜9之烷基 2 1 2-403 -0- -(CH2)b- -coo- 環己基環 碳數1〜9之烷氧基 0 1 2-404 -(CH2)b- -coo- 環己基環 苯環 碳數1〜9之垸氧基 1 1 2-405 -0- -(CH2)b- -coo- 環己基環 苯環 碳數1〜9之烷氧基 2 1 2-406 -(CH2)b- -coo- 環己基環 碳數1〜9之烷基 0 1 2-407 -0- -(CH2)b- -coo- 環己基環 環己基環 碳數1〜9之烷基 1 1 2-408 -(CH2)b- -coo- 環己基環 環己基環 碳數1〜9之院基 2 1 2-409 -0- -(CH2)b- -coo- 環己基環 碳數1〜9之烷氧基 0 1 2-410 -0- -(CH2)b- -coo- 環己基環 環己基環 碳數卜9之烷氧基 1 1 2-411 -(CH2)b- -coo- 環己基環 環己基環 碳數1~9之烷氧基 2 1 2-412 -(CH2)b- -oco- 苯環 碳數1〜9之烷基 0 1 2-413 -0- -(CH2)b- -oco- 苯環 苯環 碳數1〜9之院基 1 1 2-414 -0- -(CH2)b- -oco- 苯環 苯環 碳數1~9之烷基 2 1 2-415 -(CH2)b- -oco- 苯環 碳數1〜9之烷氧基 0 1 2-416 -(CH2)b- -oco- 苯環 苯環 碳數1~9之烷氧基 1 1 2-417 -0- -(CH2)b- -oco- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-418 -0- -(CH2)b- -oco- 苯環 碳數1~9之烷基 0 1 2-419 -0- -(CH2)b- -oco- 苯環 環己基環 碳數1〜9之烷基 1 1 2-420 -0- -(CH2)b- -oco- 苯環 環己基環 碳數卜9之烷基 2 1 b爲1〜10之整數 -42 - 201217433 〔表 23〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-421 -0- -(CH2)b- -oco- 苯環 碳數1〜9之烷氧基 0 1 2-422 -0- -(CH2)b- -oco- 苯環 環己II環 碳數1〜9之烷氧基 1 1 2-423 -0- -(CH2)b- -OCO- 苯環 環己基環 碳數1〜9之烷氧基 2 1 2-424 -0- -(CH2)b- -OCO- 環己基環 碳數1〜9之院基 0 1 2-425 -0- -(CH2)b- -OCO- 環己基環 本壤 碳數1〜9之烷基 1 1 2-426 -0- -(CH2)b- -OCO- 環己基環 苯環 碳數1〜9之烷基 2 1 2-427 -0- -(CH2)b- -OCO- 環己基環 碳數1〜9之烷氧基 0 1 2-428 -0- -(CH2)b- -OCO- 環己基環 苯環 碳數1〜9之烷氧基 1 1 2-429 -0- -(CH2)b- -OCO- 環己基環 苯環 碳數1〜9之烷氧基 2 1 2-430 -0- -(CH2)b- -oco- 環己基環 碳數1〜9之烷基 0 1 2-431 -0- -(CH2)b- -oco- 環己基環 環己基環 碳數1〜9之院基 1 1 2-432 -0- -(CH2)b- -oco- 環己基環 環己基環 碳數1〜9之烷基 2 1 2-433 -0- _(CH2)b- -oco- 環己基環 碳數1〜9之烷氧基 0 1 2-434 -0- -(CH2)b- -oco- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-435 -0- -(CH2)b- -oco- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-436 -CH20- -(CH2)b- 單鍵 苯環 碳數1〜9之烷基 0 1 2-437 -CH20- -(CH2)b- 單鍵 苯環 苯環 碳數1~9之烷基 1 1 2-438 -CH20- -(CH2)b- 單鍵 苯環 苯環 碳數1〜9之烷基 2 1 2-439 -CH20- -(CH2)b- 單鍵 苯環 碳數1〜9之烷氧基 0 1 2-440 -CH20- -(CH2)b- 單鍵 苯環 苯環 碳數1〜9之烷氧基 1 1 2-441 -CH20- -(CH2)b- 單鍵 苯環 苯環 碳數1〜9之烷氧基 2 1 b爲1〜10之整數 -43- 201217433 〔表 24〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-442 -CH20- -(CH2)b- 單鍵 苯環 碳數1〜9之院基 0 1 2-443 -CH20- -(CH2)b- 單鍵 苯環 環己基環 碳數1〜9之烷基 1 1 2-444 -CH20- -(CH2)b- 單鍵 苯環 環己基環 碳數1〜9之烷基 2 1 2-445 -CH20- -(CH2)b- 單鍵 苯環 碳數1~9之烷氧基 0 1 2-446 -CH20- -(CH2)b- 單鍵 苯環 環己基環 碳數1〜9之烷氧基 1 1 2-447 -CH20- -(CH2)b- 單鍵 苯環 環己基環 碳數1〜9之烷氧基 2 1 2-448 -CH20- _(CH2)b- 單鍵 環己基環 碳數1〜9之烷基 0 1 2-449 -CH20- -(CH2)b- 單鍵 環己基環 苯環 碳數1〜9之烷基 1 1 2-450 -CH20- -(CH2)b- 單鍵 環己基環 苯環 碳數1〜9之烷基 2 1 2-451 -CH20- -(CH2)b- 單鍵 環己基環 碳數之烷氧基 0 1 2-452 -CH20- -(CH2)b- 單鍵 環己基環 苯環 碳數1〜9之烷氧基 1 1 2-453 -CH20- -(CH2)b- 單鍵 環己基環 苯環 碳數1〜9之烷氧基 2 1 2-454 -CH20- -(CH2)b- 單鍵 環己基環 碳數1〜9之烷基 0 1 2-455 -CH20- -(CH2)b- 單鍵 環己基環 環己基環 碳數1〜9之烷基 1 1 2-456 -CH20- -(CH2)b- 單鍵 環己基環 環己基環 碳數1〜9之烷基 2 1 2-457 -CH20- -(CH2)b- 單鍵 環己基環 碳數1〜9之烷氧基 0 1 2-458 -CH20- -(CH2)b- 單鍵 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-459 -CH20- -(CH2)b- 單鍵 環己基環 環己基環 碳數1〜9之院氧基 2 1 2-460 -CH20- -(CH2)b- -0- 苯環 碳數1〜9之烷基 0 1 2-461 -CH20- -(CH2)b- -0- 苯環 苯環 碳數1〜9之烷基 1 1 2-462 -CH20- -(CH2)b- -0- 苯環 苯環 碳數1〜9之烷基 2 1 b爲1〜10之整數 201217433 〔表 25〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-463 -CH20- -(CH2)b- 苯環 碳數1〜9之烷氧基 0 1 2-464 -CH20- -(CH2)b- 苯環 苯環 碳數1〜9之烷氧基 1 1 2-465 -CH20- -(CH2)b- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-466 -CH20- -(CH2)b- 苯環 碳數1〜9之烷基 0 1 2-467 -CH20- -(CH2)b- -o- 苯環 環己基環 碳數1〜9之烷基 1 1 2-468 -CH20- -(CH2)b- -o- 苯環 環己基環 碳數1〜9之烷基 2 1 2-469 -CH20- -(CH2)b- -o- 苯壞 碳數1〜9之烷氧基 0 1 2-470 -CH20- -(CH2)b- -o- 苯環 環己基環 碳數1〜9之烷氧基 1 1 2-471 -CH20- -(CH2)b- -o- 苯環 環己基環 碳數1〜9之烷氧基 2 1 2-472 -CH20- -(CH2)b- 環己基環 碳數1〜9之烷基 0 1 2-473 -CH20- -(CH2)b- -o- 環己基環 苯環 碳數1~9之烷基 1 1 2-474 -CH20- -(CH2)b- -o- 環己基環 苯環 碳數1〜9之烷基 2 1 2-475 -CH20- -(CH2)b- -o- 環己基環 碳數1〜9之烷氧基 0 1 2-476 -CH20- -(CH2)b- -o- 環己基環 苯環： 碳數1〜9之烷氧基 1 1 2-477 -CH20- -(CH2)b- -o- 環己基環 苯環 碳數1~9之烷氧基 2 1 2-478 -CH20- -(CH2)b- -o- 環己基環 碳數1〜9之院基 0 1 2-479 -CH20- -(CH2)b- -o- 環己基環 環己基環 碳數1~9之烷基 1 1 2-480 -CH20- -(CH2)b- -o- 環己基環 環己基環 碳數1〜9之院基 2 1 2-481 -CH20- -(CH2)b- -o- 環己基環 碳數1〜9之烷氧基 0 1 2-482 -CH20- -(CH2)b- -o- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-483 -CH20- -(CH2)b- -o- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 b爲1〜10之整數 -45- 201217433 〔表 26〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-484 -CH20- -(CH2)b- -COO- 苯環 碳數卜9之烷基 0 1 2-485 -CH20- -(CH2)b- -coo- 苯環 苯環 碳數1〜9之烷基 1 1 2-486 -CH20- -(CH2)b- -coo- 苯環 苯環 碳數1〜9之烷基 2 1 2-487 -CH20- -(CH2)b- -coo- 苯環 碳數1〜9之烷氧基 0 1 2-488 -CH20- -(CH2)b- -coo- 苯環 苯環 碳數1〜9之院氧基 1 1 2-489 -CH20- -(CH2)b- -coo- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-490 -CH20- -(CH2)b- -coo- 苯環 碳數1〜9之烷基 0 1 2-491 -CH20- _(CH2)b- -coo- 苯環 環己基環 碳數1〜9之烷基 1 1 2-492 -CH20- -(CH2)b- -coo- 苯環 環己基環 碳數1〜9之院基 2 1 2-493 -CH20- -(CH2)b- -coo- 本壞 碳數1〜9之烷氧基 0 1 2-494 -CH20- -(CH2)b- -coo- 苯環 環己基環 碳數1~9之烷氧基 1 1 2-495 -CH20- -(CH2)b- -coo- 苯環 環己基環 碳數1~9之烷氧基 2 1 2-496 -CH20- -(CH2)b- -coo- 環己基環 碳數1〜9之烷基 0 1 2-497 -CH20- -(CH2)b- -coo- 環己基環 苯環 碳數1〜9之烷基 1 1 2-498 -CH20- -(CH2)b- -coo- 環己基環 苯環 碳數1〜9之烷基 2 1 2-499 -CH20- -(CH2)b- -coo- 環己基環 碳數1〜9之烷氧基 0 1 2-500 -CH20- -(CH2)b- -coo- 環己基環 苯環 碳數1~9之烷氧基 1 1 2-501 -CH20- _(CH2)b- -coo- 環己基環 苯環 碳數1〜9之院氧基 2 1 2-502 -CH20- -(CH2)b- -coo- 環己基環 碳數1〜9之烷基 0 1 2-503 -CH20- -(CH2)b- -COO- 環己基環 環己棊環 碳數1〜9之烷基 1 1 2-504 -CH20- -(CH2)b- -coo- 環己基環 環己基環 碳數1~9之烷基 2 1 b爲1〜1 0之整數Y6) [2] in }m In the formula [2], Y1 is a single bond, -(CH2) a- (a is an integer of 1 to 15), -0-, -CH20-, -COO- or OCO- . Among them, a single bond, -(CH2) a-(a is an integer of 1 to 15), -Ο-, -CH20- or COO- is preferred because it is easy to synthesize a side chain structure. More preferably, it is a single bond, -(CH2) a- (a is an integer of 1 to 10), -〇-, -CH20- or COO-. In the formula [2], Y2 is a single bond or (CH2)b- (b is an integer of 1 to 15). Among them, a single bond or (CH2) b- (b is an integer of 1 to 1 Å) is preferable. In the formula [2], Y3 is a single bond, -(CH2)c- (c is an integer of 15), -〇-, -CH20., -COO- or OCO-. Among them, single bond, -(CH2). - (c is an integer from 1 to 15), -〇-, -ch2〇-, -COO- or OCO- is easier to combine -21 - 201217433, so it is preferred. More preferably, it is a single bond, -(CH2)e-(c is an integer of 1 to 10), -0-, -CH20-, -COO- or OCO-0. In the formula [2], Y4 is selected from a benzene ring, a cyclic group in which a cyclohexane ring and a heterocyclic ring are grouped, and any hydrogen atom on the cyclic group ' may be an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, or carbon. The fluorine-containing alkyl group having 1 to 3, the fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom is substituted. Further, γ4 is an organic group having a carbon number of 12 to 25 of a steroid skeleton. Among them, a benzene ring, a cyclohexane ring or an organic group having a carbon number of 12 to 25 having a steroid skeleton is preferred. In the formula [2], Y5 is a cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring, and any hydrogen atom on the cyclic group may be a group having a carbon number of 33. The alkoxy group having 1 to 3 carbon atoms, the fluorine-containing alkyl group having 1 to 3 carbon atoms, the fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom is substituted. In the formula [2], η is an integer of 0 to 4. Preferably, it is an integer of 〇~2. In the formula [2], Υ6 is an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkoxy group having a carbon number of 18. Among them, an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 part carbon number, an alkoxy group having a carbon number of 18 or a fluorine-containing alkoxy group having 1 to 1 carbon number is preferable. More preferably, it is an alkyl group having 1 to 12 carbon atoms or an alkoxy group having 1 to 12 carbon atoms. More preferably, it is an alkyl group having 1 to 9 carbon atoms or an alkoxy group having 1 to 9 carbon atoms. In the formula [2], m is an integer of 1 to 4. Preferably, it is an integer of one. Preferred combinations of Υ1, Υ2, Υ3, Υ4, Υ5, Υ6, η and m in the formula [2] are shown in Tables 3 to 32. 201217433 [Table 3] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-1 One-touch single-button single-button ^5+:τ& Ocean: 3⁄4 Carbon number 1 to 9 alkyl 0 1 2-2 One-touch single-button single button Benzene ring benzene ring 1~9 alkyl 1 1 2-3 single bond single bond single bond benzene ring benzene ring carbon number 1~9 alkyl 2 1 2-4 single bond single bond single bond benzene ring carbon number 1 to 9 alkoxy 0 1 2-5 single bond single bond single bond benzene ring benzene ring carbon number 9 alkoxy group 1 1 2-6 single bond single bond single bond benzene ring benzene ring carbon number 1~9 Alkoxy 2 1 2-7 single bond single bond single bond benzene ring carbon number 1 to 9 alkyl 0 1 2-8 single bond single bond single bond benzene ring cyclohexyl ring carbon number 1 to 9 alkyl 1 1 2-9 single bond single bond single bond benzene ring cyclohexyl ring carbon number 1 to 9 alkyl 2 1 2-10 single bond single bond single bond lift carbon number 1 to 9 alkoxy 0 1 2-11 Single bond single bond single bond present ring cyclohexyl ring carbon number 1 to 9 oxime 1 1 2-12 single bond single bond single bond rate bad cyclohexyl ring carbon number 1 to 9 alkoxy 2 1 2-13 Single bond single bond single bond cyclohexyl ring carbon number 1 to 9 alkyl group 0 1 2-14 single bond single bond single bond cyclohexyl ring benzene ring carbon number 1 to 9 alkyl 1 1 2-15 Key single bond single bond cyclohexyl ring benzene ring carbon number 1 to 9 alkyl 2 1 2-16 single bond single bond single bond cyclohexyl ring carbon number 1 to 9 alkoxy 0 1 2-17 single bond single bond Mono-bonded cyclohexylcyclobenzene ring 1 to 9 alkoxy 1 1 2-18 single bond single bond single bond cyclohexyl ring benzene ring 1 to 9 alkoxy 2 1 2-19 single bond single bond Single bond cyclohexyl ring C 1~9 alkyl 0 1 2-20 single bond single bond single bond cyclohexyl cyclohexyl ring carbon number 1 to 9 alkyl 1 1 2-21 single bond single bond single bond ring Hexylcyclocyclohexylcycloalkyl group 1 to 9 alkyl 2 1 -23- 201217433 [Table 4] Y1 Y2 Y3 Y4 Υ5 Υ6 η m 2-22 single bond single bond single bond cyclohexyl ring carbon number 1 to 9 alkane Oxyl 0 1 2-23 single bond single bond single bond cyclohexyl cyclohexyl ring carbon number 1 to 9 alkoxy 1 1 2-24 single bond single bond single bond cyclohexyl cyclohexyl ring carbon number 1 to 9 Alkoxy 2 1 2-25 single bond single bond -(CH2)c- phenyl ring carbon number 1 to 9 alkyl group 0 1 2-26 single bond single bond -(CH2)c- benzene ring benzene ring carbon number 1 to 9 alkyl 1 1 2-27 single bond single bond -(CH2)c- phenyl ring benzene ring carbon number 1 to 9 alkyl 2 1 2-28 single bond single -(CH2)c- alkoxy group having 1 to 9 carbon atoms of benzene ring 0 1 2-29 single bond single bond -(CH2)c- benzene ring benzene ring alkoxy group having 1 to 9 carbon atoms 1 1 2-30 Single bond single bond -(CH2)c- phenyl ring benzene ring alkoxy group having 1 to 9 carbon atoms 2 1 2-31 single bond single bond -(CH2)c- alkyl group having 1 to 9 carbon atoms of benzene ring 0 1 2-32 single bond single bond -(CH2)c- 浑^cyclohexyl ring carbon number 1 to 9 alkyl 1 1 2-33 single bond single bond -(CH2)c- benzene ring cyclohexyl ring carbon number 1 ~9 alkyl 2 1 2-34 single bond single bond -(CH2)c- benzene ring carbon number 1 to 9 alkoxy group 0 1 2-35 single bond single bond -(CH2)c- benzene ring cyclohexyl Alkoxy group having 1 to 9 ring carbon atoms 1 1 2-36 single bond single bond -(CH2)c- benzene ring cyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 2-37 single bond single bond - ( CH2)c-cyclohexylcycloalkyl 1 to 9 alkyl 0 1 2-38 single bond single bond -(CH2)c-cyclohexylcyclobenzene ring 1 to 9 alkyl 1 1 2-39 single bond Single bond-(CH2)c-cyclohexylcyclobenzene ring C 1~9 alkyl 2 1 2-40 single bond single bond -(CH2)c-cyclohexyl ring carbon number 1~9 alkoxy 0 1 2-41 single bond single bond -(CH2)c- cyclohexyl ring benzene ring alkoxy group 1 to 9 alkoxy 1 1 2-42 single bond single bond _(CH2 C-cyclohexylcyclobenzene ring alkoxy group having a carbon number of 1 to 9 2 1 c is an integer of 1 to 10 201217433 [Table 5] Y1 Y2 Y3 Y4 Y5 Υ6 η m 2-43 Single bond single bond - (CH2) C-cyclohexylcycloalkyl 1 to 9 alkyl 0 1 2-44 single bond single bond -(CH2)c-cyclohexylcyclohexyl ring carbon number 1 to 9 alkyl 1 1 2-45 single bond single Bond-(CH2)c-cyclohexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 2 1 2-46 single bond single bond -(CH2)c-cyclohexyl ring 1 to 9 alkoxy group 0 1 2-47 single bond single bond -(CH2)c-cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 1 1 2-48 single bond single bond -(CH2)c-cyclohexylcyclocyclohexyl ring carbon Number 1 to 9 alkoxy 2 1 2-49 single bond single bond-0- phenyl ring carbon number 1 to 9 alkyl 0 1 2-50 single bond single bond-0-benzene ring benzene ring carbon number 1~ 9 alkyl 1 1 2-51 single bond single bond -o- phenyl ring benzene ring carbon number 1 to 9 alkyl 2 1 2-52 single bond single bond-0- benzene ring carbon number 1~9 alkoxy Base 0 1 2-53 single bond single bond-0- benzene ring benzene ring 1 to 9 alkoxy 1 1 2-54 single bond single bond-0- benzene ring benzene ring carbon number 1 to 9 alkoxy Base 2 1 2-55 single bond single bond-0- benzene ring carbon number 1~9 Alkyl 0 1 2-56 single bond single bond-0-benzene ring cyclohexyl ring alkyl group 1 to 9 alkyl 1 1 2-57 single bond single bond benzene ring cyclohexyl ring carbon number 1 to 9 alkyl 2 1 2-58 Single button single bond-0- phenyl ring carbon number 1 to 9 oxime 0 1 2-59 single bond single bond-0-benzene ring cyclohexyl ring carbon number 1 to 9 alkoxy 1 1 2-60 single bond single bond -o- benzene ring τεβ-Π Gan group field alkoxy group having 1 to 9 carbon atoms 2 1 2-61 single bond single bond-0-cyclohexyl ring carbon number 1 to 9 alkyl group 0 1 2-62 single bond single bond -o- cyclohexyl ring tea ring carbon number 1 to 9 alkyl 1 1 2-63 single bond single bond-0-cyclohexyl ring benzene ring carbon number 1 to 9 alkyl 2 1 c is an integer from 1 to 1 0 - 201217433 [Table 6] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-64 Single bond single bond-0-cyclohexyl ring carbon number 1 to 9 alkoxy group 0 1 2-65 single bond single bond-0-cyclohexyl ring benzene ring 1 to 9 alkoxy 1 1 2-66 single bond single bond cyclohexyl ring benzene ring 1 to 9 alkoxy 2 1 2 -67 single bond single bond-0-cyclohexyl ring carbon number 1 to 9 alkyl group 0 1 2-68 single bond single bond-0-cyclohexylcyclocyclohexyl ring carbon number 1 to 9 alkyl 1 1 2- 69 One-touch single button -0- Cyclohexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 2 1 2-70 single bond single bond-0-cyclohexyl ring carbon number 1 to 9 alkoxy 0 1 2-71 single bond single bond-0- Cyclohexylcyclocyclohexylcycloalkyl 1 to 2 alkoxy 1 1 2-72 single bond single bond-0-cyclohexylcyclohexyl ring carbon number 1 to 9 alkoxy 2 1 2-73 single bond Bond-CH20- phenyl ring carbon number 1 to 9 alkyl group 0 1 2-74 single bond single bond -CH20- phenyl ring benzene ring carbon number 1 to 9 alkyl 1 1 2-75 single bond single bond -CH20- Benzene ring benzene ring 1 to 9 alkyl 2 1 2-76 single bond single bond -CH20- benzene ring carbon number 1 to 9 alkoxy 0 1 2-77 single bond single bond -CH20- benzene ring benzene Alkoxy group having 1 to 9 ring carbon number 1 1 2-78 single bond single bond -CH20- phenyl ring benzene ring alkoxy group having 1 to 9 carbon atoms 2 1 2-79 single bond single bond -CH20- benzene ring carbon Number 1 to 9 alkyl 0 1 2-80 single bond single bond -CH20- benzene ring cyclohexyl ring carbon number 1 to 9 alkyl 1 1 2-81 single bond single bond -CH20- benzene ring cyclohexyl ring carbon Number 1 to 9 alkyl 2 1 2-82 single bond single bond -CH20- benzene ring carbon number 1 to 9 alkoxy group 0 1 2-83 single bond single bond -CH20- benzene ring cyclohexyl ring carbon number 1 ~9 alkoxy 1 1 2-84 single bond single bond -CH20- benzene ring cyclohexyl ring carbon number 1 to 9 alkoxy 2 1 -26 201217433 [Table 7] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-85 single bond single bond -CH20-cyclohexylcycloalkyl 1 to 9 alkyl 0 1 2-86 single bond single bond -CH20- cyclohexylcyclobenzene ring carbon number 9 alkyl 1 1 2-87 single bond single bond -CH20- Cyclohexyl ring benzene ring 1 to 9 carbon number 2 1 2-88 single bond single bond -CH20- cyclohexyl ring carbon number 1 to 9 alkoxy.  0 1 2-89 single bond single bond -CH20- cyclohexyl ring benzene ring 1 to 9 alkoxy 1 1 2-90 single bond single bond -CH20- cyclohexyl ring benzene ring carbon number 9 alkoxy Base 2 1 2-91 single bond single bond -CH20- cyclohexyl ring carbon number 1 to 9 alkyl group 0 1 2-92 single bond single bond -CH20- cyclohexyl cyclocyclohexyl ring carbon number 1 to 9 alkyl group 1 1 2-93 single bond single bond -CH20- cyclohexylcyclocyclohexyl ring carbon number 9 alkyl 2 1 2-94 single bond single bond -CH20- cyclohexyl ring carbon number 1 to 9 alkoxy 0 1 2-95 single bond single bond -CH20- cyclohexyl cyclohexyl ring carbon number 1 to 9 alkoxy group 1 1 2-96 single bond single bond -CH20- cyclohexylcyclocyclohexyl ring carbon number 1 to 9 Alkoxy 2 1 2-97 single bond single bond -COO- acknowledgment carbon number 1 to 9 alkyl 0 1 2-98 single bond single bond -COO- phenyl ring benzene ring carbon number 1 to 9 alkyl 1 1 2-99 single bond single bond -COO- phenyl ring benzene ring carbon number 9 alkyl 2 1 2-100 single bond single bond -COO- benzene ring carbon number 1~9 alkoxy 0 1 2-101 Single-button single bond-COO- phenyl ring benzene ring alkoxy group 1 to 9 1-102 2-102 single bond single bond -COO- benzene ring benzene ring carbon number 1 to 9 alkoxy 2 1 2-103 single Single bond-COO- This group has a carbon number of 1 to 9 alkyl 0 1 2-104 Single bond single bond -COO- Benzene ring cyclohexyl ring C 1~9 alkyl 1 1 2-105 Single bond single bond -coo - Benzene ring isa-1, gangrene sag, carbon number 1 to 9 alkyl 2 1 -27- 201217433 [Table 8] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-106 single bond single bond -COO- benzene ring carbon Number 1 to 9 alkoxy 0 1 2-107 single bond single bond -COO- benzene ring cyclohexyl ring 1 to 9 alkoxy 1 1 2-108 single bond single bond -COO-benzene ring cyclohexyl Alkoxy group having a ring carbon number of 1 to 9 2 1 2-109 single bond single bond -coo-cyclohexyl ring alkyl group having 1 to 9 carbon atoms 0 1 2-110 single bond single bond -coo-cyclohexylcyclobenzene ring Alkyl group having a carbon number of 1 to 9 1 1 2-111 single bond single bond -coo-cyclohexyl ring benzene ring alkyl group having 1 to 9 carbon atoms 1 1 2-112 single bond single bond -coo- cyclohexyl ring carbon number 1 to 9 alkoxy 0 1 2-113 single bond single bond -coo- cyclohexyl ring benzene ring 1 to 9 alkoxy 1 1 2-114 single bond single bond -coo-cyclohexylcyclobenzene ring Alkoxy group having 1 to 9 carbon atoms 2 1 2-115 single bond single bond -coo-cyclohexyl ring alkyl group having 1 to 9 carbon atoms 0 1 2-116 single bond single bond -coo-cyclohexyl ring Hexyl ring carbon number 1 to 9 of the hospital base 1 1 2-117 single bond single bond -coo- cyclohexyl cyclohexyl ring carbon number 1 to 9 alkyl 2 1 2-118 single bond single bond -coo-cyclohexyl Alkoxy group having a ring carbon number of 1 to 9 0 1 2-119 single bond single bond -coo-cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 1 1 2-120 single bond single bond -coo- ring Hexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 2-121 single bond single bond -OCO- phenyl ring carbon number 1 to 9 alkyl group 0 1 2-122 single bond single bond -OCO-benzene ring Benzene ring carbon number 1-9 alkyl 1 1 2-123 single bond single bond -OCO- phenyl ring benzene ring carbon number 1 to 9 alkyl 2 1 2-124 single bond single bond -OCO- benzene ring carbon number 1 to 9 alkoxy 0 1 2-125 single bond single bond -OCO- benzene ring benzene ring 1 to 9 alkoxy 1 1 2-126 single bond single bond -OCO- benzene ring benzene ring carbon number 1 to 9 alkoxy 2 1 s -28- 201217433 [Table 9] Y1 Y2 Υ3 Υ4 Y5 Y6 η m 2-127 Single bond single bond-OCO- phenyl ring carbon number 1 to 9 alkyl 0 1 2- 128 single bond single bond -OCO- benzene ring cyclohexyl ring carbon number 1 to 9 alkyl 1 1 2-129 single bond single bond -OCO- this bad cyclohexyl ring carbon number 1~9 alkyl 2 1 2- 130 Key single bond -OCO- benzene ring carbon number 1 to 9 alkoxy 0 1 2-131 single bond single bond -OCO- benzene ring cyclohexyl ring carbon number 1~9 of the hospitaloxy 1 1 2-132 single bond Single bond-OCO- phenylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 2-133 single bond single bond -OCO-cyclohexyl ring carbon number 1 to 9 alkyl group 0 1 2-134 single bond single Bond-OCO-cyclohexylcyclobenzene ring 1 to 9 alkyl 1 1 2-135 single bond single bond -OCO-cyclohexylcyclobenzene ring 1 to 9 alkyl 2 1 2-136 single bond bond-OCO-cyclohexyl ring carbon number 9 alkoxy group 0 1 2-137 single bond single bond -OCO- cyclohexyl ring benzene ring alkoxy group 1 to 9 alkoxy 1 1 2-138 single bond single bond -OCO-cyclohexyl ring rMrisa alkoxy group having 1 to 9 carbon atoms 2 1 2-139 single bond single bond -OCO-cyclohexyl ring alkyl group having 1 to 9 carbon atoms 0 1 2-140 single bond single bond -OCO-cyclohexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 1 1 2-141 single bond single bond -OCO-cyclohexylcyclohexyl ring carbon number 1 to 9 alkyl 2 1 2-142 single bond Single bond-OCO-cyclohexyl ring alkoxy group having a carbon number of 1 to 9 0 1 2-143 single bond single bond -OCO-cyclohexylcyclocyclohexyl ring carbon number 1 to 9 alkane Base 1 1 2-144 single bond single bond -OCO-cyclohexylcyclohexyl ring carbon number 1 to 9 alkoxy 2 1 2-145 _(CH2)a- single bond-0-benzene ring carbon number 1~ 9 alkyl group 0 1 2-146 -(CH2)a- single bond-0- benzene ring tea field carbon number 1~9 alkyl 1 1 2-147 _(CH2)a- single bond-0-benzene ring Benzene ring carbon number 1 to 9 alkyl 2 1 a is 1 to 1 0 integer -29 - 201217433 [Table ι] Y1 Y2 Y3 Y4 Υ5 Υ6 η m 2-148 -(CH2)a- single bond-0 - alkoxy group having 1 to 9 carbon atoms of benzene ring 0 1 2-149 -(CH2)a- single bond-0- alkoxy group having 1 to 9 carbon atoms of benzene ring benzene ring 1 1 2-150 -(CH2) A- single bond-0-benzene ring benzene ring alkoxy group 1 to 9 2 2 2-151 -(CH2)a- single bond-0- phenyl ring carbon number 1~9 of the yard base 0 1 2- 152 -(CH2)a- single bond-0-benzene ring cyclohexyl ring alkyl group 1 to 9 alkyl 1 1 2-153 -(CH2)a- single bond-0-benzene ring cyclohexyl ring carbon number 1~ 9 yard base 2 1 2-154 -(CH2)a- single bond-0- benzene ring carbon number 1~9 alkoxy 0 1 2-155 -(CH2)a- single bond-0-benzene ring Alkoxy group having a hexyl ring carbon number of 1 to 9 1 1 2-156 -(CH2)a-mono bond-0-benzene ring cyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 2-157 -(CH2) A- single key-0 - a cyclohexyl ring having 1 to 9 carbon atoms. 0 1 2-158 -(CH2)a- single bond-0-cyclohexylcyclobenzene ring 1 to 9 alkyl 1 1 2-159 -(CH2) A-mono-bond-0-cyclohexylcyclobenzene ring 1 to 9 alkyl 2 1 2-160 -(CH2)a- single bond-0-cyclohexyl ring 1 to 9 alkoxy group 0 1 2-161 -(CH2)a- single bond-0-cyclohexylcyclobenzene ring alkoxy group having 1 to 9 carbon atoms 1 1 2-162 -(CH2)a- single bond-0- -1 gansin ρ Ω · bad Alkoxy group having 1 to 9 carbon atoms in the benzene ring 2 1 2-163 -(CH2)a-mono bond-0-cyclohexyl ring 1 to 9 alkyl group 0 1 2-164 -(CH2) A-mono-bond-0-cyclohexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 1 1 2-165 -(CH2)a- single bond-0-cyclohexylcyclocyclohexylcyclocarbon number 1 to 9 alkane Base 2 1 2-166 -(CH2)a- single bond-0-cyclohexyl ring alkoxy group having 1 to 9 carbon atoms 0 1 2-167 -(CH2)a- single bond-0-cyclohexylcyclohexyl Alkoxy group having 1 to 9 ring carbon atoms 1 1 2-168 -(CH2)a-mono bond-0-cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 a is an integer of 1 to 10 -30- 201217433 [Table 11] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-169 -(CH2)a- Single bond-COO- The base of the benzene ring carbon number 1~9 0 1 2-170 -(CH2)a- single bond-COO- phenyl ring benzene ring alkyl group 1~9 alkyl 1 1 2-171 -(CH2)a- single bond-COO- benzene ring benzene ring carbon number 1 to 9 alkyl 2 1 2-172 -(CH2)a- single bond -COO- benzene ring alkoxy group having 1 to 9 carbon atoms 0 1 2-173 -(CH2)a- single bond-COO-benzene Cycloalkyl ring 1 to 9 alkoxy 1 1 2-174 -(CH2)a- single bond-coo- benzene ring benzene ring alkoxy group 1 to 9 2 1 2-175 -(CH2) a-monobond-COO-alkyl group having 1 to 9 carbon atoms of phenyl ring 0 1 2-176 -(CH2)a- single bond-COO- phenylcyclocyclohexyl ring 1 to 9 alkyl group 1 1 2- 177 -(CH2)a- single bond-coo- phenylcyclohexyl ring carbon number 1 to 9 alkyl 2 1 2-178 -(CH2)a- single bond-coo- tea ring carbon number 1 to 9 alkane Oxyl 0 1 2-179 -(CH2)a- single bond-coo- phenylcyclocyclohexyl ring 1 to 9 oxime 1 1 2-180 -(CH2)a- single bond-coo- benzene ring Cyclohexyl ring 1 to 9 alkoxy 2 1 2-181 -(CH2)a- single bond-coo- cyclohexyl ring 1 to 9 of the yard base 0 1 2-182 -(CH2)a- Single bond-COO-cyclohexyl ring zfefcTsa.  The alkyl group having a bad carbon number of 1 to 9 1 1 2-183 -(CH2)a- single bond-COO-cyclohexylcyclobenzene ring having 1 to 9 carbon atoms 2 1 2-184 -(CH2)a- Single bond-coo-cyclohexyl ring alkoxy group having a carbon number of 1 to 9 0 1 2-185 -(CH2)a- single bond-coo- cyclohexyl ring benzene ring 1 to 9 of alkoxy 1 1 2 -186 -(CH2)a- Single bond-coo- Cyclohexyl ring phenyl ring Alkoxy group of 1 to 9 carbon 2 1 2-187 -(CH2)a- Single bond-coo- Cyclohexyl ring carbon number 1~ 9 yard base 0 1 2-188 -(CH2)a- single bond-coo- cyclohexylcyclocyclohexyl ring alkyl group 1 to 9 alkyl 1 1 2-189 -(CH2)a- single bond-COO- Cyclohexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 2 1 a is an integer from 1 to 10 -31 - 201217433 [Table 12] Y1 Y2 Y3 Y4 Υ5 Υ6 η m 2-190 -(CH2)a- Single bond -COO-cyclohexyl ring alkoxy group having 1 to 9 carbon atoms. 0 1 2-191 -(CH2)a- single bond-COO-cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 1 1 2- 192 -(CH2)a- single bond-COO-cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 2-193 -(CH2)a- single bond-OCO- benzene ring carbon number 1 to 9 The base of the hospital 0 1 2-194 -(CH2)a- single bond-OCO- benzene bad benzene ring alkyl 1~9 alkyl 1 1 2-1 95 -(CH2)a- single bond-OCO- phenyl ring benzene ring alkyl group 1 to 9 2 2 2-196 -(CH2)a- single bond-OCO- benzene ring carbon number 1~9 alkoxy Base 0 1 2-197 -(CH2)a- single bond-OCO- phenyl ring benzene ring alkoxy group 1 to 9 2-198 -(CH2)a- single bond-OCO- benzene ring benzene ring Alkoxy group having 1 to 9 carbon atoms 2 1 2-199 -(CH2)a-monobond-OCO-alkyl group having 1 to 9 carbon atoms of phenyl ring 0 1 2-200 -(CH2)a- single bond-OCO - Benzene cyclohexyl ring carbon 1 to 9 alkyl 1 1 2-201 -(CH2)a- single bond -OCO- phenylcyclohexyl ring carbon number 1 to 9 alkyl 2 1 2-202 - ( CH2)a- Single bond-OCO- Alkoxy group of benzene ring carbon number 1~9 0 1 2-203 -(CH2)a- Single bond-OCO- Alkoxy group of benzene ring cyclohexyl ring carbon number 1~9 1 1 2-204 -(CH2)a- Single bond-OCO- phenylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 2-205 -(CH2)a- single bond-OCO-cyclohexyl ring carbon Number 1 to 9 alkyl 0 1 2-206 -(CH2)a- single bond-OCO-cyclohexylcyclobenzene ring 1 to 9 alkyl 1 1 2-207 -(CH2)a- single bond- OCO-cyclohexylcyclobenzene ring alkyl 1 to 9 alkyl 2 1 2-208 -(CH2)a- single bond-OCO-cyclohexyl ring alkoxy group 1 to 9 alkoxy 0 1 2-209 - ( CH2)a- Bond-OCO-cyclohexylcyclobenzene ring alkoxy group having 1 to 9 carbon atoms 1 1 2-210 -(CH2)a- single bond-OCO-cyclohexylcyclobenzene ring alkoxy group having 1 to 9 carbon number 2 1 a is an integer from 1 to 10 - 32 - 201217433 [Table 13] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-211 -(CH2)a- Single bond-0C0- Alkyl group having a carbon number of 1 to 9 1 2-212 -(CH2)a- single bond-0C0-cyclohexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 1 1 2-213 -(CH2)a- single bond-0C0-cyclohexylcyclohexyl Alkyl group having a ring carbon number of 1 to 9 2 1 2-214 -(CH2)a-mono bond-0C0-cyclohexyl ring alkoxy group having 1 to 9 carbon atoms 0 1 2-215 -(CH2)a- single bond -0C0-cyclohexylcyclocyclohexyl ring 1 to 9 of alkoxy 1 1 2-216 -(CH2)a- single bond-0C0-cyclohexylcyclocyclohexyl ring 1 to 9 alkoxy 2 1 2-217 -0- single bond-(CH2)c- phenyl ring carbon number 1 to 9 alkyl group 0 1 2-218 -0- single bond -(CH2)c- benzene ring benzene ring carbon number 1~9 Alkyl 1 1 2-219 -0-monobond-(CH2)c- phenyl ring phenyl ring alkyl 1 to 9 alkyl 2 1 2-220 -0- single bond-(CH2)c- phenyl ring carbon Alkoxy group number 1 to 9 0 1 2-221 -0- single bond -(CH2)c- benzene ring benzene ring alkoxy group having 1 to 9 carbon atoms 1 1 2-222 Single bond-(CH2)c- phenyl ring benzene ring 1 to 9 oxime 2 1 2-223 -0- single bond-(CH2)c- phenyl ring carbon number 1 to 9 alkyl 0 1 2 -224 -0- Single bond-(CH2)c- phenylcyclocyclohexyl ring Alkyl group 1 to 9 1 1 2-225 -0- Single bond-(CH2)c- Benzene cyclohexyl ring carbon number 1 ～Alkyl 2 1 2-226 -0- Single bond-(CH2)c- Alkoxy group of benzene ring carbon number 1 to 9 0 1 2-227 -0- Single bond-(CH2)c- Ben bad Cyclohexyl ring Alkoxy group having 1 to 9 carbon atoms 1 1 2-228 -0- Single bond -(CH2)c- Benzene cyclohexyl ring Alkoxy group having 1 to 9 carbon atoms 2 1 2-229 -0- Mono-bond-(CH2)c-cyclohexyl ring, carbon number 1 to 9, 0 1 2-230 -0-, single bond-(CH2)c-cyclohexylcyclobenzene ring, alkyl group 1 to 9, 1 1 2-231 -0- Single bond-(CH2)c- Cyclohexyl ring phenyl ring Alkyl group 1 to 9 2 1 a, c is independently an integer from 1 to 10 -33- 201217433 [Table 14] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-232 -0- single bond-(CH2)c- cyclohexyl ring carbon number 1~9 of the oxy group 0 1 2-233 -0- single bond-(CH2)c- ring Alkyl benzene ring 1 to 9 alkoxy 1 1 2-234 -0- single bond -(CH2)c-cyclohexylcyclobenzene ring 1 to 9 alkoxy 2 1 2-235 -0 - a single bond -(CH2)c-cyclohexylcycloalkyl group 1 to 9 alkyl group 0 1 2-236 -0- single bond-(CH2)c-cyclohexylcyclocyclohexyl ring carbon number 1 to 9 alkyl group 1 1 2-237 -0- single bond-(CH2)c- cyclohexylcyclocyclohexyl ring 1 to 9 of the group 2 1 2-238 -0- single bond-(CH2)c-cyclohexyl ring carbon Alkoxy group number 1 to 9 0 1 2-239 -0- single bond -(CH2)c-cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 1 1 2-240 -0- single bond - (CH2)c-cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 2-241 -0- single bond-CH20- alkoxy group having 1 to 9 carbon atoms of benzene ring 0 1 2-242 - 0-monobond-CH20- phenyl ring benzene ring alkoxy group 1 to 9 alkoxy 1 1 2-243 -0- single bond-CH20- phenyl ring benzene ring alkoxy group 1 to 9 2 1 2- 244 -0- single bond-CH20- phenyl ring carbon number 1 to 9 alkyl group 0 1 2-245 -0- single bond -CH20- phenyl ring benzene ring carbon number 1 to 9 alkyl 1 1 2-246 - 0- single bond-CH20- phenyl ring benzene ring alkyl group 1~9 alkyl 2 1 2-247 -0- single bond-CH20- benzene ring carbon number 1~9 alkoxy 0 1 2-248 -0 - Single bond-CH20- Benzene cyclohexyl ring carbon number 1 to 9 alkoxy group 1 1 2-249 -0- Single bond -CH20- phenylcyclohexyl ring Number 1 to 9 alkoxy 2 1 2-250 -0- single bond -CH20- phenyl ring carbon number 1 to 9 alkyl group 0 1 2-251 -0- single bond -CH20- benzene ring cyclohexyl ring carbon Number 1 to 9 alkyl 1 1 2-252 -0- single bond -CH20- phenylcyclocyclohexyl ring C 1~9 alkyl 2 1 c is an integer from 1 to 10 -34 201217433 [Table 15] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-253 -0- Single bond-CH20- Alkoxy group of benzene ring carbon number 1 to 9 0 1 2-254 -0- Single bond-CH20- Benzene ring cyclohexyl ring carbon number 1 ~9 alkoxy 1 1 2-255 -0- single bond -CH20- phenylcyclocyclohexyl ring 1 to 9 alkoxy 2 1 2-256 -0- single bond -CH20- cyclohexyl ring carbon Number 1~9 alkyl 0 1 2-257 -0- single bond-CH20- cyclohexyl ring benzene ring alkyl 1~9 alkyl 1 1 2-258 -0- single bond-CH20- cyclohexyl cyclic benzene Alkyl group having a ring carbon number of 1 to 9 2 1 2-259 -0- Single bond -CH20- Alkoxy group having a carbon number of 1 to 9 of a cyclohexyl ring 0 1 2-260 -0- Single bond-CH20-Cyclohexyl ring Benzene ring carbon number 1-9 alkoxy group 1 1 2-261 -0- single bond-CH20- cyclohexyl ring benzene ring alkoxy group having 1 to 9 carbon atoms 2 1 2-262 -0- single bond-CH20 - a cyclohexyl ring having 1 to 9 carbon atoms. 0 1 2-263 single bond -CH20- ring Base ring cyclohexyl ring C 1~9 alkyl 1 1 2-264 -0- single bond -CH20- cyclohexyl cyclohexyl ring carbon number 1~9 of the base 2 1 2-265 -0- single bond -CH20-cyclohexyl ring alkoxy group having 1 to 9 carbon atoms 0 1 2-266 -0- single bond-CH20-cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 1 1 2-267 single bond -CH20-cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 2-268 -CH20- single bond -(CH2)c- alkyl group having 1 to 9 carbon atoms of phenyl ring 0 1 2-269 - CH20- single bond-(CH2)c- phenyl ring benzene ring carbon number b 9 yard base 1 1 2-270 -CH20- single bond -(CH2)c- phenyl ring benzene ring carbon number 1~9 alkyl 2 1 2-271 -CH20- single bond-(CH2)c- alkoxy group having 1 to 9 carbon atoms of benzene ring 0 1 2-272 -CH20- single bond-(CH2)c- benzene ring benzene ring carbon number 1~ 9 alkoxy 1 1 2-273 -CH20- single bond -(CH2)c- benzene ring benzene ring alkoxy group 1 to 9 2 1 c is 1~1 0 integer -35- 201217433 [Table 16] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-274 -CH20- Single bond-(CH2)c- Alkyl group having 1 to 9 carbon atoms of phenyl ring 0 1 2-275 -CH20- Single bond-(CH2)c- Benzene cyclohexyl ring carbon 1 to 9 alkyl 1 1 2-276 -CH20- single bond -(CH2)c-benzene ring Base ring carbon number 1 to 9 alkyl 2 1 2-277 -CH20- single bond -(CH2)c- benzene ring carbon number 1 to 9 alkoxy group 0 1 2-278 -CH20- single bond - (CH2 C- phenylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 1 1 2-279 -CH20-monobond-(CH2)c- benzene ring cyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 2 -280 -CH20- Single bond-(CH2)c- Cyclohexyl ring C 1~9 alkyl 0 1 2-281 -CH20- Single bond-(CH2)c- Cyclohexyl ring benzene ring Carbon number 1~9 Alkyl 1 1 2-282 -CH20-monobond-(CH2)c-cyclohexylcyclobenzene ring 1 to 9 alkyl 2 1 2-283 -CH20-monobond-(CH2)c-cyclohexyl Alkoxy group having a ring carbon number of 1 to 9 0 1 2-284 -CH20-monobond-(CH2)c-cyclohexylcyclobenzene ring alkoxy group having 1 to 9 carbon atoms 1 1 2-285 -CH20- single bond -(CH2)c-cyclohexylcyclobenzene ring alkoxy group having 1 to 9 carbon atoms 2 1 2-286 -CH20-monobond-(CH2)c-cyclohexyl ring alkyl group having 1 to 9 carbon atoms 0 1 2 -287 -CH20- Single bond-(CH2)c-cyclohexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 1 1 2-288 -CH20- single bond-(CH2)c-cyclohexylcyclohexylcyclocarbon Alkyloxy group having 1 to 9 alkyl groups 2 1 2-289 -CH20-monobond-(CH2)c-cyclohexyl ring having 1 to 9 carbon atoms 0 1 2-290 -CH20- Single bond-(CH2)c-cyclohexylcyclocyclohexyl ring Alkoxy group having 1 to 9 carbon atoms 1 1 2-291 -CH20- Single bond-(CH2)c-cyclohexyl ring Cyclohexyl ring 1 to 9 alkoxy 2 1 2-292 -CH20- single bond -CH20- phenyl ring 1 to 9 alkyl 0 1 2-293 -CH20- single bond-CH20- benzene ring Alkyl group having 1 to 9 carbon atoms of phenyl ring 1 1 2-294 -CH20- Single bond -CH20- Alkyl group having 1 to 9 carbon atoms of benzene ring benzene ring 1 1 C is an integer of 1 to 10 - 36 - 201217433 [Table 17] Y1 Y2 Υ3 Υ4 Υ5 Υ6 η m 2-295 -CH20- single bond-CH20- alkoxy group of benzene ring carbon number 1 to 9 0 1 2-296 -CH20- single bond-CH20- benzene ring benzene ring carbon Number 1 to 9 alkoxy 1 1 2-297 -CH20- single bond -CH20- phenyl ring benzene ring alkoxy group 1 to 9 2 2 2-298 -CH20- single bond -CH20- benzene ring carbon Alkyl 9 alkyl 2- 1 2-299 -CH20- single bond-CH20- phenylcyclocyclohexyl ring 1 to 9 alkyl 1 1 2-300 -CH20- single bond-CH20- phenylcyclohexyl ring Alkyl group with a carbon number of 1 to 9 2 1 2-301 -CH20- Single bond -CH20- Alkyl group having a carbon number of 1 to 9 of a benzene ring 0 1 2-302 -CH20- Single bond-CH20- Benzene cyclohexyl ring Alkoxy group having 1 to 9 carbon atoms 1 1 2-303 -CH20- single bond-CH20- phenylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 2-304 -CH20- single bond-CH20- cyclohexyl ring carbon number 1 to 9 alkyl group 0 1 2- 305 -CH20- Single bond-CH20- Cyclohexyl ring phenyl ring Alkyl group 1 to 9 1 1 2-306 -CH20- Single bond-CH20- Cyclohexyl ring benzene ring C 1~9 alkyl 2 1 2-307 -CH20- Single bond-CH20- Cyclohexyl ring Alkoxy group having 1 to 9 carbon atoms 0 1 2-308 -CH20- Single bond-CH20- Cyclohexyl ring benzene ring Alkoxy group having 1 to 9 carbon atoms 1 1 2-309 -CH20- single bond-CH20- cyclohexyl ring benzene ring alkoxy group having 1 to 9 carbon atoms 2 1 2-310 -CH20- single bond -CH20- cyclohexyl ring carbon number 1 1 2-311 -CH20- single bond-CH20-cyclohexylcyclocyclohexyl ring carbon number 9 alkyl 1 1 2-312 -CH20- single bond-CH20- cyclohexylcyclocyclohexyl ring carbon number 1~9 House base 2 1 2-313 -CH20- single bond -CH20- cyclohexyl ring carbon number 1 to 9 alkoxy group 0 1 2-314 -CH20- single bond -CH20- cyclohexylcyclocyclohexyl ring carbon number 1~ 9 alkoxy 1 1 2-315 -CH20- single bond -CH20-cyclohexyl ring IS-I χ θ · bad C ring ring 1 to 9 alkoxy 2 1 -37- 201217433 [Table 18] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-316 -COO- Single bond-(CH2)c- Alkyl group having 1 to 9 carbon atoms of phenyl ring 0 1 2-317 -COO- Single bond-(CH2)c- benzene ring benzene ring carbon Number 1 to 9 alkyl 1 1 2-318 -COO- single bond -(CH2)c- phenyl ring benzene ring alkyl 1 to 9 alkyl 2 1 2-319 -COO- single bond -(CH2)c - alkoxy group having a benzene ring number of 1 to 9 0 1 2-320 -COO- single bond -(CH2)c- benzene ring benzene ring alkoxy group having 1 to 9 carbon atoms 1 1 2-321 -COO- single Bond-(CH2)c- phenyl ring benzene ring alkoxy group having 1 to 9 carbon atoms 2 1 2-322 -COO- single bond -(CH2)c- phenyl ring carbon number 1 to 9 alkyl group 0 1 2- 323 -coo- single bond-(CH2)c- phenylcyclocyclohexyl ring 1 to 9 alkyl 1 1 2-324 -coo- single bond-(CH2)c- benzene ring cyclohexyl ring carbon number 1~ 9 alkyl 2 1 2-325 -coo- single bond-(CH2)c- alkoxy having 1 to 9 carbon atoms of phenyl ring 0 1 2-326 -coo- single bond-(CH2)c-benzene ring Alkoxy group having 1 to 9 carbon atoms in the hexyl ring 1 1 2-327 -coo-monobond-(CH2)c- alkoxy group having 1 to 9 carbon atoms in the benzene ring cyclohexyl group 2 1 2-328 -coo- Key-(CH2)c-cyclohexylcycloalkyl 1 to 9 alkyl 0 1 2-329 -coo- single bond-(CH2)c-cyclohexylcyclobenzene ring 1 to 9 alkyl 1 1 2 -330 -coo - a single bond -(CH2)c-cyclohexylcyclobenzene ring 1 to 9 alkyl 2 1 2-331 -coo- single bond-(CH2)c-cyclohexyl ring 1 to 9 alkoxy group 0 1 2-332 -coo- single bond-(CH2)c-cyclohexyl ring tea bad alkoxy group 1 to 9 alkoxy 1 1 2-333 -coo- single bond-(CH2)c-cyclohexylcyclobenzene Alkoxy group having a ring carbon number of 1 to 9 2 1 2-334 -coo-mono bond-(CH2)c-cyclohexyl ring alkyl group having 1 to 9 carbon atoms 0 1 2-335 -coo- single bond-(CH2 C-cyclohexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 1 1 2-336 -coo- single bond-(CH2)c-cyclohexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 2 1 c An integer from 1 to 10 -38- 201217433 [Table 19] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-337 -COO- Single bond-(CH2)c- Cyclohexyl ring Alkoxy group having 1 to 9 carbon atoms 1 2-338 -coo- Single bond-(CH2)c- rm-t Glycol O-ring cyclohexyl ring Alkoxy group having 1 to 9 carbon atoms 1 1 2-339 -coo- Single bond-(CH2)c - cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 2-340 -coo- single bond-CH20- alkyl group having 1 to 9 carbon atoms of phenyl ring 0 1 2-341 -coo- single bond- CH20- phenyl ring benzene ring alkyl 1 to 9 alkyl 1 1 2-342 -coo- single bond-CH20- phenyl ring benzene ring The number of carbon atoms 1 to 9 is 2 1 2-343 -COO- single bond -CH20- alkoxy group having 1 to 9 carbon atoms of benzene ring 0 1 2-344 -COO- single bond-CH20- benzene ring benzene ring carbon Number 1-9 alkoxy 1 1 2-345 -coo- single bond-CH20- phenyl ring benzene ring alkoxy group 1 to 9 2 2 2-346 -coo- single bond-CH20- benzene ring carbon Number 1-9 alkyl 0 1 2-347 -coo- single bond-CH20- phenylcyclocyclohexyl ring 1 to 9 alkyl 1 1 2-348 -coo- single bond-CH20- phenylcyclohexene Alkyl group having a carbon number of 1 to 9 2 1 2-349 -COO- Single bond-CH20- Thin: alkoxy group having a bad carbon number of 1 to 9 0 1 2-350 -coo- single bond-CH20-benzene ring Alkoxy group having 1 to 9 carbon atoms in the hexyl ring 1 1 2-351 -COO- single bond -CH20- alkoxy group having 1 to 9 carbon atoms in the lower ring hexyl ring 2 1 2-352 -coo- single bond-CH20 - Cyclohexyl ring carbon number 1 to 9 院 0 1 2-353 -COO- single bond -CH20- cyclohexyl ring benzene ring 1 to 9 alkyl 1 1 2-354 -COO- single bond -CH20 - a cyclohexylcyclobenzene ring having 1 to 9 carbon atoms 2 1 2-355 -coo- single bond-CH20-cyclohexyl ring carbon number 1 to 9 alkoxy group 0 1 2-356 -coo- single bond- CH20-cyclohexylcyclobenzene ring alkoxy group 1 to 9 alkoxy 1 1 2-357 -coo- Single bond-CH20-cyclohexylcyclobenzene ring Alkoxy group having a carbon number of 1 to 9 2 1 c is an integer of 1 to 10 - 39 - 201217433 [Table 20] Y1 Y2 Y3 Y4 Y5 Υ6 η m 2-358 -COO- Single bond-CH20-Cyclohexyl ring C 1~9 alkyl 0 1 2-359 -coo- Single bond-CH20- Cyclohexyl cyclohexyl ring C 1~9 alkyl 1 1 2-360 -coo - single bond-CH20-cyclohexylcyclocyclohexyl ring alkyl 1 to 9 alkyl 2 1 2-361 -coo- single bond-CH20- cyclohexyl ring carbon number 1 to 9 oxime 0 1 2-362 -coo- single bond-CH20-cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 1 1 2-363 -coo- single bond-CH20-cyclohexylcyclohexyl ring carbon number 1 to 9 alkoxy Base 2 1 2-364 -0- -(CH2)b- -0- alkyl group having 1 to 9 carbon atoms of phenyl ring 0 1 2-365 -0- -(CH2)b- -0- benzene ring benzene ring carbon Number 1 to 9 alkyl 1 1 2-366 -0- -(CH2)b- -0- phenyl ring benzene ring alkyl 1 to 9 alkyl 2 1 2-367 -0- -(CH2)b- -0- phenyl ring carbon number 1 to 9 oxime 0 1 2-368 -0- -(CH2)b- -0- phenyl ring oxime bad carbon number 1 to 9 alkoxy 1 1 2-369 - 0- -(CH2)b- -0- phenyl ring benzene ring alkoxy group 1 to 9 2 2 2-370 -0- -(CH2)b- -0- benzene ring carbon number 1 Alkyl group of 9 0 1 2-371 -0- -(CH2)b- -0- phenyl ring cyclohexyl ring carbon number 1 1 2-372 -0- -(CH2)b- -0- benzene ring Cyclohexyl ring C 1~9 alkyl 2 1 2-373 -0- -(CH2)b- -0- phenyl ring 1 to 9 alkoxy 0 1 2-374 -0- -(CH2 B- -0- phenylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 1 1 2-375 -0- -(CH2)b- -0- benzene ring cyclohexyl ring alkoxy group having 1 to 9 carbon atoms Base 2 1 2-376 -0- -(CH2)b- -0-cyclohexylcycloalkyl 1 to 9 alkyl 0 1 2-377 -0- -(CH2)b- -0-cyclohexylcyclobenzene Alkyl group having 1 to 9 ring carbon number 1 1 2-378 -0- -(CH2)b- -0- Cyclohexyl ring phenyl ring 1 to 9 of the group 2 1 b is an integer of 1 to 10 -40 - 201217433 [Table 21] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-379 -0- -(CH2)b- -0- Cyclohexyl ring Alkoxy group having 1 to 9 carbon atoms 0 1 2-380 -0- - (CH2)b- -0-cyclohexyl ring present % alkoxy group having 1 to 9 carbon atoms 1 1 2-381 -0- -(CH2)b- -0- cyclohexyl ring benzene ring carbon number 1 to 9 Alkoxy 2 1 2-382 -0- -(CH2)b- -0-cyclohexylcycloalkyl 1 to 9 alkyl 0 1 2-383 -(CH2)b- -0-cyclohexylcyclohexyl The base of the ring carbon number 1~9 1 1 2-384 -(CH2)b- -0- ring Base ring cyclohexyl ring C 1~9 alkyl 2 1 2-385 -0- -(CH2)b- -0- cyclohexyl ring 1 to 9 alkoxy 0 1 2-386 -(CH2 B- -0-cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 1 1 2-387 -(CH2)b- -0-cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 2-388 -(CH2)b- -coo- The base of the benzene ring carbon number 1~9 0 1 2-389 -(CH2)b- -coo- The benzene ring is a bad carbon number 1~9 alkyl group 1 1 2-390 -0- -(CH2)b- -coo- phenyl ring 1 to 9 alkyl 2 1 2-391 -0- -(CH2)b- -coo- benzene ring carbon number 1~ 9 alkoxy 0 1 2-392 -(CH2)b- -coo- benzene ring benzene ring alkoxy group 1 to 9 1 1 2-393 -(CH2)b- -coo- benzene ring benzene ring Alkyl groups having a carbon number of 1 to 9 2 2 2-394 -(CH2)b- -coo- A phenyl ring having a carbon number of 1 to 9 0 1 2-395 -(CH2)b- -coo- benzene ring The base of the hexyl ring carbon number 1 to 9 1 1 2-396 -(CH2)b- -coo- phenylcyclohexyl ring carbon number 1 to 9 of the yard base 2 1 2-397 -0- -(CH2)b - -coo- alkoxy group having a benzene ring number of 1 to 9 0 1 2-398 -(CH2)b- -coo- benzene ring cyclohexyl ring carbon number 9 alkoxy group 1 1 2-399 -(CH2 ) b- -coo- benzene cyclohexyl ring carbon 1 to 9 alkoxy 2 1 b is an integer from 1 to 10 -41 - 201217433 [Table 22] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-400 -(CH2)b- -COO- Cyclohexyl ring carbon number 1 ～9 alkyl 0 1 2-401 -(CH2)b- -coo- cyclohexylcyclobenzene ring 1 to 9 alkyl 1 1 2-402 -0- -(CH2)b- -coo- ring Alkyl ring benzene ring 1 to 9 carbon 2 1 2-403 -0- -(CH2)b- -coo- cyclohexyl ring alkoxy group 1 to 9 alkoxy 0 1 2-404 -(CH2) B--coo-cyclohexylcyclobenzene ring 1 to 9 decyloxy 1 1 2-405 -0- -(CH2)b- -coo- cyclohexylcyclobenzene ring 1 to 9 alkoxy group 2 1 2-406 -(CH2)b- -coo- cyclohexylcycloalkyl 1 to 9 alkyl 0 1 2-407 -0- -(CH2)b- -coo- cyclohexylcyclohexyl ring carbon number 1 to 9 alkyl 1 1 2-408 -(CH2)b- -coo- cyclohexylcyclohexyl ring carbon number 1 to 9 of the hospital base 2 1 2-409 -0- -(CH2)b- -coo - alkoxy group having 1 to 9 carbon atoms of cyclohexyl ring 0 1 2-410 -0- -(CH2)b- -coo- cyclohexylcyclocyclohexyl carbon number 9 alkoxy group 1 1 2-411 - (CH2)b--coo-cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 2-412 -(CH2)b- -oco- alkyl group having 1 to 9 carbon atoms of benzene ring 0 1 2-413 -0- -(CH2)b- -oco- phenyl ring benzene ring 1 to 9 of the yard base 1 1 2-414 -0- -(CH2)b- -oco- benzene ring benzene ring carbon number 1~9 alkyl 2 1 2-415 -(CH2)b- -oco- alkoxy group having a benzene ring number of 1 to 9 0 1 2-416 -(CH2)b- -oco- benzene ring benzene ring carbon Number 1-9 alkoxy 1 1 2-417 -0- -(CH2)b- -oco- phenyl ring benzene ring alkoxy group 1 to 9 2 2 2-418 -0- -(CH2) B- -oco- phenyl ring carbon number 1-9 alkyl 0 1 2-419 -0- -(CH2)b- -oco- phenylcyclocyclohexyl ring 1 to 9 alkyl 1 1 2-420 -0- -(CH2)b- -oco- phenylcyclohexyl ring carbon number 9 alkyl 2 1 b is an integer from 1 to 10 -42 - 201217433 [Table 23] Y1 Y2 Y3 Y4 Y5 Y6 η m 2 -421 -0- -(CH2)b- -oco- alkoxy group having 1 to 9 carbon atoms of benzene ring 0 1 2-422 -0- -(CH2)b- -oco- phenylcyclohexylene II ring carbon number 1 to 9 alkoxy 1 1 2-423 -0- -(CH2)b- -OCO- phenylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 2-424 -0- -(CH2) B- -OCO-cyclohexyl ring carbon number 1~9 of the yard base 0 1 2-425 -0- -(CH2)b- -OCO- cyclohexyl ring soil carbon number 1~9 alkyl 1 1 2- 426 -0- -(CH2)b- -OCO- cyclohexylcyclobenzene ring 1 to 9 carbon 2 1 2-427 -0- -(CH2)b- -OCO- alkoxy group having 1 to 9 carbon atoms of cyclohexyl ring 0 1 2-428 -0- -(CH2)b- -OCO-cyclohexylcyclobenzene Alkoxy group having 1 to 9 ring carbon atoms 1 1 2-429 -0- -(CH2)b- -OCO- alkoxy group having 1 to 9 carbon atoms of cyclohexyl ring benzene ring 2 1 2-430 -0- - (CH2)b--oco-cyclohexyl ring 1 to 9 alkyl group 0 1 2-431 -0- -(CH2)b- -oco- cyclohexylcyclohexyl ring carbon number 1 to 9 1 1 2-432 -0- -(CH2)b- -oco- Cyclohexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 2 1 2-433 -0- _(CH2)b- -oco-cyclohexyl Alkoxy group having a ring carbon number of 1 to 9 0 1 2-434 -0- -(CH2)b- -oco-cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 1 1 2-435 -0- -(CH2)b-oco-cyclohexylcyclocyclohexylcycloalkoxy group having 1 to 9 carbon atoms 2 1 2-436 -CH20- -(CH2)b- a single bond phenyl ring having 1 to 9 carbon atoms 0 1 2-437 -CH20- -(CH2)b- single bond phenyl ring benzene ring alkyl 1~9 alkyl 1 1 2-438 -CH20- -(CH2)b- single bond benzene ring benzene ring carbon number 1 to 9 alkyl 2 1 2-439 -CH20- -(CH2)b- single bond benzene ring 1 to 9 alkoxy 0 1 2-440 -CH20- -(CH2)b- single bond benzene Alkoxy group having a ring number of benzene rings of 1 to 9 1 1 2-441 -CH20- -(CH2)b- single bond phenyl ring benzene ring alkoxy group 1 to 9 2 1 b is an integer of 1 to 10 -43- 201217433 [Table 24] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-442 -CH20- -(CH2)b- single bond phenyl ring carbon number 1~9 of the yard base 0 1 2-443 -CH20- -(CH2)b- single bond benzene ring cyclohexyl ring carbon Number 1 to 9 alkyl 1 1 2-444 -CH20- -(CH2)b- single bond phenylcyclohexyl ring carbon number 1 to 9 alkyl 2 1 2-445 -CH20- -(CH2)b- Single-bond benzene ring 1 to 9 alkoxy group 0 1 2-446 -CH20- -(CH2)b- single bond benzene ring cyclohexyl ring alkoxy group 1 to 9 alkoxy 1 1 2-447 -CH20 - -(CH2)b- single bond phenylcyclohexyl ring carbon number 1 to 9 alkoxy 2 1 2-448 -CH20- _(CH2)b- single bond cyclohexyl ring carbon number 1 to 9 alkyl 0 1 2-449 -CH20- -(CH2)b-monobonded cyclohexylcyclophenylene alkyl 1 to 9 alkyl 1 1 2-450 -CH20- -(CH2)b-monocyclic cyclohexylcyclobenzene ring Alkyl group having 1 to 9 carbon atoms 1 1 2-451 -CH20- -(CH2)b- alkoxy group having a single bond cyclohexyl ring carbon number 0 1 2-452 -CH20- -(CH2)b- single bond ring Hexylcyclobenzene ring 1 to 9 alkoxy 1 1 2-453 -CH20- -(CH2)b-monobonded cyclohexylcyclobenzene ring Number 1 to 9 alkoxy 2 1 2-454 -CH20- -(CH2)b-monobonded cyclohexylcycloalkyl 1 to 9 alkyl 0 1 2-455 -CH20- -(CH2)b- Cyclohexylcyclohexylcyclohexylcycloalkyl 1 to 9 alkyl 1 1 2-456 -CH20- -(CH2)b-monobonded cyclohexylcyclohexylcycloalkyl 1 to 9 alkyl 2 1 2-457 -CH20- -(CH2)b-monocyclic cyclohexyl ring alkoxy group having 1 to 9 carbon atoms 0 1 2-458 -CH20- -(CH2)b-monobonded cyclohexylcyclohexyl ring carbon number 1 to 9 Alkoxy 1 1 2-459 -CH20- -(CH2)b-monobonded cyclohexylcyclohexyl ring carbon number 1~9 of alkoxy 2 1 2-460 -CH20- -(CH2)b- - 0-Alkyl group having 1 to 9 carbon atoms of phenyl ring 0 1 2-461 -CH20- -(CH2)b- -0- Alkyl group having 1 to 9 carbon atoms of phenyl ring benzene ring 1 1 2-462 -CH20- - (CH2)b- -0- phenyl ring benzene ring C 1~9 alkyl 2 1 b is an integer from 1 to 10 201217433 [Table 25] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-463 -CH20- -( CH2)b- alkoxy group having a benzene ring carbon number of 1 to 9 0 1 2-464 -CH20- -(CH2)b- benzene ring benzene ring alkoxy group having 1 to 9 carbon atoms 1 1 2-465 -CH20- -(CH2)b- phenylcyclobenzene ring alkoxy group having 1 to 9 carbon atoms 2 1 2-466 -CH20- -(CH2)b-alkyl group having 1 to 9 carbon atoms 0 1 2-467 -CH20- -(CH2)b- -o- phenylcyclocyclohexylcycloalkyl 1 to 9 alkyl 1 1 2-468 -CH20- -(CH2)b- -o- benzene ring Alkyl group having a carbon number of 1 to 9 hexyl 2 1 2-469 -CH20- -(CH2)b- -o- alkoxy group having a benzene bad carbon number of 1 to 9 0 1 2-470 -CH20- -(CH2) B--o- phenylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 1 1 2-471 -CH20- -(CH2)b- -o- phenylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 2-472 -CH20- -(CH2)b-cyclohexylcycloalkyl 1 to 9 alkyl 0 1 2-473 -CH20- -(CH2)b- -o- cyclohexylcyclobenzene ring carbon number 1 ~9 alkyl 1 1 2-474 -CH20- -(CH2)b- -o- cyclohexylcyclobenzene ring 1 to 9 alkyl 2 1 2-475 -CH20- -(CH2)b- - O-cyclohexyl ring alkoxy group having 1 to 9 carbon atoms 0 1 2-476 -CH20- -(CH2)b- -o-cyclohexylcyclobenzene ring: alkoxy group having 1 to 9 carbon atoms 1 1 2- 477 -CH20- -(CH2)b- -o- cyclohexylcyclobenzene ring alkoxy group 1 to 9 2 2 2-478 -CH20- -(CH2)b- -o- cyclohexyl ring carbon number 1 0-9 2-479 -CH20- -(CH2)b- -o- cyclohexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 1 1 2-480 -CH20- -(CH2)b- -o- cyclohexylcyclocyclohexyl ring carbon number 1~9 2 1 2-481 -CH20- -(CH2)b- -o- alkoxy group having 1 to 9 carbon atoms of cyclohexyl ring 0 1 2-482 -CH20- -(CH2)b- -o-cyclohexyl ring Alkoxy group having 1 to 9 carbon atoms in the hexyl ring 1 1 2-483 -CH20- -(CH2)b- -o- alkoxy group having 1 to 9 carbon atoms in the cyclohexylcyclohexyl ring 2 1 b is 1 to 10 Integer-45- 201217433 [Table 26] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-484 -CH20- -(CH2)b- -COO- phenyl ring carbon number 9 alkyl 0 1 2-485 -CH20- -(CH2)b- -coo- phenyl ring phenyl ring alkyl 1 to 9 alkyl 1 1 2-486 -CH20- -(CH2)b- -coo- phenyl ring benzene ring carbon number 1 to 9 alkyl 2 1 2-487 -CH20- -(CH2)b- -coo- alkoxy group having 1 to 9 carbon atoms of phenyl ring 0 1 2-488 -CH20- -(CH2)b- -coo- benzene ring benzene ring carbon Number 1 to 9 of alkoxy 1 1 2-489 -CH20- -(CH2)b- -coo- phenyl ring benzene ring alkoxy group 1 to 9 2 1 2-490 -CH20- -(CH2) B- -coo- alkyl group having 1 to 9 carbon atoms of phenyl ring 0 1 2-491 -CH20- _(CH2)b- -coo- alkyl group having 1 to 9 carbon atoms of benzene ring cyclohexyl ring 1 1 2-492 -CH20- -(CH2)b- -coo- phenylcyclohexyl ring carbon number 1~9 of the hospital base 2 1 2-493 -CH20- -(CH2)b- -coo- the bad carbon number 1~9 Alkoxy 0 1 2-494 -CH20- -(CH2)b- -coo- phenylcyclocyclohexyl ring 1 to 9 alkoxy 1 1 2-495 -CH20- -(CH2)b- -coo- phenylcyclohexyl ring carbon number 1~9 Alkoxy 2 1 2-496 -CH20- -(CH2)b- -coo-cyclohexylcycloalkyl 1 to 9 alkyl 0 1 2-497 -CH20- -(CH2)b- -coo- ring Alkyl ring phenyl ring 1 to 9 alkyl 1 1 2-498 -CH20- -(CH2)b- -coo- cyclohexylcyclobenzene ring 1 to 9 alkyl 2 1 2-499 -CH20- -(CH2)b- -coo- alkoxy having 1 to 9 carbon atoms of cyclohexyl ring 0 1 2-500 -CH20- -(CH2)b- -coo- a cyclohexane ring having 1 to 9 carbon atoms Oxyl 1 1 2-501 -CH20- _(CH2)b- -coo- cyclohexylcyclophenyl ring 1 to 9 of alkoxy 2 1 2-502 -CH20- -(CH2)b- -coo- Cyclohexyl ring C 1~9 alkyl 0 1 2-503 -CH20- -(CH2)b- -COO- Cyclohexylcyclohexyl ring C 1~9 alkyl 1 1 2-504 -CH20 - -(CH2)b- -coo- Cyclohexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 2 1 b is an integer from 1 to 1 0

-46- 201217433 〔表 27〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-505 -CH20- -(CH2)b- -COO- 環己基環 碳數1〜9之烷氧基 0 1 2-506 -CH20- -(CH2)b- -coo- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-507 -CH20- -(CH2)b- -COO- 環己基環 環己基環 碳數1〜9之院氧基 2 1 2-508 -CH20- -(CH2)b- -oco- 苯環 碳數1〜9之烷基 0 1 2-509 -CH20- -(CH2)b- -oco- 苯環 苯環 碳數1〜9之烷基 1 1 2-510 -CH20- -(CH2)b- -oco- 苯環 苯環 碳數1〜9之烷基 2 1 2-511 -CH20- -(CH2)b- -oco- 苯環 碳數1〜9之院氧基 0 1 2-512 -CH20- -(CH2)b- -oco- 苯環 苯環 碳數1~9之烷氧基 1 1 2-513 -CH20- -(CH2)b- -oco- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-514 -CH20- -(CH2)b- -oco- 苯環 碳數1〜9之烷基 0 1 2-515 -CH20- -(CH2)b- -oco- 苯環 環己基環 碳數1〜9之院基 1 1 2-516 -CH20- -(CH2)b- -oco- 苯環 環己基環 碳數1〜9之烷基 2 1 2-517 -CH20- -(CH2)b- -oco- 苯環 碳數1〜9之烷氧基 0 1 2-518 -CH20- -(CH2)b- -oco- 苯環 環己基環 碳數1〜9之烷氧基 1 1 2-519 -CH20- -(CH2)b- -oco- 苯環 環己基環 碳數1〜9之院氧基 2 1 2-520 -CH20- -(CH2)b- -oco- 環己基環 碳數1〜9之院基 0 1 2-521 -CH20- -(CH2)b- -oco- 環己基環 苯環 碳數1〜9之烷基 1 1 2-522 -CH20- -(CH2)b- -oco- 環己基環 苯環 碳數1〜9之烷基 2 1 2-523 -CH20- -(CH2)b- -oco- 環己基環 碳數1〜9之烷氧基 0 1 2-524 -CH20- -(CH2)b- -oco- 環己基環 苯環 碳數1〜9之垸氧基 1 1 2-525 -CH20- -(CH2)b- -oco- 環己基環 苯環 碳數1〜9之烷氧基 2 1 b爲1〜10之整數 -47- 201217433 〔表 28〕 Y1 Y2 Y3 Y4 Y5 Y6 Π m 2-526 -CH20- -(CH2)b- -oco- 環己基環 碳數1〜9之烷基 0 1 2-527 -CH20- -(CH2)b- -OCO- 環己基環 環己基環 碳數1〜9之烷基 1 1 2-528 -CH20- -(CH2)b- -oco- 環己基環 環己基環 碳數1〜9之烷基 2 1 2-529 -CH20- -(CH2)b- -oco- 環己基環 碳數1〜9之烷氧基 0 1 2-530 -CH20- -(CH2)b- -oco- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-531 -CH20- -(CH2)b- -oco- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-532 -COO- -(CH2)b- -0- 苯環 碳數1~9之烷基 0 1 2-533 -COO- -(CH2)b- -0- 苯環 苯環 碳數1〜9之烷基 1 1 2-534 -COO- -(CH2)b- -0- 苯環 苯環 碳數1〜9之烷基 2 1 2-535 -COO- -(CH2)b- -0- 苯環 碳數1〜9之烷氧基 0 1 2-536 -COO- -(CH2)b- -0- 苯環 苯環 碳數1〜9之烷氧基 1 1 2-537 -COO- -(CH2)b- -0- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-538 -COO- -(CH2)b- -o- 苯環 碳數1〜9之院基 0 1 2-539 -COO- -(CH2)b- -0- 苯環 環己基環 碳數1〜9之烷基 1 1 2-540 -coo- -(CH2)b- -0- 苯環 環己基環 碳數1~9之烷基 2 1 2-541 -coo- -(CH2)b- -0- 苯環 碳數1〜9之烷氧基 0 1 2-542 -coo- -(CH2)b- -0- 苯環 環己基環 碳數1〜9之烷氧基 1 1 2-543 -coo- -(CH2)b- -0- 苯環 環己基環 碳數1~9之烷氧基 2 1 2-544 -coo- -(CH2)b- -0- 環己基環 碳數1~9之烷基 0 1 2-545 -coo- -(CH2)b- -0- 環己基環 苯環 碳數1〜9之烷基 1 1 2-546 -coo- -(CH2)b- -o- 環己基環 苯環 碳數1〜9之烷基 2 1 b爲1~10之整數-46- 201217433 [Table 27] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-505 -CH20- -(CH2)b- -COO- Cyclohexyl ring alkoxy group having 1 to 9 carbon atoms 0 1 2-506 -CH20 - -(CH2)b- -coo-cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 1 1 2-507 -CH20- -(CH2)b- -COO- cyclohexylcyclocyclohexyl ring carbon number 1 to 9 oxime 2 1 2-508 -CH20- -(CH2)b- -oco- phenyl ring alkyl 1 to 9 alkyl 0 1 2-509 -CH20- -(CH2)b- -oco - phenylcyclophenylene ring 1 to 9 alkyl 1 1 2-510 -CH20- -(CH2)b- -oco- phenyl ring benzene ring 1 to 9 alkyl 2 1 2-511 -CH20- -(CH2)b- -oco- phenyl ring carbon number 1 to 9 oxime 0 1 2-512 -CH20- -(CH2)b- -oco- phenyl ring benzene ring carbon number 1~9 alkoxy 1 1 2-513 -CH20- -(CH2)b- -oco- phenyl ring benzene ring alkoxy group 1 to 9 2 2 2-514 -CH20- -(CH2)b- -oco- benzene ring carbon Number 1 to 9 alkyl 0 1 2-515 -CH20- -(CH2)b- -oco- phenylcyclohexyl ring carbon number 1 to 9 of the hospital base 1 1 2-516 -CH20- -(CH2)b - -oco- phenylcyclocyclohexylcycloalkyl 1 to 9 alkyl 2 1 2-517 -CH20- -(CH2)b- -oco- phenyl ring 1 to 9 alkoxy 0 1 2-518 -CH20- -(CH2)b- -oco- benzene Cyclohexyl ring 1 to 9 alkoxy 1 1 2-519 -CH20- -(CH2)b- -oco- phenylcyclohexyl ring carbon number 1 to 9 alkoxy 2 1 2-520 -CH20 - -(CH2)b- -oco- Cyclohexyl ring having a carbon number of 1 to 9 0 1 2-521 -CH20- -(CH2)b- -oco- Cyclohexylcyclobenzene ring 1 to 9 alkane Base 1 1 2-522 -CH20- -(CH2)b- -oco-cyclohexylcyclobenzene ring 1 to 9 alkyl 2 1 2-523 -CH20- -(CH2)b- -oco- cyclohexyl Alkoxy group having a ring carbon number of 1 to 9 0 1 2-524 -CH20- -(CH2)b- -oco- a cyclohexyl ring benzene ring having a carbon number of 1 to 9 1 1 2-525 -CH20- - (CH2)b-oco-cyclohexylcyclobenzene ring alkoxy group having a carbon number of 1 to 9 2 1 b is an integer of 1 to 10 - 47 - 201217433 [Table 28] Y1 Y2 Y3 Y4 Y5 Y6 Π m 2-526 -CH20- -(CH2)b--oco-cyclohexylcycloalkyl 1 to 9 alkyl 0 1 2-527 -CH20- -(CH2)b- -OCO-cyclohexylcyclohexyl ring carbon number 1~ 9 alkyl 1 1 2-528 -CH20- -(CH2)b- -oco- cyclohexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 2 1 2-529 -CH20- -(CH2)b- - Oco-cyclohexyl ring alkoxy group having 1 to 9 carbon atoms 0 1 2-530 -CH20- -(CH2)b- -oco- cyclohexylcyclocyclohexyl ring carbon number 1 to 9 Alkoxy 1 1 2-531 -CH20- -(CH2)b- -oco-cyclohexylcyclocyclohexylcycloalkoxy group 1 to 9 alkoxy 2 1 2-532 -COO- -(CH2)b- - 0-Alkyl group having 1 to 9 carbon atoms of phenyl ring 0 1 2-533 -COO- -(CH2)b- -0- Alkyl group having 1 to 9 carbon atoms of phenyl ring benzene ring 1 1 2-534 -COO- - (CH2)b- -0- phenyl ring benzene ring alkyl group 1 to 9 2 2 2-535 -COO- -(CH2)b- -0- alkoxy group having 1 to 9 carbon atoms of benzene ring 0 1 2-536 -COO- -(CH2)b- -0- alkoxy group having 1 to 9 carbon atoms of benzene ring benzene ring 1 1 2-537 -COO- -(CH2)b- -0- benzene ring benzene ring carbon Number 1 to 9 alkoxy 2 1 2-538 -COO- -(CH2)b- -o- phenyl ring carbon number 1 to 9 yard base 0 1 2-539 -COO- -(CH2)b- - 0- phenylcyclocyclohexylcycloalkyl 1 to 9 alkyl 1 1 2-540 -coo- -(CH2)b- -0- phenylcyclohexylcyclocarbon 1 to 9 alkyl 2 1 2-541 -coo- -(CH2)b- -0- alkoxy group having 1 to 9 carbon atoms of phenyl ring 0 1 2-542 -coo- -(CH2)b- -0- phenylcyclohexyl ring carbon number 1~9 Alkoxy 1 1 2-543 -coo- -(CH2)b- -0- phenylcyclocyclohexylcycloalkane 1 to 9 alkoxy 2 1 2-544 -coo- -(CH2)b- - 0-cyclohexylcycloalkyl 1 to 9 alkyl 0 1 2-545 -coo- -(CH2)b- -0- cyclohexylcyclobenzene ring Number 1~9 alkyl group of 1 1 2-546 -coo- - (CH2) b- -o- benzene ring carbon atoms of 1~9 alkyl cyclohexyl 2 1 b is an integer of from 1 to 10

S -48- 201217433 〔表 29〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-547 -COO- -(CH2)b- -0- 環己基環 碳數1〜9之烷氧基 0 1 2-548 -COO- -(CH2)b- -0- 環己基環 碳數1〜9之烷氧基 1 1 2-549 -COO- -(CH2)b- -0- 環己基環 苯環 碳數1〜9之烷氧基 2 1 2-550 -COO- -(CH2)b- -0- 環己基環 碳數1〜9之院基 0 1 2-551 -coo- -(CH2)b- -0- 環己基環 環己基環 碳數1〜9之烷基 1 1 2-552 -COO- -(CH2)b- -0- 環己基環 環己基環 碳數1〜9之烷基 2 1 2-553 -coo- -(CH2)b- -0- 環己基環 碳數1〜9之烷氧基 0 1 2-554 -COO- -(CH2)b- -o- 環己基環 環己基環 碳數1~9之烷氧基 1 1 2-555 -coo- -(CH2)b- -0- 環己基環 im—I -η-is 壞C暴壞 碳數1〜9之烷氧基 2 1 2-556 -coo- -(CH2)b- -COO- 本壞 碳數1〜9之烷基 0 1 2-557 -COO- -(CH2)b- -coo- 苯環 苯環 碳數1〜9之烷基 1 1 2-558 -COO- -(CH2)b- -coo- 苯環 苯環 碳數1〜9之烷基 2 1 2-559 -coo- -(CH2)b- -coo- 苯環 碳數1〜9之烷氧基 0 1 2-560 -coo- -(CH2)b- -coo- 苯環 苯環 碳數1〜9之烷氧基 1 1 2-561 -COO- -(CH2)b- -COO- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-562 -COO- -(CH2)b- -coo- 苯環 碳數1〜9之烷基 0 1 2-563 -COO- -(CH2)b- -coo- zfefrTs. 本壞 環己基環 碳數1〜9之烷基 1 1 2-564 -coo- -(CH2)b- -coo- 苯環 環己基環 碳數1〜9之烷基 2 1 2-565 -COO- -(CH2)b- -COO- 苯環 碳數1〜9之烷氧基 0 1 2-566 -COO- -(CH2)b- -COO- 苯環 環己基環 碳數1~9之烷氧基 1 1 2-567 -COO- -(CH2)b- -coo- 苯環 環己基環 碳數1〜9之烷氧基 2 1 b爲1〜10之整數 -49- 201217433 〔表 3 0〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-568 -COO- _(CH2)b- -COO- 環己基環 碳數1〜9之烷基 0 1 2-569 -COO- -(CH2)b- -coo- 環己基環 苯環 碳數1〜9之烷基 1 1 2-570 -COO- -(CH2)b- -coo- 環己基環 苯環 碳數1〜9之院基 2 1 2-571 -COO- -(CH2)b- -coo- 環己基環 碳數1〜9之烷氧基 0 1 2-572 -COO- -(CH2)b- -coo- 環己基環 苯環 碳數1〜9之烷氧基 1 1 2-573 -COO- -(CH2)b- -coo- 環己基環 苯環 碳數1〜9之烷氧基 2 1 2-574 -COO- -(CH2)b- -coo- 環己基環 碳數1〜9之烷基 0 1 2-575 -COO- -(CH2)b- -coo- 環己基環 環己基環 碳數1〜9之烷基 1 1 2-576 -coo- -(CH2)b- -coo- 環己基環 環己基環 碳數1〜9之烷基 2 1 2-577 -coo- -(CH2)b- -coo- rm—1 甘:pa 壞C基壞 碳數1〜9之院氧基 0 1 2-578 -coo- -(CH2)b- -coo- 環己基環 環己基環 碳數1〜9之烷氧基 1 1 2-579 -coo- -(CH2)b- -coo- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-580 -coo- -(CH2)b- -oco- z+itrsa 本壞 碳數1〜9之烷基 0 1 2-581 -coo- -(CH2)b- -oco- 苯環 苯環 碳數1〜9之烷基 1 1 2-582 -coo- -(CH2)b- -oco- 苯環 本壞 碳數1〜9之烷基 2 1 2-583 -coo- -(CH2)b- -oco- 本環 碳數1〜9之烷氧基 0 1 2-584 -coo- -(CH2)b- -oco- 本壞 苯環 碳數1〜9之烷氧基 1 1 2-585 -coo- -(CH2)b- -oco- 苯環 苯環 碳數1〜9之烷氧基 2 1 2-586 -coo- -(CH2)b- -oco- 苯環 碳數1〜9之烷基 0 1 2-587 -coo- -(CH2)b- -oco- 苯環 環己基環 碳數1〜9之院基 1 1 2-588 -coo- -(CH2)b- -oco- 苯環 環己基環 碳數1〜9之烷基 2 1 b爲1〜10之整數 -50- 201217433 〔表 31〕 Y1 Y2 Y3 Y4 Υ5 Υ6 η m 2-589 -COO- -(CH2)b- -OCO- 苯環 碳數1〜9之烷氧基 0 1 2-590 -coo- -(CH2)b- -OCO- 苯環 環己基環 碳數1〜9之烷氧基 1 1 2-591 -coo- -(CH2)b- -OCO- 苯環 環己基環 碳數1〜9之院氧基 2 1 2-592 -coo- -(CH2)b- -OCO- 環己基環 碳數1〜9之烷基 0 1 2-593 -coo- -(CH2)b- -OCO- 環己基環 苯環 碳數1〜9之烷基 1 1 2-594 -coo- -(CH2)b- -OCO- 環己基環 苯環 碳數卜9之烷基 2 1 2-595 -coo- -(CH2)b- -OCO- 環己基環 碳數1〜9之院氧基 0 1 2-596 -coo- -(CH2)b- -OCO- 環己基環 苯環 碳數1〜9之烷氧基 1 1 2-597 -coo- -(CH2)b- -OCO- 環己基環 苯環 碳數1〜9之烷氧基 2 1 2-598 -coo- -(CH2)b- -OCO- 環己基環 碳數1〜9之烷基 0 1 2-599 -coo- -(CH2)b- -OCO- 環己基環 環己基環 碳數卜9之烷基 1 1 2-600 -coo- -(CH2)b- -OCO- 環己基環 環己基環 碳數1~9之烷基 2 1 2-601 -coo- -(CH2)b- -OCO- 環己基環 碳數卜9之烷氧基 0 1 2-602 -coo- -(CH2)b- -OCO- 環己基環 環己基環 碳數1〜9之院氧基 1 1 2-603 -coo- -(CH2)b- -OCO- 環己基環 環己基環 碳數1〜9之烷氧基 2 1 2-604 單鍵 單鍵 單鍵 具有膽固醇骨架 之碳數12〜25之 有機基 碳數1〜9之烷基 0 1 2-605 單鍵 單鍵 -(CH2)c- 具有膽固醇骨架 之碳數12~25之 有機基 碳數1〜9之烷基 0 1 2-606 單鍵 單鍵 -0- 具有膽固醇骨架 之碳數12〜25之 有機基 碳數1〜9之烷基 0 1 2-607 單鍵 單鍵 -CH20- 具有膽固醇骨架 之碳數12~25之 有機基 碳數1〜9之烷氧基 0 1 2-608 單鍵 單鍵 -COO- 具有膽固醇骨架 之碳數12〜25之 有機基 碳數1〜9之烷氧基 0 1 2-609 單鍵 單鍵 -OCO- 具有膽固醇骨架 之碳數12〜25之 有機基 碳數1~9之烷氧基 0 1 b，c係各自獨立爲1〜10之整數 -51 - 201217433 〔表 32〕 Y1 Y2 Y3 Y4 Y5 Y6 η m 2-610 單鍵 -(CH2)b- -0- 具有膽固醇骨架之 碳數12~25之有機基 碳數1〜9之烷基 0 1 2-611 單鍵 -(CH2)b- -coo- 具有膽固醇骨架之 碳數12〜25之有機基 碳數1〜9之烷氧 基 0 1 2-612 單鍵 -(CH2)b- -oco- 具有膽固醇骨架之 碳數12〜25之有機基 碳數1〜9之烷氧 基 0 1 2-613 -0- 單鍵 -(CH2)c- 具有膽固醇骨架之 碳數12〜25之有機基 碳數1〜9之烷基 0 1 2-614 -0- 單鍵 -CH20- 具有膽固醇骨架之 碳數12〜25之有機基 碳數1〜9之烷氧 基 0 1 2-615 -0- -(CH2)b- -0- 具有膽固醇骨架之 碳數12〜25之有機基 碳數1〜9之烷基 0 1 2-616 -(CH2)b- -coo- 具有膽固醇骨架之 碳數12~25之有機基 碳數1~9之烷氧 基 0 1 2-617 _(CH2)b- -oco- 具有膽固醇骨架之 碳數12〜25之有機基 碳數1〜9之烷氧 基 0 1 2-618 -CH20- 單鍵 -(CH2)c- 具有膽固醇骨架之 碳數12~25之有機基 碳數1〜9之烷基 0 1 2-619 -CH20- -(CH2)b- 單鍵 具有膽固醇骨架之 碳數12〜25之有機基 碳數1〜9之烷氧 基 0 1 2-620 -CH20- -(CH2)b- -0 具有膽固醇骨架之 碳數12〜25之有機基 碳數1~9之烷基 0 1 2-621 -CH20- -(CH2)b- -COO- 具有膽固醇骨架之 碳數12〜25之有機基 碳數1〜9之烷氧 基 0 1 2-622 -CH20- -(CH2)b- -OCO- 具有膽固醇骨架之 碳數12〜25之有機基 碳數1〜9之烷氧 基 0 1 2-623 -coo- 單鍵 單鍵 具有膽固醇骨架之 碳數12〜25之有機基 碳數1〜9之烷基 0 1 2-624 -coo- 單鍵 -(CH2)c- 具有膽固醇骨架之 碳數12〜25之有機基 碳數1〜9之烷基 0 1 2-625 -coo- -(CH2)b- 單鍵 具有膽固醇骨架之 碳數12〜25之有機基 碳數1〜9之烷氧 基 0 1 2-626 -coo- -(CH2)b- 具有膽固醇骨架之 碳數12〜25之有機基 碳數1〜9之烷基 0 1 2-627 -coo- -(CH2)b- -COO- 具有膽固醇骨架之 碳數12〜25之有機基 碳數1〜9之烷氧 基 0 1 2-628 -coo- -(CH2)b- -OCO- 具有膽固醇骨架之 碳數12〜25之有機基 碳數1~9之烷氧 基 0 1 b，c係各自獨立爲1〜10之整數 -52- 201217433 更具體而言，例如有下述式[2_1]〜式[2-31]表示之二 胺化合物。 [化 12]S -48- 201217433 [Table 29] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-547 -COO- -(CH2)b- -0- Cyclohexyl ring alkoxy group having 1 to 9 carbon atoms 0 1 2-548 - COO- -(CH2)b- -0-cyclohexyl ring alkoxy group having 1 to 9 carbon atoms 1 1 2-549 -COO- -(CH2)b- -0-cyclohexylcyclobenzene ring carbon number 1~9 Alkoxy 2 1 2-550 -COO- -(CH2)b- -0-cyclohexyl ring 1 to 9 of the yard base 0 1 2-551 -coo- -(CH2)b- -0- ring Hexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 1 1 2-552 -COO- -(CH2)b- -0-cyclohexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 2 1 2-553 - Coo- -(CH2)b- -0- alkoxy group having 1 to 9 carbon atoms of cyclohexyl ring 0 1 2-554 -COO- -(CH2)b- -o- cyclohexylcyclocyclohexyl ring carbon number 1~ 9 alkoxy 1 1 2-555 -coo- -(CH2)b- -0-cyclohexyl ring im-I -η-is bad C violent carbon number 1 to 9 alkoxy 2 1 2-556 -coo- -(CH2)b- -COO- The alkyl group having a bad carbon number of 1 to 9 0 1 2-557 -COO- -(CH2)b- -coo- benzene ring benzene ring carbon number 1 to 9 Base 1 1 2-558 -COO- -(CH2)b- -coo- phenyl ring phenyl ring alkyl 1 to 9 alkyl 2 1 2-559 -coo- -(CH2)b- -coo- phenyl ring carbon Number 1 to 9 alkoxy 0 1 2-560 -coo- -(CH2 ) b- -coo- phenyl ring benzene ring alkoxy group having 1 to 9 carbon atoms 1 1 2-561 -COO- -(CH2)b- -COO- alkoxy group having a benzene ring benzene ring number of 1 to 9 1 2-562 -COO- -(CH2)b- -coo- alkyl group having 1 to 9 carbon atoms of phenyl ring 0 1 2-563 -COO- -(CH2)b- -coo- zfefrTs. Alkyl group having 1 to 9 carbon atoms 1 1 2-564 -coo- -(CH2)b- -coo- phenylcyclocyclohexyl ring 1 to 9 alkyl group 2 1 2-565 -COO- -(CH2) B--COO- alkoxy group having a benzene ring carbon number of 1 to 9 0 1 2-566 -COO- -(CH2)b- -COO- benzene ring cyclohexyl ring alkoxy group having 1 to 9 carbon atoms 1 1 2 -567 -COO- -(CH2)b- -coo- Benzene cyclohexyl ring carbon number 1 to 9 alkoxy 2 1 b is an integer from 1 to 10 -49- 201217433 [Table 3 0] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-568 -COO- _(CH2)b- -COO- Cyclohexylcycloalkyl 1 to 9 alkyl 0 1 2-569 -COO- -(CH2)b- -coo-cyclohexyl ring Alkyl group having a benzene ring of 1 to 9 carbon atoms 1 1 2-570 -COO- -(CH2)b- -coo- Cyclohexyl ring benzene ring 1 to 9 of a group 2 1 2-571 -COO- -( CH2)b--coo-cyclohexyl ring alkoxy group having 1 to 9 carbon atoms 0 1 2-572 -COO- -(CH2)b- -coo- alkoxy group of a cyclohexylcyclobenzene ring having 1 to 9 carbon atoms 1 1 2-573 -COO- -(C H2)b--coo-cyclohexylcyclobenzene ring alkoxy group having 1 to 9 carbon atoms 2 1 2-574 -COO- -(CH2)b- -coo- alkyl group having 1 to 9 carbon atoms of cyclohexyl ring 1 2-575 -COO- -(CH2)b- -coo-cyclohexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 1 1 2-576 -coo- -(CH2)b- -coo- cyclohexyl ring Cyclohexyl ring C 1~9 alkyl 2 1 2-577 -coo- -(CH2)b- -coo- rm-1 G:pa bad C-based bad carbon number 1~9 of the hospitaloxy 0 1 2 -578 -coo- -(CH2)b- -coo-cyclohexylcyclocyclohexylcycloalkaloxy group 1 to 9 alkoxy 1 1 2-579 -coo- -(CH2)b- -coo- cyclohexyl ring Alkoxy group having a hexyl ring carbon number of 1 to 9 2 1 2-580 -coo- -(CH2)b- -oco- z+itrsa Alkyl group having a bad carbon number of 1 to 9 0 1 2-581 -coo- - (CH2)b- -oco- phenyl ring benzene ring alkyl 1 to 9 alkyl 1 1 2-582 -coo- -(CH2)b- -oco- benzene ring bad carbon number 1 to 9 alkyl 2 1 2-583 -coo- -(CH2)b- -oco- alkoxy group having 1 to 9 carbon atoms in the ring 0 1 2-584 -coo- -(CH2)b- -oco- carbon number of the bad benzene ring 1 to 9 alkoxy 1 1 2-585 -coo- -(CH2)b- -oco- phenyl ring benzene ring alkoxy group 1 to 9 2 2 2-586 -coo- -(CH2)b - -oco- phenyl ring carbon number 1 to 9 alkyl 0 1 2-587 -coo- -(CH2)b- -oco- phenylcyclohexyl ring carbon number 1~9 of the hospital base 1 1 2-588 -coo- -(CH2)b- -oco- benzene ring cyclohexyl ring Alkyl group having a carbon number of 1 to 9 2 1 b is an integer of 1 to 10 - 50 - 201217433 [Table 31] Y1 Y2 Y3 Y4 Υ5 Υ6 η m 2-589 -COO- -(CH2)b- -OCO- benzene ring Alkoxy group having a carbon number of 1 to 9 0 1 2-590 -coo- -(CH2)b- -OCO- alkoxy group having 1 to 9 carbon atoms of a benzene ring cyclohexyl ring 1 1 2-591 -coo- -( CH2)b--OCO- phenylcyclocyclohexyl ring carbon number 1~9 oxime 2 1 2-592 -coo- -(CH2)b- -OCO- cyclohexyl ring carbon number 1~9 alkyl 0 1 2-593 -coo- -(CH2)b- -OCO-cyclohexylcyclobenzene ring 1 to 9 alkyl 1 1 2-594 -coo- -(CH2)b- -OCO-cyclohexylcyclobenzene Cyclocarbon number 9 alkyl 2 1 2-595 -coo- -(CH2)b- -OCO- cyclohexyl ring carbon number 1 to 9 oxime 0 1 2-596 -coo- -(CH2)b - -OCO-cyclohexylcyclobenzene ring alkoxy group having 1 to 9 carbon atoms 1 1 2-597 -coo- -(CH2)b- -OCO- cyclohexylcyclobenzene ring alkoxy group having 1 to 9 carbon atoms 1 2-598 -coo- -(CH2)b- -OCO-cyclohexylcycloalkyl 1 to 9 alkyl 0 1 2-599 -coo- -(CH2)b- -OCO-cyclohexylcyclohexyl ring Carbon number 9 alkyl 1 1 2-600 -coo- -(CH2)b- -OCO-cyclohexylcyclocyclohexylcycloalkyl 1 to 9 alkyl 2 1 2-601 -coo- -(CH2)b- - OCO-cyclohexyl ring carbon number 9 alkoxy 0 1 2-602 -coo- -(CH2)b- -OCO- cyclohexylcyclohexyl ring carbon number 1~9 of alkoxy 1 1 2-603 -coo- -(CH2)b- -OCO-cyclohexylcyclocyclohexyl ring alkoxy group having 1 to 9 carbon atoms 2 1 2-604 single bond single bond single bond organic group having a carbon number of 12 to 25 of a cholesterol skeleton Alkyl group having a carbon number of 1 to 9 0 1 2-605 Single bond single bond -(CH2)c- Alkyl group having a carbon number of 12 to 25 having a cholesterol skeleton 1 to 9 alkyl group 0 1 2-606 A single bond Single bond-0-Alkyl group having a carbon number of 12 to 25 having a cholesterol skeleton of 1 to 9 alkyl group 0 1 2-607 Single bond single bond -CH20- Organic carbon having a carbon number of 12 to 25 of a cholesterol skeleton Number 1 to 9 alkoxy 0 1 2-608 single bond single bond -COO- having a carbon number of 12 to 25 of the cholesterol skeleton, an alkoxy group having 1 to 9 carbon atoms 0 1 2-609 single bond single bond -OCO- has an alkyl group having a carbon number of 12 to 25 and alkoxy group of 1 to 9 having a carbon number of 1 to 2, and c is each independently 1 to 10 -51 - 201217433 [Table 32] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-610 Single bond-(CH2)b- -0- The alkyl group having a carbon number of 12 to 25 having a cholesterol skeleton of 1 to 9 0 1 2-611 Single bond-(CH2)b- -coo- Alkoxy group having a carbon number of 12 to 25 having a cholesterol skeleton of 1 to 9 0 1 2-612 Single bond -(CH2)b- -oco- Alkoxy group having a carbon number of 12 to 25 with a cholesterol skeleton of 1 to 9 and alkoxy group 0 1 2-613 -0- Single bond -(CH2)c- having a carbon number of 12 to 25 of a cholesterol skeleton Organic group C 1~9 alkyl 0 1 2-614 -0- Single bond -CH20- Alkyloxy group having a carbon number of 12 to 25 having a cholesterol skeleton of 1 to 9 0 1 2-615 - 0- -(CH2)b- -0- an alkyl group having a carbon number of 12 to 25 having a cholesterol skeleton of 1 to 9 0 1 2-616 -(CH2)b- -coo- a carbon having a cholesterol skeleton Number 12 to 25 organic group carbon number 1 to 9 alkoxy group 0 1 2-617 _(CH2)b- -oco- having a carbon number of 12 to 25 of the cholesterol skeleton, an alkoxy group having 1 to 9 carbon atoms Base 0 1 2-618 -CH20- Single bond -(CH2)c- Alkyl group having 1 to 9 carbon atoms having a carbon number of 12 to 25 having a cholesterol skeleton 0 1 2-619 -CH20- -(CH2)b- a single bond having a carbon number of 12 to 25 of the cholesterol skeleton, an alkoxy group having 1 to 9 carbon atoms, 0 1 2-620 -CH20- -(CH2)b- - 0 has an alkyl group having a carbon number of 12 to 25 in the cholesterol skeleton, and an alkyl group having 1 to 9 carbon atoms. 0 1 2-621 -CH20- -(CH2)b- -COO- an organic group having a carbon number of 12 to 25 in a cholesterol skeleton Alkoxy group having a carbon number of 1 to 9 0 1 2-622 -CH20- -(CH2)b- -OCO- an alkoxy group having a carbon number of 12 to 25 having a cholesterol skeleton of 1 to 9 0 1 2 -623 -coo- One-button single bond having a carbon number of 12 to 25 of the cholesterol skeleton, an alkyl group having 1 to 9 carbon atoms. 0 1 2-624 -coo- Single bond-(CH2)c- Carbon having a cholesterol skeleton Number 12 to 25 of an organic alkyl group having 1 to 9 alkyl groups 0 1 2-625 -coo- -(CH2)b- a single bond having a carbon number of 12 to 25 carbon atoms of the cholesterol skeleton 1 to 9 Oxyl 0 1 2-626 -coo- -(CH2)b- having an alkyl group having a carbon number of 12 to 25 and having an alkyl group of 1 to 9 carbon atoms 0 1 2-627 -coo- -(CH2)b- -COO- having a carbon number of 12 to 25 of the cholesterol skeleton, an alkoxy group having 1 to 9 carbon atoms, 0 1 2-628 -coo- -(CH2)b- -OCO- having a cholesterol The alcohol group has a carbon number of 12 to 25, an organic group carbon number of 1 to 9 alkoxy group 0 1 b, and c is each independently an integer of 1 to 10 - 52 - 201217433 More specifically, for example, the following formula [2_1 a diamine compound represented by the formula [2-31]. [化 12]

(R5 係表示-〇-、-〇CH2-、-CH20-、-COOCH2 -或-CH2OCO-，R6係碳數1~22之烷基、烷氧基、含氟烷基或含 氣院氧基）。 -53- 201217433 [化 13](R5 represents -〇-, -〇CH2-, -CH20-, -COOCH2 - or -CH2OCO-, R6 is an alkyl group having 1 to 22 carbon atoms, an alkoxy group, a fluorine-containing alkyl group or a gas-containing alkoxy group ). -53- 201217433 [Chem. 13]

(R7係表示-COO-、-OCO-、-CONH-、 COOCH2-、-CH2OCO-、-CH20-、-OCH2-或-CH(R7 represents -COO-, -OCO-, -CONH-, COOCH2-, -CH2OCO-, -CH20-, -OCH2- or -CH

碳數1〜22之烷基、烷氧基、含氟烷基或含氟烷IAlkyl, alkoxy, fluoroalkyl or fluoroalkane having 1 to 22 carbon atoms

[化 14] NHCO-、--，R8係係 基）。[Chem. 14] NHCO-, --,, R8 system).

[2-8] (R9 係表示-COO-、-OCO-、-CONH-、 COOCH2- ' -CH2OCO- ' -CH2O- ' -OCH2- ' -CH NH-，R1Q係表示氟基、氰基、三氟甲烷基、硝^ 、甲醯基、乙醯基、乙醯氧基或羥基）。 NHCO-、-2* ' - Ο -或_ S、偶氮基[2-8] (R9 represents -COO-, -OCO-, -CONH-, COOCH2- '-CH2OCO- '-CH2O- ' -OCH2- ' -CH NH-, R1Q is a fluorine group, a cyano group, Trifluoromethyl, nitrate, formazan, ethenyl, ethoxylated or hydroxy). NHCO-, -2* ' - Ο - or _ S, azo

S -54- 201217433 [化 15]S -54- 201217433 [Chem. 15]

11 [2-9] [2-10] (R11係碳數3~12之烷基，1，4_環己烯之順式-反式異 構係各自爲反式異構物）。 [化16]11 [2-9] [2-10] (R11 is an alkyl group having 3 to 12 carbon atoms, and a cis-trans isomer of 1,4_cyclohexene is a trans isomer). [Chemistry 16]

R12 [2-12] (R12係碳數3~12之烷基’ 1,4 -環己烯之順式-反式異 構係各自爲反式異構物）。 [化 17]R12 [2-12] (R12 is an alkyl group having 3 to 12 carbon atoms) The cis-trans isomers of 1,4 -cyclohexene are each a trans isomer). [Chem. 17]

HjN NH,HjN NH,

(C H2)ar A1-(C H2)a2-A2-A3 [2-13] (A4係可被氟原子取代之碳數3~20之烷基’ A3係i，4_ 伸環己烯基或1，4 -伸苯基。A2係氧原子或-C Ο Ο - * (但是附 -55- 201217433 「*」之連結鍵與A3鍵結），A1係氧原子或-COO-* (但是 附「*」之連結鍵與（CH2 ) a2 )鍵結）。又，31係0或1之 整數，a2係2〜10之整數，a3係0或1之整數）。(C H2)ar A1-(C H2)a2-A2-A3 [2-13] (A4 is an alkyl group having 3 to 20 carbon atoms which may be substituted by a fluorine atom) A3 is an i,4_cyclohexene group or 1,4 -phenylene. A2 oxygen atom or -C Ο Ο - * (but with -55- 201217433 "*" linkage and A3 linkage), A1 oxygen atom or -COO-* (but attached The "*" link is linked to (CH2) a2). Further, 31 is an integer of 0 or 1, and a2 is an integer of 2 to 10, and a3 is an integer of 0 or 1.

SS

[化 18][Chem. 18]

-56- 201217433 [化 19]-56- 201217433 [Chem. 19]

57- 201217433 [化 20] nh757- 201217433 [化20] nh7

S -58- 201217433S -58- 201217433

[化2U NH,[2U NH,

59- 201217433 [化 22]59- 201217433 [Chem. 22]

其中特定側鏈型二胺化合物較佳爲式[2-式[2-9]~式[2-31]表示之化合物。特佳爲式[2 式[2-9]〜式[2-12]、式[2-15]、式[2-16]、式 23]表示之化合物。 本發明中，在不影響本發明之效果的範 定側鏈型二胺化合物以外之其他的二胺化合 爲其他二胺化合物）作爲二胺化合物使用。 -60- 1]〜式[2-6]或 1 ]〜式[2-6]、 2-22]或式[2- 目內’可將特 3 (以下也稱 C具體例如下 201217433 述。 對-苯二胺、2,3,5,6-四甲基-對-苯二胺、2,5-二甲基-對-苯二胺、間-苯二胺、2,4-二甲基-間-苯二胺、2,5-二胺 基甲苯、2,6-二胺基甲苯、2,5-二胺基酚、2,4-二胺基酚、 3,5-二胺基酚、3,5-二胺基苄醇、2,4-二胺基苄醇、4,6-二 胺基間苯二酚、4,4’-二胺基聯苯、3,3’-二甲基-4,4’-二胺 基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、3,3’-二羥基-4,4’-二胺基聯苯、3,3’：二羧基-4,4’-二胺基聯苯、3,3’-二 氟-4,4’-聯苯、3,3’-三氟甲基-4,4’-二胺基聯苯、3,4’-二胺 基聯苯、3,3’-二胺基聯苯、2,2’-二胺基聯苯、2,3’-二胺 基聯苯、4,4’-二胺基二苯基甲烷、3,3’-二胺基二苯基甲烷 、3,4’-二胺基二苯基甲烷、2,2’-二胺基二苯基甲烷、 2,3’-二胺基二苯基甲烷、4,4’-二胺基二苯基醚、3,3’-二 胺基二苯基醚、3,4’-二胺基二苯基醚、2,2’-二胺基二苯基 醚、2,3’-二胺基二苯基醚、4,4’-磺醯基二苯胺、3,3’-磺 醯基二苯胺、雙（4-胺基苯基）矽烷、雙（3-胺基苯基） 矽烷、二甲基-雙（4-胺基苯基）矽烷、二甲基-雙（3-胺 基苯基）矽烷、4,4’-硫二苯胺、3，:Γ-硫二苯胺、4,4’-二 胺基二苯基胺、3,3’-二胺基二苯基胺、3,4’-二胺基二苯基 胺、2,2’-二胺基二苯基胺、2,3’-二胺基二苯基胺、Ν-甲基 (4,4’-二胺基二苯基）胺、>^-甲基（3,3’-二胺基二苯基） 胺、Ν-甲基（3,4’_二胺基二苯基）胺、Ν-甲基（2,2’_二胺 基二苯基）胺、Ν-甲基（2,3’-二胺基二苯基）胺、4,4’-二 胺基二苯甲酮、3,3’-二胺基二苯甲酮、3，4’-二胺基二苯甲 -61 - 201217433 酮、1,4-二胺基萘、2,2’-二胺基二苯甲酮、2,3’-二胺基二 苯甲酮、〗，5-二胺基萘、1，6-二胺基萘、1,7-二胺基萘、 1,8-二胺基萘、2,5-二胺基萘、2,6 -二胺基萘、2,7-二胺基 萘、2,8-二胺基萘、1，2-雙（4-胺基苯基）乙烷、1,2-雙（ 3_胺基苯基）乙烷、1，3-雙（4-胺基苯基）丙烷、1,3-雙（ 3-胺基苯基）丙烷、1,4-雙（4-胺基苯基）丁烷、1，4-雙（ 3-胺基苯基）丁烷、雙（3,5-二乙基-4-胺基苯基）甲烷、 1.4- 雙（4-胺基苯氧基）苯、1，3-雙（4-胺基苯氧基）苯、 1.4- 雙（4_胺基苯基）苯、1,3-雙（4-胺基苯基）苯、1,4-雙（4-胺基苄基）苯、1，3-雙（4-胺基苯氧基）苯、4,4’- 〔1,4-伸苯基雙（亞甲基）〕二苯胺、4,4’-〔 1，3-伸苯基 雙（亞甲基）〕二苯胺、3,4’-〔 1，4-伸苯基雙（亞甲基） 〕二苯胺、3,4’-〔 1，3-伸苯基雙（亞甲基）〕二苯胺、 3,3’-〔 1，4-伸苯基雙（亞甲基）〕二苯胺、3,3’-〔 1，3-伸 苯基雙（亞甲基）〕二苯胺、1,4-伸苯基雙〔（4-胺基苯 基）甲酮〕、1，4-伸苯基雙〔（3-胺基苯基）甲酮〕、 1，3-伸苯基雙〔（4_胺基苯基）甲酮〕' 1，3-伸苯基雙〔 (3-胺基苯基）甲酮〕、I，4-伸苯基雙（4-胺基苯甲酸酯 )、1，4-伸苯基雙（3-胺基苯甲酸酯）、1，3-伸苯基雙（4-胺基苯甲酸酯）、1，3-伸苯基雙（3-胺基苯甲酸酯）、雙 (4-胺基苯基）對苯二甲酸酯、雙（3-胺基苯基）對苯二 甲酸酯、雙（4-胺基苯基）間苯二甲酸酯、雙（3-胺基苯 基）間苯二甲酸酯、N，N’-( 1,4-伸苯基）雙（4-胺基苯醯 胺）、>^少’-(1,3-伸苯基）雙（4-胺基苯醯胺）、N，N’- -62- 201217433 (1，4-伸苯基）雙（3-胺基苯醯胺）、Ν,Ν’-雙（1，3-伸苯 基）雙（3-胺基苯醯胺）、N，N’-雙（4-胺基苯基）對苯二 甲醯胺、N，N’-雙（3-胺基苯基）對苯二甲醯胺、Ν,Ν’-雙 (4-胺基苯基）間苯二甲醯胺、Ν，Ν’-雙（3-胺基苯基）間 苯二甲醯胺、9,10-雙（4_胺基苯基）蒽、4,4’-雙（4-胺基 苯氧基）二苯基颯、2，2’-雙〔4-(4-胺基苯氧基）苯基〕 丙烷、2，2’-雙〔4- (4_胺基苯氧基）苯基〕六氟丙烷、 2,2’-雙（4-胺基苯基）六氟丙烷、2,2’-雙（3-胺基苯基） 六氟丙烷、2,2’ -雙（3 -胺基-4-甲基苯基）六氟丙烷、 2,2’-雙（4-胺基苯基）丙烷、2,2’-雙（3-胺基苯基）丙烷 、2,2’-雙（3-胺基-4-甲基苯基）丙烷、1，3-雙（4-胺基苯 氧基）丙烷、1，3-雙（3-胺基苯氧基）丙烷、1，4-雙（4-胺 基苯氧基）丁烷、I,4-雙（3-胺基苯氧基）丁烷、1，5-雙 (4-胺基苯氧基）戊烷、1，5-雙（3-胺基苯氧基）戊烷、 1,6-雙（4-胺基苯氧基）己烷、1，6_雙（3-胺基苯氧基）己 烷、1，7-雙（4-胺基苯氧基）庚烷、1,7-雙（3-胺基苯氧基 )庚烷、1,8-雙（4-胺基苯氧基）辛烷、1，8-雙（3-胺基苯 氧基）辛烷、1，9-雙（4-胺基苯氧基）壬烷、1，9-雙（3-胺 基苯氧基）壬烷、1,10-(4-胺基苯氧基）癸烷、1,10-(3-胺基苯氧基）癸烷、1,11- (4-胺基苯氧基）十一烷、 1,11-(3-胺基苯氧基）十一烷、1,1 2-(4-胺基苯氧基）十 二烷、1,12-(3-胺基苯氧基）十二烷、4-(胺基甲基）苯 胺、3-(胺基甲基）苯胺、4- ( 2-胺基乙基）苯胺、3-( 2-胺基乙基）苯胺、雙（4-胺基環己基）甲烷、雙（4-胺 -63- 201217433 基-3-甲基環己基）甲烷、1，3-二胺基丙烷、1，4-二胺基丁 烷、1，5-二胺基戊烷、1,6-二胺基己烷、1，7-二胺基庚烷、 1，8-二胺基辛烷、1,9-二胺基壬烷、1，1〇-二胺基癸烷、 1，1 1-二胺基十一烷或1，12-二胺基十二烷等。 另外，在不影響本發明之效果的範圍內，可使用在二 胺側鏈具有烷基或含氟烷基之二胺化合物。 具體而言，例如有下述式[DA1]〜式[DA12]表示之二胺 化合物。 [化 23]The specific side chain type diamine compound is preferably a compound represented by the formula [2-form [2-9] to formula [2-31]. Particularly preferred are compounds represented by the formula [2 [2-9] to the formula [2-12], the formula [2-15], the formula [2-16], and the formula 23]. In the present invention, a diamine compound other than the exemplary side chain type diamine compound which does not affect the effects of the present invention is used as a diamine compound. -60-1]~Formula [2-6] or 1]~Formula [2-6], 2-22] or formula [2-intra-" can be a special 3 (hereinafter also referred to as C specifically as described in 201217433 below. p-Benzyldiamine, 2,3,5,6-tetramethyl-p-phenylenediamine, 2,5-dimethyl-p-phenylenediamine, m-phenylenediamine, 2,4-dimethyl Base-m-phenylenediamine, 2,5-diaminotoluene, 2,6-diaminotoluene, 2,5-diaminophenol, 2,4-diaminophenol, 3,5-diamine Phenolic, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6-diaminoresorcinol, 4,4'-diaminobiphenyl, 3,3' -Dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 3,3'-dihydroxy-4,4'- Diaminobiphenyl, 3,3':dicarboxy-4,4'-diaminobiphenyl, 3,3'-difluoro-4,4'-biphenyl, 3,3'-trifluoromethyl -4,4'-diaminobiphenyl, 3,4'-diaminobiphenyl, 3,3'-diaminobiphenyl, 2,2'-diaminobiphenyl, 2,3'- Diaminobiphenyl, 4,4'-diaminodiphenylmethane, 3,3'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 2,2'- Diaminodiphenylmethane, 2,3'-diaminodiphenylmethane, 4,4'-diaminodiphenyl Ether, 3,3'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 2,2'-diaminodiphenyl ether, 2,3'-diaminodi Phenyl ether, 4,4'-sulfonyldiphenylamine, 3,3'-sulfonyldiphenylamine, bis(4-aminophenyl)decane, bis(3-aminophenyl)decane, dimethyl Base-bis(4-aminophenyl)decane, dimethyl-bis(3-aminophenyl)decane, 4,4'-thiodiphenylamine, 3,:thracene-thiodiphenylamine, 4,4' -diaminodiphenylamine, 3,3'-diaminodiphenylamine, 3,4'-diaminodiphenylamine, 2,2'-diaminodiphenylamine, 2, 3'-Diaminodiphenylamine, Ν-methyl (4,4'-diaminodiphenyl)amine, >^-methyl(3,3'-diaminodiphenyl)amine , Ν-methyl (3,4'-diaminodiphenyl)amine, Ν-methyl (2,2'-diaminodiphenyl)amine, Ν-methyl (2,3'-di Aminodiphenyl)amine, 4,4'-diaminobenzophenone, 3,3'-diaminobenzophenone, 3,4'-diaminobiphenyl-61 - 201217433 ketone , 1,4-diaminonaphthalene, 2,2'-diaminobenzophenone, 2,3'-diaminobenzophenone, 〗, 5-diaminonaphthalene, 1,6- Amino naphthalene, 1,7-diaminonaphthalene, 1,8-diaminonaphthalene, 2,5-diaminonaphthalene, 2,6-diaminonaphthalene, 2,7-diaminonaphthalene, 2 , 8-diaminonaphthalene, 1,2-bis(4-aminophenyl)ethane, 1,2-bis(3-aminophenyl)ethane, 1,3-bis(4-amino group Phenyl)propane, 1,3-bis(3-aminophenyl)propane, 1,4-bis(4-aminophenyl)butane, 1,4-bis(3-aminophenyl)butyl Alkane, bis(3,5-diethyl-4-aminophenyl)methane, 1.4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene , 1.4-bis(4-aminophenyl)benzene, 1,3-bis(4-aminophenyl)benzene, 1,4-bis(4-aminobenzyl)benzene, 1,3-double ( 4-aminophenoxy)benzene, 4,4'-[1,4-phenylenebis(methylene)]diphenylamine, 4,4'-[1,3-phenylene bis (methylene Diphenylamine, 3,4'-[1,4-phenylenebis(methylene)]diphenylamine, 3,4'-[1,3-phenylenebis(methylene)] Aniline, 3,3'-[1,4-phenylenebis(methylene)]diphenylamine, 3,3'-[1,3-phenylphenylbis(methylene)]diphenylamine, 1, 4-phenylene bis[(4-amine) Phenyl phenyl) ketone], 1,4-phenylphenyl bis[(3-aminophenyl)methanone], 1,3-phenylene bis[(4-aminophenyl)methanone] 1,3-phenylene bis[(3-aminophenyl)methanone], I,4-phenylphenylbis(4-aminobenzoate), 1,4-phenylene bis(3) -amino benzoate), 1,3-phenylene bis(4-aminobenzoate), 1,3-phenylene bis(3-aminobenzoate), double (4 -aminophenyl)terephthalate, bis(3-aminophenyl)terephthalate, bis(4-aminophenyl)isophthalate, bis(3-amine Phenylphenyl)isophthalate, N,N'-(1,4-phenylene)bis(4-aminophenylguanamine), >^ less '-(1,3-phenylene) ) bis(4-aminophenylguanamine), N,N'--62-201217433 (1,4-phenylene) bis(3-aminophenylguanamine), hydrazine, Ν'-bis (1, 3-phenylene)bis(3-aminophenylguanamine), N,N'-bis(4-aminophenyl)terephthalamide, N,N'-bis(3-aminobenzene Benzyl phthalamide, hydrazine, Ν'-bis(4-aminophenyl)m-xylylenediamine, hydrazine, Ν'-bis(3-aminophenyl)isophthalene Formamide, 9,10-bis(4-aminophenyl)anthracene, 4,4'-bis(4-aminophenoxy)diphenylanthracene, 2,2'-bis[4-(4 -aminophenoxy)phenyl]propane, 2,2'-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2'-bis(4-aminophenyl) Hexafluoropropane, 2,2'-bis(3-aminophenyl)hexafluoropropane, 2,2'-bis(3-amino-4-methylphenyl)hexafluoropropane, 2,2' - bis(4-aminophenyl)propane, 2,2'-bis(3-aminophenyl)propane, 2,2'-bis(3-amino-4-methylphenyl)propane, 1 , 3-bis(4-aminophenoxy)propane, 1,3-bis(3-aminophenoxy)propane, 1,4-bis(4-aminophenoxy)butane, I, 4-bis(3-aminophenoxy)butane, 1,5-bis(4-aminophenoxy)pentane, 1,5-bis(3-aminophenoxy)pentane, 1 , 6-bis(4-aminophenoxy)hexane, 1,6-bis(3-aminophenoxy)hexane, 1,7-bis(4-aminophenoxy)heptane, 1,7-bis(3-aminophenoxy)heptane, 1,8-bis(4-aminophenoxy)octane, 1,8-bis(3-aminophenoxy)octane 1,9-bis (4-amino group) Oxy) decane, 1,9-bis(3-aminophenoxy)decane, 1,10-(4-aminophenoxy)decane, 1,10-(3-aminophenoxyl) Base) decane, 1,11-(4-aminophenoxy)undecane, 1,11-(3-aminophenoxy)undecane, 1,1 2-(4-aminobenzene Oxy) dodecane, 1,12-(3-aminophenoxy)dodecane, 4-(aminomethyl)aniline, 3-(aminomethyl)aniline, 4-(2-amine Benzyl)aniline, 3-(2-aminoethyl)aniline, bis(4-aminocyclohexyl)methane, bis(4-amine-63-201217433-3-methylcyclohexyl)methane, 1 , 3-diaminopropane, 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diaminohexane, 1,7-diaminoheptane, 1, 8-Diaminooctane, 1,9-diaminodecane, 1,1 -diaminodecane, 1,1 1-diaminoundecane or 1,12-diamino-12 Alkane, etc. Further, a diamine compound having an alkyl group or a fluorine-containing alkyl group in the side chain of the diamine can be used within a range not affecting the effects of the present invention. Specifically, for example, there is a diamine compound represented by the following formula [DA1] to formula [DA12]. [Chem. 23]

[DA4] [DA5] (S1爲碳數1以上22以下之烷基或含氟烷基）。 -64- 201217433 [化 24][DA4] [DA5] (S1 is an alkyl group having 1 or more and 22 or less carbon atoms or a fluorine-containing alkyl group). -64- 201217433 [Chem. 24]

[DA6] [DA7] [DA8] [DA9] [DA10] [DA11] (S2 表示-COO-、-OCO-、-CONH-、-NHCO-、 、-0-、-CO_或NH-，S3表示碳數1以上22以下之烷 -ch2- 基或含 氟烷基）。 -65- 201217433 [化 25][DA6] [DA7] [DA8] [DA9] [DA10] [DA11] (S2 means -COO-, -OCO-, -CONH-, -NHCO-, -0-, -CO_ or NH-, S3 An alkane-ch2- group or a fluorine-containing alkyl group having 1 or more and 22 or less carbon atoms. -65- 201217433 [Chem. 25]

HzN—<CH2)3HzN—<CH2)3

51-j-Sl— CH3 /p ch3 Si—(CH2)3-NH2 [DA12] (p爲1〜10之整數）。 此外，在不影響本發明之效果的範圍內，也可使用下 述式[DA13卜式[DA20]表示之二胺化合物。51-j-Sl—CH3/p ch3 Si—(CH 2 )3-NH 2 [DA12] (p is an integer from 1 to 10). Further, the diamine compound represented by the following formula [DA13] [DA20] can also be used insofar as it does not impair the effects of the present invention.

S -66 - 201217433 [化 26]S -66 - 201217433 [Chem. 26]

[DA20] (m係0〜3之整數，η係1 ~ 5之整數）。 在不影響本發明之效果的範圍內，也可使用下述式 -67- 201217433 [DA2 1卜式[DA25]表示之分子內具有羧基的二胺化合物 [化 27][DA20] (m is an integer from 0 to 3, and η is an integer from 1 to 5). In the range which does not affect the effects of the present invention, the following formula -67-201217433 [DA2 1 [DA25] represents a diamine compound having a carboxyl group in the molecule [Chem. 27]

COOH)!!^ H2Os4vQ·""2 [DA21]COOH)!!^ H2Os4vQ·""2 [DA21]

NH 2 (COOH)m2 (COOH)m3 [DA22]NH 2 (COOH)m2 (COOH)m3 [DA22]

h2 (1^係 1 〜4之整數，S4係單鍵、-CH2-、-C2H4-、-C ( CH3 ) 2-、-CF2-、-C ( CF3 ) -、-O-、-CO-、-NH-、-N ( CH3) -、-CONH-、-NHCO-、-CH20-、-OCH2-、-COO-、-OCO-、-CON ( CH3 )-或 N ( CH3) CO-，m2 及 m3係各自爲 〇〜4之整數，且m2 + m3係1〜4之整數。m4及m5係各自獨立爲 1〜5之整數，S5係碳數1~5之直鏈或支鏈烷基，1116係1~5之 整數。S6 係單鍵、-CH2-、-C2H4-、-C(CH3) 2-、-CF2-、-C ( CF3 ) -、-0-、-CO-、-NH-、-N ( CH3 ) -、-CONH-、- NHCO-、-CH20-、-OCH2·、-COO-、-OCO·、-CON ( CH3 )-或N(CH3) CO-，m7係1〜4之整數）。 s -68- 201217433 上述特定側鏈型二胺化合物及其他之二胺化合物係配 合作爲液晶配向膜時之液晶配向性、電壓保持率、蓄積電 荷等的特性，可使用1種類或混合2種類以上使用。 爲了得到本發明之特定聚合物時，下述式[3]表示之四 殘酸二野（也稱爲特定四殘酸二酐）作爲原料之一部份使 用較佳。 [化 28]H2 (1^ is an integer from 1 to 4, S4 is a single bond, -CH2-, -C2H4-, -C(CH3)2-, -CF2-, -C(CF3)-, -O-, -CO- , -NH-, -N (CH3) -, -CONH-, -NHCO-, -CH20-, -OCH2-, -COO-, -OCO-, -CON(CH3)- or N(CH3) CO-, Each of m2 and m3 is an integer of 〇~4, and m2 + m3 is an integer of 1 to 4. m4 and m5 are each independently an integer of 1 to 5, and S5 is a linear or branched alkane having 1 to 5 carbon atoms. Base, 1116 is an integer from 1 to 5. S6 is a single bond, -CH2-, -C2H4-, -C(CH3) 2-, -CF2-, -C(CF3)-, -0-, -CO-, -NH-, -N (CH3)-, -CONH-, -NHCO-, -CH20-, -OCH2·, -COO-, -OCO·, -CON(CH3)- or N(CH3) CO-,m7 An integer from 1 to 4). s -68-201217433 The above-mentioned specific side chain type diamine compound and other diamine compounds are used as a liquid crystal alignment film, such as liquid crystal alignment property, voltage retention ratio, and charge accumulation, and can be used in one type or in a mixture of two or more types. use. In order to obtain the specific polymer of the present invention, the four-residual acid di-subfield represented by the following formula [3] (also referred to as a specific tetra-residual acid dianhydride) is preferably used as a part of the raw material. [化 28]

式〔3〕中’ Z1爲碳數4〜13之四價有機基，且含有碳 數4〜10之非芳香族環狀烴基。具體而言係下述式〔3a〕〜 式〔3j〕表示之結構的基團。 -69- 201217433 [化 29] Z2 Z4 23 Z5 [3a]In the formula [3], 'Z1' is a tetravalent organic group having 4 to 13 carbon atoms and a non-aromatic cyclic hydrocarbon group having 4 to 10 carbon atoms. Specifically, it is a group having a structure represented by the following formula [3a] to formula [3j]. -69- 201217433 [Chem. 29] Z2 Z4 23 Z5 [3a]

文文XX文文XX

[3b] [3c] [3f ] [3d][3b] [3c] [3f ] [3d]

[3e][3e]

、氯原子或本環的基團，式〔3g〕中，26及27係各自獨立 爲氫原子或甲基。 式〔3〕中’ Ζι之特佳結構係從聚合反應性或合成容 易性的觀點’爲式〔3a〕、式〔3c〕、式〔3d〕、式〔3e 〕、式〔3f〕或式〔3g〕。 本發明中，在不影響本發明之效果的範圍內，可使用 特定四殘酸二軒以外之其他四殘酸二酐（以下也稱爲其他Or a chlorine atom or a group of the present ring, and in the formula [3g], each of 26 and 27 is independently a hydrogen atom or a methyl group. In the formula [3], the structure of the Ζι is particularly good from the viewpoint of polymerization reactivity or ease of synthesis, and is a formula [3a], a formula [3c], a formula [3d], a formula [3e], a formula [3f] or a formula. [3g]. In the present invention, other four-residual acid dianhydrides other than the specific tetrahydro acid can be used within the range which does not impair the effects of the present invention (hereinafter also referred to as other

-70- 201217433 四羧酸二酐）。其他四羧酸二酐例如有以下所示之四羧酸 之四羧酸二酐》 其具體例有均苯四酸、2,3,6,7-萘四羧酸、1，2,5,6-萘 四羧酸、1，4,5,8-萘四羧酸、2,3,6,7-蒽四羧酸、1，2,5,6-蒽 四羧酸、3,3’，4,4’-聯苯四羧酸、2,3,3’，4-聯苯四羧酸、雙 (3,4-二羧基苯基）醚、3,3’，4,4’-二苯甲酮四羧酸、雙（ 3,4-二羧基苯基）颯、雙（3,4-二羧基苯基）甲烷、2,2-雙 (3,4-二羧基苯基）丙烷、1,1，1，3,3,3-六氟-2,2-雙（3,4-二羧基苯基）丙烷、雙（3,4-二羧基苯基）二甲基矽烷、 雙（3,4-二羧基苯基）二苯基矽烷、2,3,4,5-吡啶四羧酸、 2,6-雙（3,4-二羧基苯基）吡啶、3,3’，4,4’-二苯基颯四羧 酸、3,4,9，10-菲（perylene )四殘酸、或 1,3-二苯基_ 1，2,3,4-環丁烷四羧酸。 上述特定四羧酸二酐及其他四羧酸二酐係配合作爲液 晶配向膜時之液晶配向性、電壓保持率、蓄積電荷等特性 ，可使用1種或混合2種類以上使用。 本發明之特定聚合物係選自聚醯亞胺前驅物及聚醯亞 胺所成群之至少一種聚合物，聚醯亞胺前驅物係指式[A] 表示之結構。 本發明中，合成特定聚合物的方法無特別限定。通常 爲藉由使二胺成分與四羧酸二酐成分進行反應所得。一般 而言，使選自四羧酸及其衍生物所成群之至少1種的四羧 酸成分與由1種或複數種之二胺化合物所構成之二胺成分 進行反應，得到聚醯胺酸。爲了得到聚醯胺酸烷酯時，可 -71 - 201217433 使用使聚醯胺酸之羧基轉換成酯的方法。爲了得到聚醯亞 胺時’可使用使前述聚醯胺酸或聚醯胺酸烷酯進行醯亞胺 化’形成聚醯亞胺的方法。 使用本發明之特定聚合物所得之液晶配向膜係當上述 二胺成分中之特定側鏈型二胺化合物之含有比例越多，越 能提高液晶之預傾角。爲了提高此特性時，較佳爲二胺成 分之5〜80莫耳％爲特定側鏈型二胺化合物。其中，從液晶 配向處理劑之塗佈性及作爲液晶配向膜之電特性的觀點， 較佳爲二胺成分之5~60莫耳％爲特定側鏈型二胺化合物。 又爲了得到本發明之特定聚合物時，四羧酸二酐成分 較佳爲使用特定四羧酸二酐。此時，較佳爲四羧酸二酐成 分之1莫耳％以上爲特定四羧酸二酐，更佳爲5莫耳％以上 、更佳爲10莫耳％以上。此外，也可爲四羧酸二酐成分之 1〇〇莫耳％爲特定四羧酸二酐。 二胺成分與四羧酸成分之反應，通常在有機溶劑中進 行。此時所用的有機溶劑只要是可溶解生成之聚醯亞胺前 驅物者時，無特別限定。其具體例如下述。 N，N-二甲基甲醯胺' n，N-二甲基乙醯胺、N -甲基- 2-吡咯烷酮、N -甲基已內醯胺、二甲基亞颯、四甲基脲、吡 啶、二甲基颯、六甲基亞颯、γ_ 丁內酯、異丙醇、甲氧基 甲基戊醇、二戊烯、乙基戊基酮、甲基壬基酮、甲基乙基 酮 '甲基異戊基酮、甲基異丙基酮、甲基賽路蘇（ cellosolve)、乙基賽路蘇、甲基賽路蘇乙酸酯、乙基賽 路蘇乙酸酯、丁基卡必醇、乙基卡必醇、乙二醇、乙二醇-70- 201217433 Tetracarboxylic dianhydride). Other tetracarboxylic dianhydrides are, for example, tetracarboxylic dianhydrides of tetracarboxylic acids shown below. Specific examples thereof include pyromellitic acid, 2,3,6,7-naphthalenetetracarboxylic acid, 1,2,5, 6-naphthalenetetracarboxylic acid, 1,4,5,8-naphthalenetetracarboxylic acid, 2,3,6,7-nonanetetracarboxylic acid, 1,2,5,6-nonanetetracarboxylic acid, 3,3' , 4,4'-biphenyltetracarboxylic acid, 2,3,3',4-biphenyltetracarboxylic acid, bis(3,4-dicarboxyphenyl)ether, 3,3',4,4'- Benzophenone tetracarboxylic acid, bis(3,4-dicarboxyphenyl)anthracene, bis(3,4-dicarboxyphenyl)methane, 2,2-bis(3,4-dicarboxyphenyl)propane 1,1,1,3,3,3-hexafluoro-2,2-bis(3,4-dicarboxyphenyl)propane, bis(3,4-dicarboxyphenyl)dimethylnonane, double (3,4-dicarboxyphenyl)diphenylnonane, 2,3,4,5-pyridinetetracarboxylic acid, 2,6-bis(3,4-dicarboxyphenyl)pyridine, 3,3', 4,4'-diphenylphosphonium tetracarboxylic acid, 3,4,9,10-perylene tetraresidic acid, or 1,3-diphenyl-1,2,3,4-cyclobutane IV carboxylic acid. When the specific tetracarboxylic dianhydride and the other tetracarboxylic dianhydride are blended as a liquid crystal alignment film, the liquid crystal alignment property, the voltage retention ratio, and the storage charge can be used in one type or in a mixture of two or more types. The specific polymer of the present invention is selected from the group consisting of a polyimine precursor and at least one polymer of a polyimine, and the polyimine precursor refers to a structure represented by the formula [A]. In the present invention, a method of synthesizing a specific polymer is not particularly limited. It is usually obtained by reacting a diamine component with a tetracarboxylic dianhydride component. In general, a tetracarboxylic acid component selected from the group consisting of tetracarboxylic acid and a derivative thereof is reacted with a diamine component composed of one or more kinds of diamine compounds to obtain a polyamine. acid. In order to obtain a polyalkylene amide, a method of converting a carboxyl group of polylysine into an ester can be used as -71 - 201217433. In order to obtain a polyimine, a method of forming a polyimine by subjecting the aforementioned polyamic acid or polyalkyl amide to ruthenium can be used. The liquid crystal alignment film obtained by using the specific polymer of the present invention is such that the more the content ratio of the specific side chain type diamine compound in the above diamine component, the higher the pretilt angle of the liquid crystal. In order to enhance this property, it is preferred that the diamine component is 5 to 80 mol% as a specific side chain type diamine compound. In particular, from the viewpoint of the coatability of the liquid crystal alignment agent and the electrical properties of the liquid crystal alignment film, it is preferred that 5 to 60 mol% of the diamine component is a specific side chain type diamine compound. Further, in order to obtain a specific polymer of the present invention, it is preferred to use a specific tetracarboxylic dianhydride as the tetracarboxylic dianhydride component. In this case, it is preferably 1 mol% or more of the tetracarboxylic dianhydride component to be a specific tetracarboxylic dianhydride, more preferably 5 mol% or more, still more preferably 10 mol% or more. Further, it may be a specific tetracarboxylic dianhydride of 1% by mole of the tetracarboxylic dianhydride component. The reaction of the diamine component with the tetracarboxylic acid component is usually carried out in an organic solvent. The organic solvent to be used at this time is not particularly limited as long as it is a polyimine precursor which can be produced by dissolution. Specifically, it is as follows. N,N-dimethylformamide 'n,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-methylcaprolactam, dimethyl hydrazine, tetramethylurea , pyridine, dimethyl hydrazine, hexamethylarylene, γ-butyrolactone, isopropanol, methoxymethylpentanol, dipentene, ethyl amyl ketone, methyl decyl ketone, methyl Ketone 'methyl isoamyl ketone, methyl isopropyl ketone, cellosolve, ethyl celecoxib, methyl sarbuta acetate, ethyl sarbuta acetate, Butyl carbitol, ethyl carbitol, ethylene glycol, ethylene glycol

S -72- 201217433 單乙酸酯、乙二醇單異丙基醚、乙二醇單丁基醚、丙二醇 、丙二醇單乙酸酯、丙二醇單甲基醚、丙二醇第三丁基醚 、二丙二醇單甲基醚、二乙二醇、二乙二醇單乙酸酯、二 乙二醇二甲基醚、二丙二醇單乙酸酯單甲基醚、二丙二醇 單甲基醚、二丙二醇單乙基醚、二丙二醇單乙酸酯單乙基 醚、二丙二醇單丙基醚、二丙二醇單乙酸酯單丙基醚、3-甲基-3-甲氧基丁基乙酸酯、三丙二醇甲基醚、3-甲基-3-甲氧基丁醇、二異丙基醚、乙基異丁基醚、二異丁烯、乙 酸戊酯、丁酸丁酯、丁基醚、二異丁基酮、甲基環己烯、 丙基醚、二己基醚、二噁烷、正己烷、正戊烷、正辛烷、 二乙基醚、環己酮、碳酸乙烯酯、碳酸丙烯酯、乳酸甲酯 、乳酸乙酯、乙酸甲酯、乙酸乙酯、乙酸正丁酯、乙酸丙S -72- 201217433 monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, propylene glycol, propylene glycol monoacetate, propylene glycol monomethyl ether, propylene glycol tert-butyl ether, dipropylene glycol Monomethyl ether, diethylene glycol, diethylene glycol monoacetate, diethylene glycol dimethyl ether, dipropylene glycol monoacetate monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol single B Ethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetate monopropyl ether, 3-methyl-3-methoxybutyl acetate, tripropylene glycol Methyl ether, 3-methyl-3-methoxybutanol, diisopropyl ether, ethyl isobutyl ether, diisobutylene, amyl acetate, butyl butyrate, butyl ether, diisobutyl Ketone, methylcyclohexene, propyl ether, dihexyl ether, dioxane, n-hexane, n-pentane, n-octane, diethyl ether, cyclohexanone, ethylene carbonate, propylene carbonate, lactate Ester, ethyl lactate, methyl acetate, ethyl acetate, n-butyl acetate, acrylic acid

甲酯、3 -乙氧基丙酸甲基乙酯、3 -甲氧基丙酸乙酯、3 -乙 氧基丙酸、3-甲氧基丙酸、3-甲氧基丙酸丙酯、3-甲氧基 丙酸丁酯、二甘醇二甲醚（Diglyme) 、4-羥基-4-甲基-2-戊酮等。此等可單獨使用，亦可混合使用。再者，即使是 不溶解聚醯亞胺前驅物的溶劑，只要是不會使生成後之聚 醯亞胺前驅動析出的範圍內，可與上述溶劑混合使用。又 ，有機溶劑中之水分會阻礙聚合反應，成爲使生成之聚醯 亞胺前驅物水解的原因，故有機溶劑較佳爲使用經脫水乾 燥者。 使二胺成分與四羧酸二酐在有機溶劑中反應時，可使 用下列方法：使二胺成分分散或溶解於有機溶劑之溶液進 -73- 201217433 行攪拌，將四羧酸二酐成分直接添加、或經分散或溶解於 有機溶劑後進行添加的方法：相反地，例如將二胺成分添 加於使四羧酸二酐成分分散或溶解於有機溶劑之溶液中的 方法、交互添加四羧酸二酐成分與二胺成分的方法等，也 可使用此等中任一種方法。二胺成分或四羧酸二酐成分各 自使用複數種進行反應時，可預先混合後的狀態進行反應 ，或可各別依序反應，或將各別反應後之低分子量體進行 混合反應成爲特定聚合物。此時之聚合溫度可選擇-20°C〜150°C之任意溫度，較佳爲-5°C~l〇〇°C之範圍。又， 反應可在任意的濃度下進行，但濃度過低時難以獲得高分 子量的特定聚合物，而濃度過高時，反應液之黏性過高而 難以均勻攪拌。故較佳爲1〜50質量％，更佳爲5〜30質量％ 。反應初期係在高濃度下進行，其後可追加有機溶劑。 聚醯亞胺前驅物之聚合反應中，二胺成分之合成莫耳 數與四羧酸二酐成分之合計莫耳數之比，較佳爲0.8〜1 .2。 與通常之聚縮合反應相同，此莫耳比愈接近1.0，則生成 之聚醯亞胺前驅物之分子量愈大。 本發明之聚醯亞胺係使上述聚醯亞胺前驅物進行脫水 閉環而得的聚醯亞胺’此聚醯亞胺可作爲製得液晶配向膜 之聚合物使用。 本發明之聚醯亞胺中，醯胺酸基之脫水閉環率（醯亞 胺化率）不一定要爲1 00%，可依據用途或目的任意調整。 使聚醯亞胺前驅物進行醯亞胺化的方法，例如有將聚 醯亞胺前驅物溶液直接加熱之熱醯亞胺化，或將觸媒添加 -74 · 201217433 於聚醯亞胺前驅物溶液中的觸媒醯亞胺化》 使聚醯亞胺前驅物在溶液中進行熱醯亞胺化時的溫度 爲100°C~400°C ’較佳爲120°C〜250°C，將醯亞胺化反應所 生成的水一邊排除反應體系外一邊進行醯亞胺化反應較佳 〇 聚醯亞胺前驅物之觸媒醯亞胺化係將鹼性觸媒與酸酐 添加於聚醯亞胺前驅物溶液中，以-20〜250°C，較佳爲 0~1 8 0°C下攪拌進行觸媒醯亞胺化。鹼性觸媒的量係醯胺 酸基之〇·.5〜30倍莫耳，較佳爲2〜20倍莫耳，酸酐的量爲醯 胺酸基之1〜5 0倍莫耳，較佳爲3〜3 0倍莫耳。鹼性觸媒例如 有吡啶、三乙胺、三甲胺、三丁胺 '三辛胺等，其中吡啶 由於具有進行反應所需之適度的鹼性，故較佳。酸酐例如 有乙酸酐、偏苯三酸酐、或均苯四酸酐等，其中使用乙酸 酐時，於反應結束後之純化容易，故較佳。藉由觸媒醯亞 胺化之醯亞胺化率，可藉由調節觸媒量、反應溫度、反應 時間來控制。 自聚醯亞胺前驅物或聚醯亞胺之反應溶液中回收生成 之聚醯亞胺前驅物或聚醯亞胺時，只要將反應溶液注入溶 劑中使之沈澱即可。沈澱所用的溶劑，例如有甲醇、丙酮 、己烷、丁基賽路蘇、庚烷、甲基乙基酮、甲基異丁基酮 、乙醇、甲苯、苯、水等。投入於溶劑中，經沈澱後的聚 合物係經過濾回收後，可在常壓或減壓下，於常溫或加熱 乾燥。又，將沈澱回收之聚合物再溶解於有機溶劑中，再 沈澱回收之操作重複2〜10次時，可減少聚合物中的雜質。 -75- 201217433 此時之溶劑例如有醇類、酮類、或烴等，使用由此等中選 出之三種以上的溶劑時，可更進一步提高純化效率，故較 佳。 本發明之特定聚合物的分子量，若考慮由此等所得之 聚合物被膜的強度、聚合物被膜形成時之作業性、聚合物 被膜之均勻性時，以GPC (凝膠滲透層析：（Gel Permeation Chromatography))法測定之重量平均分子量 ，較佳爲 5，000 〜1,000,000，更佳爲 1〇,〇〇〇 〜150,000。 <液晶配向處理劑> 本發明之液晶配向處理劑係形成液晶配向膜用的塗佈 液’係含有特定胺化合物 '特定聚合物、及有機溶劑的塗 佈液。 本發明之液晶配向處理劑中之特定胺化合物的含量係 相對於特定聚合物100質量份，較佳爲0.1〜150質量份，爲 了進行交聯反應’具有所望的膜硬化性，且避免液晶之配 向性降低’更佳爲0.1〜100質量份，特佳爲1〜50質量份。 本發明之液晶配向處理劑中之聚合物全部可爲本發明 之特定聚合物’又，本發明之特定聚合物中，可混合上述 以外之其他的聚合物。此時，聚合物中之上述以外之其他 的聚合物的含量係0.5〜15質量％，較佳爲1〜10質量％。上 述以外之其他的聚合物，例如有由不含特定側鏈型二胺化 合物的二胺成分與不含特定四羧酸二酐之四羧酸二酐所得 之聚醯亞胺前驅物或聚醯亞胺。此外，聚醯亞胺前驅物及 -76- 201217433 聚醯亞胺以外之聚合物，具體而言，例如有丙烯酸聚合物 、甲基丙烯酸聚合物、聚苯乙烯、聚醯胺等。 本發明之液晶配向處理劑中的有機溶劑，從藉由塗佈 形成均勻聚合物被膜的觀點，有機溶劑之含量較佳爲 7 0~99質量％。有機溶劑之含量可依據目的之液晶配向膜之 膜厚適度變更。此時之有機溶劑只要是溶解上述特定聚合 物的有機溶劑時，即無特別限定。更具體而言，例如有 N，N -二甲基甲醯胺、N，N -二甲基乙醯胺、N -甲基-2-吡咯 烷酮、N-甲基已內醯胺、2-吡咯烷酮、N-乙基-2-吡咯烷酮 、N-乙烯基吡咯烷酮、二甲基亞楓、四甲基脲、吡啶、二 甲基碾、六甲基亞颯、γ-丁內酯、1,3-二甲基-咪唑啉酮、 乙基戊基酮、甲基壬基酮、甲基乙基酮、甲基異戊基酮、 甲基異丙基酮、環己酮、碳酸乙烯酯、碳酸丙烯酯、二甘 醇二甲醚（Diglyme) 、4-羥基-4-甲基-2-戊酮等。此等可 單獨使用或混合使用。 本發明之液晶配向處理劑，在不影響本發明之效果的 範圍內，可含有具有環氧基、異氰酸酯基或氧雜環丁基的 交聯性化合物、具有選自由羥基或烷氧基所成群之至少1 種取代基的交聯性化合物、具有聚合性不飽和鍵的交聯性 化合物等。 具有環氧基或異氰酸酯基的交聯性化合物，例如有雙 酚丙酮縮水甘油醚、酚醛清漆環氧樹脂、甲酚酚醛清漆環 氧樹脂、三縮水甘油基異氰脲酸酯、四縮水甘油基胺基二 苯、四縮水甘油基-間-苯二甲胺、四縮水甘油基-1,3-雙（ -77- 201217433 胺基乙基）環己烷、四苯基縮水甘油醚乙烷、三苯基縮水 甘油醚乙烷、雙酚六氟乙醯基二縮水甘油醚' 1，3 -雙（1- (2,3-環氧基丙氧基）-1-三氟甲基- 2,2,2-三氟甲基）苯、 4,4-雙（2,3-環氧基丙氧基）八氟聯苯、三縮水甘油基-對- 胺基酚、四縮水甘油基間苯二甲胺、2- ( 4- ( 2,3-環氧基 丙氧基）苯基）-2-(4- (1，1-雙（4- (2,3-環氧基丙氧基 )苯基）乙基）苯基）丙烷、1，3-雙（4-(1-(4-(2,3-環 氧基丙氧基）苯基）-1-(4- (1-(4- (2,3-環氧基丙氧基 )苯基）-1-甲基乙基）苯基）乙基）苯氧基）_2_丙醇等 〇 具有氧雜環丁基之交聯性化合物爲具有至少2個以下 述式〔4〕表示之氧雜環丁基的交聯性化合物。 [化 30]Methyl ester, methyl ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, propyl 3-methoxypropionate , 3-methoxypropionic acid butyl ester, diglyme (Diglyme), 4-hydroxy-4-methyl-2-pentanone, and the like. These may be used alone or in combination. Further, even a solvent which does not dissolve the polyimine precursor can be used in combination with the above solvent as long as it does not drive the precipitated pre-polymerized polyimide. Further, since the water in the organic solvent hinders the polymerization reaction and causes hydrolysis of the produced polyimide precursor, the organic solvent is preferably dried by dehydration. When the diamine component and the tetracarboxylic dianhydride are reacted in an organic solvent, the following method may be used: a solution in which the diamine component is dispersed or dissolved in an organic solvent is stirred in -73 to 201217433, and the tetracarboxylic dianhydride component is directly Adding, or dispersing or dissolving in an organic solvent, adding: Conversely, for example, a method of adding a diamine component to a solution for dispersing or dissolving a tetracarboxylic dianhydride component in an organic solvent, and intercalating tetracarboxylic acid Any of these methods may be used as the method of the dianhydride component and the diamine component. When the diamine component or the tetracarboxylic dianhydride component is reacted in a plurality of kinds, the reaction may be carried out in a state of being mixed beforehand, or may be sequentially reacted, or the low molecular weight body after the respective reaction may be mixed and reacted. polymer. The polymerization temperature at this time may be selected from any temperature of from -20 ° C to 150 ° C, preferably from -5 ° C to 10 ° C. Further, the reaction can be carried out at an arbitrary concentration. However, when the concentration is too low, it is difficult to obtain a specific polymer having a high molecular weight, and when the concentration is too high, the viscosity of the reaction liquid is too high and it is difficult to uniformly agitate. Therefore, it is preferably from 1 to 50% by mass, more preferably from 5 to 30% by mass. The initial stage of the reaction is carried out at a high concentration, and thereafter an organic solvent can be added. In the polymerization reaction of the polyimine precursor, the ratio of the molar number of the synthetic mole of the diamine component to the total number of moles of the tetracarboxylic dianhydride component is preferably 0.8 to 1.2. As with the usual polycondensation reaction, the closer the molar ratio is to 1.0, the larger the molecular weight of the resulting polyimide precursor. The polyimine of the present invention is a polyimine obtained by subjecting the above polyimide precursor to dehydration and ring closure. The polyimine can be used as a polymer for producing a liquid crystal alignment film. In the polyimine of the present invention, the dehydration ring closure ratio of the proline group is not necessarily 100%, and can be arbitrarily adjusted depending on the use or purpose. A method for subjecting a polyimine precursor to ruthenium imidization, for example, by heat-imiding a polyimine precursor solution directly by heating, or adding a catalyst to -74 · 201217433 in a polyimide precursor The imidization of the catalyst in the solution. The temperature at which the polyimide precursor is thermally imidated in the solution is from 100 ° C to 400 ° C. Preferably, it is from 120 ° C to 250 ° C. The water formed by the hydrazine imidization reaction is subjected to the ruthenium imidization reaction while excluding the reaction system. The bismuth imide precursor of the ruthenium imide precursor is added to the polyruthenium. In the amine precursor solution, the catalyst is imidized by stirring at -20 to 250 ° C, preferably 0 to 180 ° C. The amount of the basic catalyst is 醯5 to 30 times moles, preferably 2 to 20 times moles, and the amount of the acid anhydride is 1 to 50 times moles of the proline group. Good for 3~3 0 times Mo. The basic catalyst is, for example, pyridine, triethylamine, trimethylamine or tributylamine 'trioctylamine, and the like, and pyridine is preferred because it has a moderate basicity required for carrying out the reaction. The acid anhydride is, for example, acetic anhydride, trimellitic anhydride or pyromellitic anhydride. When acetic anhydride is used, purification after the completion of the reaction is easy, and therefore it is preferred. The imidization ratio of the ruthenium imidized by the catalyst can be controlled by adjusting the amount of the catalyst, the reaction temperature, and the reaction time. When the resulting polyimine precursor or polyimine is recovered from the reaction solution of the polyimine precursor or the polyimine, the reaction solution may be injected into the solvent to precipitate. The solvent used for the precipitation is, for example, methanol, acetone, hexane, butyl sirolimus, heptane, methyl ethyl ketone, methyl isobutyl ketone, ethanol, toluene, benzene, water or the like. After being introduced into a solvent, the precipitated polymer is recovered by filtration, and then dried at normal temperature or under reduced pressure under normal pressure or reduced pressure. Further, the precipitate-recovered polymer is redissolved in an organic solvent, and the operation of reprecipitation and recovery is repeated 2 to 10 times to reduce impurities in the polymer. -75-201217433 The solvent in this case is, for example, an alcohol, a ketone or a hydrocarbon. When three or more solvents selected from the above are used, the purification efficiency can be further improved, which is preferable. The molecular weight of the specific polymer of the present invention is considered to be GPC (gel permeation chromatography: (Gel) in consideration of the strength of the polymer film obtained by the above, the workability at the time of forming a polymer film, and the uniformity of the polymer film. The weight average molecular weight measured by the method of Permeation Chromatography) is preferably 5,000 to 1,000,000, more preferably 1 Torr, and 〇〇〇 150,000. <Liquid Crystal Alignment Treatment Agent> The liquid crystal alignment treatment agent of the present invention is a coating liquid for forming a liquid crystal alignment film, which is a coating liquid containing a specific amine compound 'specific polymer and an organic solvent. The content of the specific amine compound in the liquid crystal alignment agent of the present invention is preferably 0.1 to 150 parts by mass based on 100 parts by mass of the specific polymer, and has a desired film hardenability for the crosslinking reaction and avoids liquid crystal. The reduction in the orientation is more preferably from 0.1 to 100 parts by mass, particularly preferably from 1 to 50 parts by mass. The polymer in the liquid crystal alignment agent of the present invention may all be a specific polymer of the present invention. Further, in the specific polymer of the present invention, other polymers than the above may be mixed. In this case, the content of the polymer other than the above in the polymer is from 0.5 to 15% by mass, preferably from 1 to 10% by mass. Other polymers other than the above include, for example, a polyamine imine precursor or a polyfluorene obtained from a diamine component containing no specific side chain type diamine compound and a tetracarboxylic dianhydride containing no specific tetracarboxylic dianhydride. Imine. Further, the polyimine precursor and the polymer other than -76-201217433 polyiminoimide include, for example, an acrylic polymer, a methacrylic polymer, polystyrene, polyamine, and the like. The organic solvent in the liquid crystal alignment agent of the present invention preferably has a content of the organic solvent of from 70 to 99% by mass from the viewpoint of forming a uniform polymer film by coating. The content of the organic solvent can be appropriately changed depending on the film thickness of the intended liquid crystal alignment film. The organic solvent in this case is not particularly limited as long as it is an organic solvent in which the above specific polymer is dissolved. More specifically, for example, N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-methylcaprolactam, 2-pyrrolidone , N-ethyl-2-pyrrolidone, N-vinylpyrrolidone, dimethyl sulfoxide, tetramethylurea, pyridine, dimethyl milling, hexamethylarylene, γ-butyrolactone, 1,3- Dimethyl-imidazolidinone, ethyl amyl ketone, methyl decyl ketone, methyl ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, cyclohexanone, ethylene carbonate, propylene carbonate Ester, diglyme, 4-hydroxy-4-methyl-2-pentanone, and the like. These can be used alone or in combination. The liquid crystal alignment treatment agent of the present invention may contain a crosslinkable compound having an epoxy group, an isocyanate group or an oxetanyl group, and having a group selected from a hydroxyl group or an alkoxy group, within a range not impairing the effects of the present invention. A crosslinkable compound having at least one substituent of the group, a crosslinkable compound having a polymerizable unsaturated bond, and the like. A crosslinkable compound having an epoxy group or an isocyanate group, for example, bisphenol acetone glycidyl ether, novolak epoxy resin, cresol novolac epoxy resin, triglycidyl isocyanurate, tetraglycidyl group Aminobiphenyl, tetraglycidyl-m-xylylenediamine, tetraglycidyl-1,3-bis(-77-201217433 aminoethyl)cyclohexane, tetraphenyl glycidyl ether ethane, Triphenyl glycidyl ether ethane, bisphenol hexafluoroethyl diglycidyl ether 1, 1, 3-bis(1-(2,3-epoxypropoxy)-1-trifluoromethyl-2 , 2,2-trifluoromethyl)benzene, 4,4-bis(2,3-epoxypropoxy)octafluorobiphenyl, triglycidyl-p-aminophenol, tetraglycidyl Xylylenediamine, 2-(4-(2,3-epoxypropoxy)phenyl)-2-(4-(1,1-bis(4-(2,3-epoxyoxypropoxy)) Phenyl)ethyl)phenyl)propane, 1,3-bis(4-(1-(4-(2,3-epoxypropoxy)phenyl)-1-(4-(1) -(4-(2,3-Epoxypropoxy)phenyl)-1-methylethyl)phenyl)ethyl)phenoxy)_2-propanol has an oxetanyl group Crosslinkable compound Said at least two of the following formula [4] represents a crosslinkable compound of the oxetanyl group. [化30]

具體而言，例如有下述式[4a]〜式[4k]表示之交聯性化 合物。 -78- 201217433 [化 31]Specifically, for example, there is a crosslinkable compound represented by the following formula [4a] to formula [4k]. -78- 201217433 [化31]

-79- 201217433 [化 32]-79- 201217433 [化32]

[4h][4h]

s -80- 201217433 [化 33] R\s -80- 201217433 [化33] R\

具有選自由羥基或烷氧基所成群之至少一種取代基的 交聯性化合物，例如具有羥基或烷氧基之胺基樹脂，例如 有三聚氰胺樹脂、脲樹脂、胍樹脂、甘醇脲-甲醛樹脂、 琥珀醯胺·甲醛樹脂、乙烯脲-甲醛樹脂等。具體而言，可 使用胺基之氫原子被羥甲基或烷氧基甲基或其兩者取代的 三聚氰胺衍生物、苯胍衍生物或甘醇脲。此三聚氰胺衍生 物或苯胍衍生物也可以二聚物或三聚物的形態存在。此等 係每1個三嗪環，平均具有3 ~6個羥甲基或烷氧基甲基者較 佳。 此等三聚氰胺衍生物或苯胍衍生物之例，例如有市售 品之每1個三嗪環，平均被3.7個甲氧基甲基取代的MX-750 -81 - 201217433 、每1個三嗪環，平均被5.8個甲氧基甲基取代的MW-30( 以上爲三和化學製造），或CYMEL 3 00、301、303、350 、370、771、325、327、703、712等之甲氧基甲基化三聚 氰胺、CYMEL 235、236、238、212、253、254等之甲氧 基甲基化丁氧基甲基化三聚氰胺、CYMEL 506、5 08等之 丁氧基甲基化三聚氰胺、如CYMEL 1141之含羧基之甲氧 基甲基化異丁氧基甲基化三聚氰胺、如CYMEL 1123之甲 氧基甲基化乙氧基甲基化苯胍、如CYMEL 1 123-10之甲氧 基甲基化丁氧基甲基化苯胍、如CYMEL 1128之丁氧基甲 基化苯胍、如CYMEL 1 1 2 5-80之含羧基之甲氧基甲基化乙 氧基甲基化苯胍（以上爲三井CYAMIDE公司製）。另外 ，甘醇脲的例，例如有CYMEL 1 170等之丁氧基甲基化甘 醇脲、如CYMEL 1 172等之羥甲基化甘醇脲等，如 POWERLINK 1174之甲氧基羥甲基化甘醇脲等。 具有羥基或烷氧基之苯或酚性化合物也可作爲交聯性 化合物。例如有1，3,5-參（甲氧基甲基）苯、1，2,4-參（異 丙氧基甲基）苯、1,4-雙（第二丁氧基甲基）苯、2,6-二 羥基甲基-對-第三丁基酚等。 具有聚合性不飽和鍵之交聯性化合物，例如有三羥甲 基丙烷三（甲基）丙烯酸酯、季戊四醇三（甲基）丙烯酸 酯、二季戊四醇五（甲基）丙烯酸酯、三（甲基）丙烯醯 氧基乙氧基三羥甲基丙烷、或甘油聚縮水甘油醚聚（甲基 )丙烯酸酯等之分子內具有3個聚合性不飽和基之交聯性 化合物：乙二醇二（甲基）丙烯酸酯、二乙二醇二（甲基a crosslinkable compound having at least one substituent selected from the group consisting of a hydroxyl group or an alkoxy group, for example, an amine-based resin having a hydroxyl group or an alkoxy group, for example, a melamine resin, a urea resin, an anthracene resin, a glycol urea-formaldehyde Resin, amber amide, formaldehyde resin, ethylene urea-formaldehyde resin, and the like. Specifically, a melamine derivative, a benzoquinone derivative or a glycol urea having a hydrogen atom of an amine group substituted with a methylol group or an alkoxymethyl group or both may be used. The melamine derivative or the benzoquinone derivative may also exist in the form of a dimer or a trimer. These are preferably one to three hydroxymethyl groups or alkoxymethyl groups per one triazine ring. Examples of such melamine derivatives or benzoquinone derivatives include, for example, MX-750 -81 - 201217433, which is substituted by 3.7 methoxymethyl groups per one triazine ring of a commercial product, and one triazine each. Ring, MW-30 (manufactured by Sanwa Chemical) with an average of 5.8 methoxymethyl groups, or CYMEL 3 00, 301, 303, 350, 370, 771, 325, 327, 703, 712, etc. Oxyxymethylated melamine, CYMEL 235, 236, 238, 212, 253, 254, etc. methoxymethylated butoxymethylated melamine, CYMEL 506, 508, etc., butoxymethylated melamine, For example, carboxy-containing methoxymethylated isobutoxymethylated melamine of CYMEL 1141, methoxymethylated ethoxymethylated benzoquinone such as CYMEL 1123, methoxyl such as CYMEL 1 123-10 Methylated butoxymethylated benzoquinone, such as butyloxymethylated phenylhydrazine of CYMEL 1128, carboxymethylated ethoxymethylated methylation of CYMEL 1 1 2 5-80 Benzoquinone (above is Mitsui CYAMIDE company). Further, examples of the glycol urea include, for example, butoxymethylated glycol urea of CYMEL 1 170, methylolated glycol urea such as CYMEL 1 172, and the like, such as methoxymethylol of POWERLINK 1174. Glycol urea and the like. A benzene or phenolic compound having a hydroxyl group or an alkoxy group can also be used as the crosslinkable compound. For example, there are 1,3,5-gin (methoxymethyl)benzene, 1,2,4-gin (isopropoxymethyl)benzene, and 1,4-bis(second butoxymethyl)benzene. , 2,6-dihydroxymethyl-p-tert-butylphenol, and the like. A crosslinkable compound having a polymerizable unsaturated bond, for example, trimethylolpropane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, dipentaerythritol penta(meth)acrylate, tris(methyl) a crosslinkable compound having three polymerizable unsaturated groups in the molecule of propylene methoxy ethoxy trimethylolpropane or glycerol polyglycidyl ether poly(meth) acrylate: ethylene glycol di(a) Acrylate, diethylene glycol di(methyl)

S -82- 201217433 )丙烯酸酯、四乙二醇二（甲基）丙烯酸酯、聚乙二醇二 (甲基）丙烯酸酯、丙二醇二（甲基）丙烯酸酯、聚丙二 醇二（甲基）丙烯酸酯、丁二醇二（甲基）丙烯酸酯、新 戊二醇二（甲基）丙烯酸酯、環氧乙烷雙酚A型二（甲基 )丙烯酸酯、環氧丙烷雙酚型二（甲基）丙烯酸酯、1，6-己二醇二（甲基）丙烯酸酯、甘油二（甲基）丙烯酸酯、 季戊四醇二（甲基）丙烯酸酯、乙二醇二縮水甘油醚二（ 甲基）丙烯酸酯、二乙二醇縮水甘油醚二（甲基）丙烯酸 酯 '苯二甲酸二縮水甘油酯二（甲基）丙烯酸酯、羥基特 戊酸新戊二醇二（甲基）丙烯酸酯等分子內具有2個聚合 性不飽和基之交聯性化合物；（甲蕋）丙烯酸2-羥基乙酯 ' (甲基）丙烯酸2-羥基丙酯、（甲基）丙烯酸2-羥基丁 酯、（甲基）丙烯酸2 -苯氧基-2-羥基丙酯、2-(甲基）丙 稀酿氧基-2-羥基丙基苯二甲酸酯、（甲基）丙烯酸3-氯-2-羥基丙酯、甘油單（甲基）丙烯酸酯、2_(甲基）丙烯 醯氧基乙基磷酸酯、或N_羥甲基（甲基）丙烯醯胺等分子 內具有1個聚合性不飽和基的交聯性化合物。 此外’例如下述式〔5〕表示之化合物也可作爲交聯 性化合物。 [化 34] 十E2 ) n⑸ (E1爲選自環己烷環、雙環己烷環、苯環、聯苯環、 聯三苯環、萘環、苐環、蒽環或菲環之1價基團，E2爲選 自下述式〔5a〕或式〔5b〕之“賈基團，η爲1~4之整數） -83 - 201217433 [化 35]S -82- 201217433 )Acrylate, tetraethylene glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, polypropylene glycol di(meth)acrylic acid Ester, butanediol di(meth)acrylate, neopentyl glycol di(meth)acrylate, ethylene oxide bisphenol A di(meth)acrylate, propylene oxide bisphenol type II Acrylate, 1,6-hexanediol di(meth)acrylate, glycerol di(meth)acrylate, pentaerythritol di(meth)acrylate, ethylene glycol diglycidyl ether di(methyl) Molecules such as acrylate, diethylene glycol glycidyl ether di(meth)acrylate phthalic acid diglycidyl di(meth)acrylate, hydroxypivalic acid neopentyl glycol di(meth)acrylate a crosslinkable compound having two polymerizable unsaturated groups; (meth) 2-hydroxyethyl acrylate '2-hydroxypropyl (meth)acrylate, 2-hydroxybutyl (meth)acrylate, (A) 2-(phenoxy-2-hydroxypropyl acrylate, 2-(methyl) propylene oxide oxy-2- Propyl phthalate, 3-chloro-2-hydroxypropyl (meth)acrylate, glycerol mono(meth)acrylate, 2-(meth)acryloxyethyl phosphate, or N_ A crosslinkable compound having one polymerizable unsaturated group in a molecule such as hydroxymethyl (meth) acrylamide. Further, for example, a compound represented by the following formula [5] can also be used as a crosslinkable compound. (E) is a monovalent group selected from the group consisting of a cyclohexane ring, a bicyclohexane ring, a benzene ring, a biphenyl ring, a terphenyl ring, a naphthalene ring, an anthracene ring, an anthracene ring or a phenanthrene ring. The group E2 is a "Jia group selected from the following formula [5a] or formula [5b], and η is an integer of 1 to 4) -83 - 201217433 [Chem. 35]

上述化合物爲交聯性化合物之一例，但並不限於此等 。又’本發明之液晶配向處理劑中所含有的交聯性化合物 可爲一種類，也可組合兩種類以上。 本發明之液晶配向處理劑中之交聯性化合物之含量係 相對於聚合物成分100質量份，較佳爲0.1-150質量份，爲 了進行交聯反應，展現目的之效果，且避免液晶之配向性 降低，更佳爲0.1〜100質量份，特佳爲1〜50質量份。 可添加含氮雜環胺化合物，作爲促進液晶配向膜中之 電荷移動，促進使用該液晶配向膜之液晶胞（cell )之電 荷排除的化合物，例如有下述式〔Ml〕〜式〔M156〕表示 之含氮雜環胺化合物。此胺化合物可直接添加於特定聚合 物之溶液中，但是以適當的溶劑形成濃度〇 . 1〜1 0質量％， 較佳爲1~7質量％的溶液後再進行添加較佳。此溶劑只要是 溶解上述特定聚合物的有機溶劑時，即無特別限定。 -84- 201217433 [化 36] qh3 ch3 H3C^k^NH2 Λ-^ΝΗ2 M1 M2 Η H^y-NH2 ^y^-NH2H3The above compound is an example of a crosslinkable compound, but is not limited thereto. Further, the crosslinkable compound contained in the liquid crystal alignment agent of the present invention may be one type or two or more types. The content of the crosslinkable compound in the liquid crystal alignment agent of the present invention is preferably 0.1 to 150 parts by mass based on 100 parts by mass of the polymer component, and the effect of the purpose is exhibited for the crosslinking reaction, and the alignment of the liquid crystal is avoided. The degree of reduction is more preferably from 0.1 to 100 parts by mass, particularly preferably from 1 to 50 parts by mass. A nitrogen-containing heterocyclic amine compound may be added as a compound which promotes charge transfer in the liquid crystal alignment film and promotes charge elimination using a liquid crystal cell of the liquid crystal alignment film, for example, the following formula [Ml]~[M156] A nitrogen-containing heterocyclic amine compound is represented. The amine compound may be directly added to a solution of a specific polymer, but it is preferably added in a concentration of from 1 to 10% by mass, preferably from 1 to 7% by mass, based on a suitable solvent. The solvent is not particularly limited as long as it is an organic solvent in which the above specific polymer is dissolved. -84- 201217433 [化36] qh3 ch3 H3C^k^NH2 Λ-^ΝΗ2 M1 M2 Η H^y-NH2 ^y^-NH2H3

M10 M6M10 M6

M7 M8 、NHM7 M8, NH

H3C fj CH 3 M11 M12H3C fj CH 3 M11 M12

M16M16

H2NH2N

H2NH2N

M17M17

H2 H2N ch3 M19 M20 h2nH2 H2N ch3 M19 M20 h2n

OO

M21 M18 〇M21 M18 〇

H2N M22 M23 M24 mh7 M25 ,ch3H2N M22 M23 M24 mh7 M25 ,ch3

h2n nh2H2n nh2

No": Ν-γ "NH2 crNo": Ν-γ "NH2 cr

NH2 M26 M27 M28 M29 -85- 201217433 [化 37]NH2 M26 M27 M28 M29 -85- 201217433 [化37]

4 M32 NH, ίΥ^ nh2 M33 ζΤ 〇r-NH2 ,nh2 Μ35 M36 M37 'Ν'、^NH2 H3CT、N M38 M39 M344 M32 NH, ίΥ^ nh2 M33 ζΤ 〇r-NH2 ,nh2 Μ35 M36 M37 'Ν', ^NH2 H3CT, N M38 M39 M34

NH2NH2

-86- 201217433 [化 38]-86- 201217433 [化38]

HH M99 M60HH M99 M60

M62 —N Λ H M63 XX-2 cv〇- _nh2 H2N- ΛΧM62 —N Λ H M63 XX-2 cv〇- _nh2 H2N- ΛΧ

nh2 M64 M65 M66 M67Nh2 M64 M65 M66 M67

M73 M74 M75 M76M73 M74 M75 M76

M81 M82 M83 M84 -87- 201217433 [化 39]M81 M82 M83 M84 -87- 201217433 [化39]

M89 M91 M92M89 M91 M92

M93 M90M93 M90

Η2Ν^/^* Μ99 ΝΗ, Cl ΗΟ 丫I Λ UL r s'-^nh2 Μ103 M104 ；F3 八 Λ V 、NHj X M108 nh2Η2Ν^/^* Μ99 ΝΗ, Cl ΗΟ 丫I Λ UL r s'-^nh2 Μ103 M104 ;F3 八 Λ V , NHj X M108 nh2

Μ105 ΝΗ2Μ105 ΝΗ2

Μ109Μ109

S -88- 201217433 [化 40]S -88- 201217433 [化 40]

-89 - 201217433 [化 41] o- M140 M141-89 - 201217433 [化41] o- M140 M141

HjC M139HjC M139

M144 O M142 M143M144 O M142 M143

»/V"Y^0-CH3 \=^N NHZ h2n M145»/V"Y^0-CH3 \=^N NHZ h2n M145

M149M149

M150M150

M151 、NH2 M148M151, NH2 M148

本發明之液晶配向處理劑在不影響本發明效果的範圍 內’可含有提高塗佈液晶配向處理劑時之聚合物被膜之膜 厚均勻性或表面平滑性的有機溶劑（也稱爲弱溶劑）或化 合物。也可含有提高液晶配向膜與基板之密著性的化合物 等。 提高膜厚均勻性或表面平滑性的弱溶劑的具體例如下 述者。 例如有異丙醇、甲氧基甲基戊醇、甲基賽路蘇、乙基 賽路蘇、丁基賽路蘇、甲基賽路蘇乙酸酯、乙基賽路蘇乙 酸酯、丁基卡必醇、乙基卡必醇、乙基卡必醇乙酸酯、乙 二醇、乙二醇單乙酸酯、乙二醇單異丙基醚、乙二醇單丁 基醚、丙二醇、丙二醇單乙酸酯、丙二醇單甲基醚、丙二 醇第三丁基醚、二丙二醇單甲基醚、二乙二醇、二乙二醇The liquid crystal alignment treatment agent of the present invention may contain an organic solvent (also referred to as a weak solvent) which improves the film thickness uniformity or surface smoothness of the polymer film when the liquid crystal alignment treatment agent is applied, within a range that does not impair the effects of the present invention. Or a compound. A compound or the like which improves the adhesion between the liquid crystal alignment film and the substrate may be contained. Specific examples of the weak solvent which improves the film thickness uniformity or the surface smoothness are as follows. For example, isopropanol, methoxymethylpentanol, methyl stilbene, ethyl celecoxib, butyl sedum, methyl sarbuta acetate, ethyl serosu acetate, Butyl carbitol, ethyl carbitol, ethyl carbitol acetate, ethylene glycol, ethylene glycol monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, Propylene glycol, propylene glycol monoacetate, propylene glycol monomethyl ether, propylene glycol tert-butyl ether, dipropylene glycol monomethyl ether, diethylene glycol, diethylene glycol

S -90- 201217433 單乙酸酯、二乙二醇二甲基醚、二丙二醇單乙酸酯單甲基 醚、二丙二醇單甲基醚、二丙二醇單乙基醚、二丙二醇單 乙酸酯單乙基醚、二丙二醇單丙基醚、二丙二醇單乙酸酯 單丙基醚、3-甲基-3-甲氧基丁基乙酸酯、三丙二醇甲基醚 、3-甲基-3-甲氧基丁醇、二異丙基醚、乙基異丁基醚、二 異丁烯、乙酸戊酯、丁酸丁酯、丁基醚、二異丁基酮、甲 基環己烯、丙基醚、二己基醚、正己烷、正戊烷、正辛烷 、二乙基醚、乳酸甲酯、乳酸乙酯..乙酸甲酯、乙酸乙酯 、乙酸正丁酯 '乙酸丙二醇單乙基醚、丙酮酸甲酯、丙酮 酸乙酯、3 -甲氧基丙酸甲酯、3 -乙氧基丙酸甲基乙酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸、3-甲氧基丙酸、3-甲氧 基丙酸丙酯、3 -甲氧基丙酸丁酯、1-甲氧基-2-丙醇、1-乙 氧基-2-丙醇、1-丁氧基-2-丙醇、1-苯氧基-2-丙醇、丙二 醇單乙酸酯、丙二醇二乙酸酯、丙二醇-1-單甲基醚-2-乙 酸酯、丙二醇-1-單乙基醚-2-乙酸酯、二丙二醇、2-(2-乙氧基丙氧基）丙醇、乳酸甲酯、乳酸乙酯、乳酸正丙酯 、乳酸正丁酯、乳酸異戊酯等具有低表面張力的有機溶劑 >〇cr 寺0 此等弱溶劑可使用一種或混合複數種使用。使用如上 述之弱溶劑時，較佳爲液晶配向處理劑中所含之有機溶劑 全部的5~80質量％，更佳20〜60質量％。 提高膜厚之均句性或表面平滑性的化合物，例如有氟 系界面活性劑、矽氧系界面活性劑、非離子系界面活性劑 等。 -91 - 201217433 更具體而言’例如有EF TOP EF301、EF303、EF352 (TOHKEM PRODUCTS 製）、MAGAFAC F171、F173、 R-30 (大曰本油墨製），FLORARD FC430、FC431 (住友 3M 製）、Asahigard AG710、SURFLON S-3 82、SC101、 SC102、SC103、SC104、SC105、SC106(旭硝子製）等。 此等界面活性劑之使用比例係相對於液晶配向處理劑中所 含有之聚合物成分100質量份，較佳爲〇.〇1〜2質量份，更 佳爲0 · 0 1〜1質量份。 提高液晶配向膜與基板之密著性之化合物的具體例， 例如有以下所示之含有官能性矽烷化合物或含有環氧基化 合物等。 例如有3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧 基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基 矽烷、N-(2-胺基乙基）-3-胺基丙基三甲氧基矽烷、Ν·( 2-胺基乙基）-3-胺基丙基甲基二甲氧基矽烷、3-脲基丙基 三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、Ν-乙氧基羰 基-3-胺基丙基三甲氧基矽烷、Ν-乙氧基羰基-3-胺基丙基 三乙氧基矽烷、Ν -三乙氧基矽烷基丙基三伸乙基三胺、Ν-三甲氧基矽烷基丙基三伸乙基三胺、10-三甲氧基矽烷基-1，4,7-三氮雜癸烷、10-三乙氧基矽烷基-1，4,7-三氮雜癸烷 、9-三甲氧基矽烷基-3,6-二氮雜壬基乙酸酯、9_三乙氧基 矽烷基-3,6-二氮雜壬基乙酸酯、Ν-苄基-3-胺基丙基三甲 氧基矽烷、Ν-苄基-3-胺基丙基三乙氧基矽烷、Ν-苯基- 3-胺基丙基三甲氧基矽烷、Ν-苯基_3_胺基丙基三乙氧基矽 8 -92- 201217433 N縮醚戊 、 二油新. 烷醇甘、 砍二水酸 基乙縮油 氧、二甘 甲烷醇水 三矽二縮 基基丙二 丙氧 '醇 基1Z,醚二 安三油丙 -B基甘聚 -3丙水、 >基縮醚 基胺二油 乙-3醇甘 伸}二水 基基乙縮 氧乙聚二 C伸、醇 雔1基醚二 N-氧油丙 、 彳甘三 烷雙水、 二醇二縮水甘油醚、1，6-己二醇二縮水甘油醚、甘油二縮 水甘油醚、2,2-二溴新戊二醇二縮水甘油醚、1,3,5,6-四縮 水甘油基-2,4-己二醇、N，N，N’，N’-四縮水甘油基-間-苯二 甲胺、1，3-雙（N，N-二縮水甘油基胺基甲基）環己烷、 冰川：^，：^’-四縮水甘油基-4,4’-二胺基二苯基甲烷等。 使用提高與基板之密著性的化合物時，相對於液晶配 向處劑所含有之聚合物成分1〇〇質量份，較佳爲0.1〜30質 量份，更佳爲1〜20質量份。未達0.1質量份時，無法期待 密著性改善的效果，高於3 0質量份時，有時液晶配向性變 差的情況。 本發明之液晶配向處理劑除上述交聯性化合物、弱溶 劑及提高密著性的化合物外，只要在不損及本發明效果的 範圍內，亦可添加爲了改變液晶配向膜之介:電率或導電性 等電特性的介電體或導電物質。 <液晶配向膜•液晶顯示元件> 本發明之液晶配向處理劑係塗佈於基板上，經燒成後 ，以摩擦處理或光照射等進行配向處理可作爲液晶配向膜 使用。此外，於垂直配向用途等時，即使未經配向處理也 可作爲液晶配向膜使用。此時使用的基板，只要是透明性 -93- 201217433 高的基板，即無特別限制，除玻璃基板外，可使用丙烯酸 基板或聚碳酸酯基板等塑膠基板等。從製程簡化的觀點而 言，較佳爲使用形成有液晶驅動用之ITO電極等的基板。 又，反射型的液晶顯示元件的情形係僅爲單側之基板時， 也可使用矽晶圓等不透明的基板，此時之電極亦可使用鋁 等反射光的材料。 液晶配向處理劑之塗佈方法並無特別限制，但工業上 —般係以網版印刷、平板印刷、軟板印刷、噴墨印刷等進 行塗佈。其他塗佈方法例如有浸漬、輥塗、狹縫塗佈、旋 轉塗佈等，可依據目的需要使用此等。 於基板上塗佈液晶配向處理劑後，藉由加熱板等加熱 手段’以50〜3 00°c，較佳爲80〜2 5 0°c使溶劑蒸發可形成聚 合物被膜。燒成後之聚合物被膜之厚度太厚時，對於液晶 顯示元件之消耗電力方面不利，太薄時，有時液晶顯示元 件有信賴性降低的情況。塗膜之厚度較佳爲5〜3 OOnm，更 佳爲1 0〜1 OOnm。使液晶水平配向或傾斜配向時，以摩擦或 偏光紫外線照射等處理燒成後的聚合物被膜。 本發明之液晶顯示元件係藉上述方法，自本發明之液 晶配向處理劑獲得含液晶配向膜的基板後，以習知方法製 作液晶胞，作成液晶顯示元件者。 液晶胞之製作方法，例如準備形成有液晶配向膜之一 對基板’於其中一片基板之液晶配向膜上散佈隔離材，使 液晶配向膜面成爲內側，再貼合另一片基板，減壓注入液 晶’進行封裝的方法，或將液晶滴下於散佈有隔離材之液S -90- 201217433 monoacetate, diethylene glycol dimethyl ether, dipropylene glycol monoacetate monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate Monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetate monopropyl ether, 3-methyl-3-methoxybutyl acetate, tripropylene glycol methyl ether, 3-methyl- 3-methoxybutanol, diisopropyl ether, ethyl isobutyl ether, diisobutylene, amyl acetate, butyl butyrate, butyl ether, diisobutyl ketone, methylcyclohexene, C Ether, dihexyl ether, n-hexane, n-pentane, n-octane, diethyl ether, methyl lactate, ethyl lactate.. methyl acetate, ethyl acetate, n-butyl acetate, propylene glycol monoethyl acetate Ether, methyl pyruvate, ethyl pyruvate, methyl 3-methoxypropionate, methyl ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, 3-ethoxypropane Acid, 3-methoxypropionic acid, propyl 3-methoxypropionate, butyl 3-methoxypropionate, 1-methoxy-2-propanol, 1-ethoxy-2-propanol Alcohol, 1-butoxy-2-propanol, 1-phenoxy-2-propanol, propylene glycol monoethyl Ester, propylene glycol diacetate, propylene glycol-1-monomethyl ether-2-acetate, propylene glycol-1-monoethyl ether-2-acetate, dipropylene glycol, 2-(2-ethoxypropane An organic solvent having a low surface tension such as oxy)propanol, methyl lactate, ethyl lactate, n-propyl lactate, n-butyl lactate or isoamyl lactate> 〇cr 寺 0 These weak solvents may be used alone or Mix multiple uses. When a weak solvent as described above is used, it is preferably 5 to 80% by mass, more preferably 20 to 60% by mass based on the total of the organic solvent contained in the liquid crystal alignment agent. Examples of the compound which improves the uniformity of the film thickness or the surface smoothness include a fluorine-based surfactant, a rhodium-based surfactant, and a nonionic surfactant. -91 - 201217433 More specifically, for example, EF TOP EF301, EF303, EF352 (manufactured by TOHKEM PRODUCTS), MAGAFAC F171, F173, R-30 (made by Otsuka Ink), FLORARD FC430, FC431 (Sumitomo 3M), Asahigard AG710, SURFLON S-3 82, SC101, SC102, SC103, SC104, SC105, SC106 (made by Asahi Glass). The ratio of use of the surfactant is 100 parts by mass, more preferably 1 to 2 parts by mass, even more preferably 0. 0 1 to 1 part by mass, based on 100 parts by mass of the polymer component contained in the liquid crystal alignment agent. Specific examples of the compound which improves the adhesion between the liquid crystal alignment film and the substrate include, for example, a functional decane compound or an epoxy group-containing compound described below. For example, 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, 2-aminopropyltrimethoxydecane, 2-aminopropyltriethoxydecane, N- (2-Aminoethyl)-3-aminopropyltrimethoxydecane, Ν(2-aminoethyl)-3-aminopropylmethyldimethoxydecane, 3-ureidopropyl Trimethoxy decane, 3-ureidopropyl triethoxy decane, hydrazine-ethoxycarbonyl-3-aminopropyltrimethoxy decane, hydrazine-ethoxycarbonyl-3-aminopropyl three Ethoxy decane, hydrazine-triethoxy decyl propyl triethylidene triamine, hydrazine-trimethoxydecyl propyl triethylidene triamine, 10-trimethoxydecyl-1, 4, 7-triazanonane, 10-triethoxydecyl-1,4,7-triazadecane, 9-trimethoxydecyl-3,6-diazaindolyl acetate, 9_Triethoxydecyl-3,6-diazaindolyl acetate, Ν-benzyl-3-aminopropyltrimethoxydecane, Ν-benzyl-3-aminopropyl Ethoxy decane, fluorenyl-phenyl-3-aminopropyltrimethoxydecane, fluorenyl-phenyl-3-ylaminopropyltriethoxy hydrazide 8-92-201217433 N-epoxide, di-oil new Alkanol Chopped dihydrate acid condensate Oxygen, diglycidyl water triterpene bis propyl propylene dipropoxyl alcohol 1Z, ether dian trioleane C-B-glycol-3, water, > condensate Amine dioletoethyl-3-ol glycerol} Dihydrate-based ethoxylated ethylene di-di-C extension, alcohol oxime 1-yl ether di-N-oxygen propylene, glycerol trioxane bis-dihydrate, diol diglycidyl ether, 1 , 6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, 1,3,5,6-tetraglycidyl-2,4-hexyl Glycol, N,N,N',N'-tetraglycidyl-m-xylylenediamine, 1,3-bis(N,N-diglycidylaminomethyl)cyclohexane, glacier: ^,:^'-tetraglycidyl-4,4'-diaminodiphenylmethane, and the like. In the case of using a compound which improves the adhesion to the substrate, the amount of the polymer component contained in the liquid crystal alignment agent is preferably 0.1 to 30 parts by mass, more preferably 1 to 20 parts by mass. When the amount is less than 0.1 part by mass, the effect of improving the adhesion cannot be expected. When the amount is more than 30 parts by mass, the alignment property of the liquid crystal may be deteriorated. In addition to the above-mentioned crosslinkable compound, weak solvent, and adhesion-improving compound, the liquid crystal alignment treatment agent of the present invention may be added in order to change the dielectric ratio of the liquid crystal alignment film as long as the effect of the present invention is not impaired. Or a dielectric or conductive substance that conducts electrical properties. <Liquid Crystal Alignment Film/Liquid Crystal Display Element> The liquid crystal alignment treatment agent of the present invention is applied onto a substrate, and after firing, it is used as a liquid crystal alignment film by an alignment treatment such as rubbing treatment or light irradiation. Further, in the case of vertical alignment use or the like, it can be used as a liquid crystal alignment film even without alignment treatment. The substrate to be used in this case is not particularly limited as long as it is a substrate having a high transparency of -93 to 201217433, and a plastic substrate such as an acrylic substrate or a polycarbonate substrate can be used in addition to the glass substrate. From the viewpoint of process simplification, it is preferred to use a substrate on which an ITO electrode or the like for driving a liquid crystal is formed. Further, in the case of a reflective liquid crystal display device, when only a single-sided substrate is used, an opaque substrate such as a germanium wafer may be used. In this case, a material such as aluminum or the like may be used. The coating method of the liquid crystal alignment agent is not particularly limited, but industrially, it is applied by screen printing, lithography, flexographic printing, ink jet printing or the like. Other coating methods include, for example, dipping, roll coating, slit coating, spin coating, etc., and may be used depending on the purpose. After the liquid crystal alignment agent is applied onto the substrate, the solvent is evaporated by a heating means such as a hot plate at 50 to 300 ° C, preferably 80 to 250 ° C to form a polymer film. When the thickness of the polymer film after firing is too thick, it is disadvantageous in terms of power consumption of the liquid crystal display element, and when it is too thin, the reliability of the liquid crystal display element may be lowered. The thickness of the coating film is preferably from 5 to 3,000 nm, more preferably from 10 to 100 nm. When the liquid crystal is aligned horizontally or obliquely, the fired polymer film is treated by rubbing or polarized ultraviolet light irradiation or the like. The liquid crystal display element of the present invention is obtained by the above method, and after obtaining a substrate containing a liquid crystal alignment film from the liquid crystal alignment treatment agent of the present invention, a liquid crystal cell is produced by a known method to form a liquid crystal display element. For the method of fabricating a liquid crystal cell, for example, one of the liquid crystal alignment films is prepared, and the spacer is spread on the liquid crystal alignment film of one of the substrates, so that the liquid crystal alignment film surface becomes the inner side, and the other substrate is bonded, and the liquid crystal is injected under reduced pressure. 'Method of encapsulation, or dropping liquid crystal on a liquid with a spacer

S -94- 201217433 晶配向膜面後，貼合基板並進行封裝的方法等。 本發明之液晶配向處理劑也可用於下述液晶顯示元件 ’此液晶顯示元件係在具備電極之一對基板間具有液晶層 所成’且前述一對基板間配置含有藉由活性能量線及熱之 至少其一進行聚合之聚合性化合物的液晶組成物，且經由 對前述電極間外加電壓，藉由活性能量線之照射及加熱之 至少其一進行使聚合性化合物聚合的步驟所製造的液晶顯 示元件。其中活性能量線較佳爲紫外線。 上述液晶顯不兀件係藉由PSA ( Polymer Sustained Alignment)方式控制液晶分子之預傾角之大小者。PSA方 式係於液晶材料中混入少量光聚合性化合物，例如光聚合 性單體’組裝液晶胞後，在將所定電壓外加於液晶層的狀 態’對光聚合性化合物照射紫外線等，藉由生成的聚合物 控制液晶分子之預傾角的大小。聚合物生成時之液晶分子 之配向狀態爲即使在去除電壓後，仍被記憶，因此藉由控 制形成於液晶層的電場等，可調整液晶分子之預傾角的大 小。又’ PS A方式不需要摩擦處理，故適合藉由摩擦處理 不易控制預傾角之垂直配向型之液晶層之形成。 換言之’本發明之液晶顯示元件係藉由上述方法，自 本發明之液晶配向處理劑獲得含液晶配向膜的基板後，製 作液晶胞，以紫外線之照射及加熱之至少其一使聚合性化 合物聚合’以控制液晶分子之配向者。 列舉液晶胞製作之一例時，例如準備形成有液晶配向 膜之一對基板’於其中一片基板之液晶配向膜上散佈隔離 -95- 201217433 材，使液晶配向膜面成爲內側，再貼合另一片基板，減壓 注入液晶並封裝的方法，或將液晶滴下於散佈有隔離材之 液晶配向膜面後，貼合基板並進行封裝的方法等。 液晶中混合有藉由熱或紫外線照射而聚合的聚合性化 合物。聚合性化合物例如有在分子內具有一個以上之丙烯 酸酯基或甲基丙烯酸酯基等聚合性不飽和基的化合物。此 時，聚合性化合物係相對於液晶成分1 00質量份，較佳爲 0.01~10質量份，更佳爲0.1〜5質量份。聚合性化合物未達 〇.〇1質量份時，聚合性化合物不會聚合，變得無法控制液 晶之配向，超過1 0質量份時，未反應之聚合性化合物變多 ，使液晶顯示元件之殘影特性降低。 製作液晶胞後，對液晶胞外加交流或直流電壓，同時 藉由熱或照射紫外線，使聚合性化合物聚合。藉此可控制 液晶分子之配向。 本發明之液晶配向處理劑也可用於下述液晶顯示元件 ’此液晶顯示元件係在具備電極之一對基板間具有液晶層 所成’且前述一對基板間配置含有藉由活性能量線及熱之 至少其一進行聚合之聚合性基等的液晶配向膜，且經由對 電極間外加電壓的步驟所製造的液晶顯示元件。其中活性 能量線較佳爲紫外線。 爲了得到含有藉由活性能量線及熱之至少其一進行聚 合之聚合性基等的液晶配向膜時，例如有將含有該聚合性 基的化合物添加於液晶配向處理劑中的方法或使用含有聚 合性基之聚合物成分的方法。聚合性基例如有丙烯酸基、 -96- 201217433 甲基丙烯酸基、乙烯基、馬來醢亞胺基等之聚合性不飽和 基》 本發明之液晶配向處理劑係含有具有藉由熱或紫外線 之照射進行反應之雙鍵部位的特定胺化合物，因此藉由紫 外線之照射及加熱之至少其一可控制液晶分子之配向。 列舉液晶胞製作之一例時，例如準備形成有液晶配向 膜之一對基板，於其中一片基板之液晶配向膜上散佈隔離 材’使液晶配向膜面成爲內側，再貼合另一片基板，減壓 注入液晶並封裝的方法’或將液晶滴下於散佈有隔離材之 液晶配向膜面後，貼合基板並進行封裝的方法等。 製作液晶胞後，對液晶胞外加交流或直流電壓，同時 藉由熱或照射紫外線，藉此可控制液晶分子之配向。 如上述。使用本發明之液晶配向處理劑所製作之液晶 顯示元件係可靠性優異者，可適用於大畫面且高精細之液 晶電視等。 【實施方式】 〔實施例〕 以下舉實施例更詳細說明本發明。但本發明不限於此 等實施例。 聚醯亞胺前驅物及聚醯亞胺之合成」 實施例中使用的化合物之簡稱係如下述。 -97- 201217433 (四羧酸二酐） CBDA: 1,2,3,4-環丁烷四羧酸二酐 BODA:雙環[3,3,0]辛烷- 2,4,6,8 -四羧酸二酐 TCA :下述式表示之四羧酸二酐 [化 42] η η η η ΟS -94- 201217433 A method in which a crystal is bonded to a film surface, and a substrate is bonded and packaged. The liquid crystal alignment agent of the present invention can also be used in a liquid crystal display device in which a liquid crystal display element is provided with a liquid crystal layer between one of the electrodes, and the active energy line and heat are disposed between the pair of substrates. A liquid crystal display produced by the step of polymerizing a polymerizable compound by at least one of irradiation and heating of an active energy ray by applying a voltage between the electrodes, and a liquid crystal composition of at least one of the polymerizable compounds to be polymerized. element. The active energy ray is preferably ultraviolet light. The liquid crystal display is controlled by a PSA (Polymer Sustained Alignment) method to control the pretilt angle of the liquid crystal molecules. In the PSA method, a small amount of a photopolymerizable compound is mixed in a liquid crystal material, for example, a photopolymerizable monomer is assembled into a liquid crystal cell, and a photopolymerizable compound is irradiated with ultraviolet rays or the like in a state where a predetermined voltage is applied to the liquid crystal layer. The polymer controls the magnitude of the pretilt angle of the liquid crystal molecules. The alignment state of the liquid crystal molecules at the time of polymer formation is such that even after the voltage is removed, the size of the pretilt angle of the liquid crystal molecules can be adjusted by controlling the electric field or the like formed in the liquid crystal layer. Further, the PS A method does not require a rubbing treatment, so that it is suitable for the formation of a vertical alignment type liquid crystal layer which is difficult to control the pretilt angle by rubbing treatment. In other words, the liquid crystal display element of the present invention is obtained by obtaining the liquid crystal alignment cell from the liquid crystal alignment treatment agent of the present invention by the above method, and polymerizing the polymerizable compound by at least one of irradiation and heating by ultraviolet rays. 'To control the alignment of liquid crystal molecules. In the case of exemplifying the production of liquid crystal cells, for example, one of the liquid crystal alignment films is prepared, and the substrate is disposed on the liquid crystal alignment film of one of the substrates, and the liquid crystal alignment film surface is formed inside, and the other film is bonded to the other side. A method in which a substrate is injected under reduced pressure into a liquid crystal and packaged, or a liquid crystal is dropped on a liquid crystal alignment film surface on which a spacer is dispersed, and a substrate is bonded and packaged. A polymerizable compound which is polymerized by irradiation with heat or ultraviolet rays is mixed in the liquid crystal. The polymerizable compound is, for example, a compound having one or more polymerizable unsaturated groups such as an acrylate group or a methacrylate group in the molecule. In this case, the polymerizable compound is preferably 0.01 to 10 parts by mass, more preferably 0.1 to 5 parts by mass, per 100 parts by mass of the liquid crystal component. When the amount of the polymerizable compound is less than 1 part by mass, the polymerizable compound does not polymerize, and the alignment of the liquid crystal cannot be controlled. When the amount exceeds 10 parts by mass, the amount of the unreacted polymerizable compound increases, and the liquid crystal display element remains. The shadow characteristics are reduced. After the liquid crystal cell is produced, an alternating current or a direct current voltage is applied to the liquid crystal cell, and the polymerizable compound is polymerized by heat or ultraviolet light. Thereby, the alignment of the liquid crystal molecules can be controlled. The liquid crystal alignment agent of the present invention can also be used in a liquid crystal display device in which a liquid crystal display element is provided with a liquid crystal layer between one of the electrodes, and the active energy line and heat are disposed between the pair of substrates. A liquid crystal display element produced by the step of applying a voltage between the counter electrodes, at least one of which is a liquid crystal alignment film such as a polymerizable group which is polymerized. The active energy ray is preferably ultraviolet light. In order to obtain a liquid crystal alignment film containing a polymerizable group or the like which is polymerized by at least one of an active energy ray and heat, for example, a method of adding a compound containing the polymerizable group to a liquid crystal alignment treatment agent or using a polymerization-containing method A method of polymerizing a polymer component. The polymerizable group is, for example, a polymerizable unsaturated group such as an acryl group, a -96-201217433 methacryl group, a vinyl group or a maleimine group. The liquid crystal alignment agent of the present invention contains a film having heat or ultraviolet rays. The specific amine compound at the double bond site where the reaction is carried out is irradiated, so that at least one of the irradiation and the heating of the ultraviolet rays can control the alignment of the liquid crystal molecules. When an example of liquid crystal cell formation is used, for example, a pair of substrates of a liquid crystal alignment film are prepared, and a spacer is dispersed on a liquid crystal alignment film of one of the substrates. The liquid crystal alignment film surface is formed inside, and the other substrate is bonded to the substrate. A method of injecting a liquid crystal and encapsulating it, or a method of laminating a liquid crystal on a liquid crystal alignment film surface on which a spacer is dispersed, bonding a substrate, and packaging the same. After the liquid crystal cell is produced, an alternating current or a direct current voltage is applied to the liquid crystal cell, and the alignment of the liquid crystal molecules can be controlled by heat or ultraviolet light. As above. The liquid crystal display device produced by using the liquid crystal alignment agent of the present invention is excellent in reliability, and can be applied to a liquid crystal television having a large screen and a high definition. [Embodiment] [Examples] Hereinafter, the present invention will be described in more detail by way of examples. However, the invention is not limited to the embodiments. Synthesis of Polyimine Precursor and Polyimine The abbreviations of the compounds used in the examples are as follows. -97- 201217433 (tetracarboxylic dianhydride) CBDA: 1,2,3,4-cyclobutane tetracarboxylic dianhydride BODA: bicyclo[3,3,0]octane-2,4,6,8 - Tetracarboxylic dianhydride TCA: tetracarboxylic dianhydride represented by the following formula [化42] η η η η Ο

(特定側鏈型二胺化合物） PCH7DAB ： 1，3-二胺基-4-〔 4-(反式-4-正庚基環己 基）苯氧基〕苯 PBCH5DAB ： 1,3-二胺基-4-{4-〔反式-4-(反式-4-正 戊基環己基）環己基〕苯氧基}苯(Specific side chain type diamine compound) PCH7DAB : 1,3-diamino-4-[4-(trans-4-n-heptylcyclohexyl)phenoxy]benzene PBCH5DAB : 1,3-diamino group -4-{4-[trans-4-(trans-4-n-pentylcyclohexyl)cyclohexyl]phenoxy}benzene

ColDAB-1 ：以下式表示之特定側鏈型二胺化合物ColDAB-1: specific side chain type diamine compound represented by the following formula

S -98- 201217433 [化 43]S -98- 201217433 [化 43]

(其他二胺化合物） p-PDA : p-苯二胺 m-PDA: m-苯二胺 DBA : 3,5-二胺基苯甲酸 [化 44](Other diamine compounds) p-PDA : p-phenylenediamine m-PDA: m-phenylenediamine DBA : 3,5-diaminobenzoic acid [Chemical 44]

p-PDAP-PDA

DBADBA

m—PDA -99- 201217433 (特定胺化合物） A-1 :下述式袠示之特定胺化合物 [化 45]M-PDA -99- 201217433 (specific amine compound) A-1 : specific amine compound shown by the following formula [Chem. 45]

HzNHzN

A-1 (胺化合物） B-1 .下述式表示之胺化合物 [化 46]A-1 (amine compound) B-1. Amine compound represented by the following formula [Chem. 46]

(有機溶劑） NMP: N -甲基-2-吡啶烷酮 BCS : 丁基溶纖素 (聚醯亞胺前驅物及聚醯亞胺之分子 合成例中之聚醯亞胺之分子量係 色譜（GPC)裝置（GPC-101)(昭 柱（KD-803、KD-805 ) ( Shodex製）(Organic solvent) NMP: N-methyl-2-pyridinone BCS: butyl cellosolve (molecular weight chromatography (GPC) of polyimine in molecular synthesis of polyimine precursor and polyimine Device (GPC-101) (Zhaozhu (KD-803, KD-805) (manufactured by Shodex)

管柱溫度：50°C 溶離液：N，N’-二甲基甲醯胺（ :測定） 專溫下使用凝膠浸透 丨電工公司製）、管 ，以下方式測定。 j加劑爲溴化鋰一水Column temperature: 50 ° C Dissolving solution: N,N'-dimethylformamide (measurement) The gel was soaked at a specific temperature, and the tube was measured by the following method. j addition agent is lithium bromide-water

S -100- 201217433 合物（LiBr· H20)爲30mmol/L、磷酸•無水結晶（〇_碟 酸）爲 30mmol/L、四氫呋喃（THF )爲 10ml/L)。 流速：1.0ml/分鐘 校正曲線製作用標準樣品：TSK標準聚環氧乙院（分 子量約 900,000、 150,000、 100,000、 30,000)(東曹公司 製）及聚乙二醇（分子量約12,000、4,000、1，000)( Polymer Libertry公司製）。 (醯亞胺化率之測定） 合成例中之聚醯亞胺之醯亞胺化率係如下述測定。將 聚醯亞胺粉末20mg放入NMR樣品管（NMR取樣管標準、φ5 (草野科學公司製））中，添加氘化二甲基亞颯（DM SO-d6，0.05質量％TMS (四甲基矽烷）混合物）〇.5 3ml，以 超音波使完全溶解。此溶液使用NMR (核磁共振）測定器 (JNW-ECA500 )(日本電子DATUM公司製）測定500MHz 之質子NMR。醯亞胺化率係以源自醯亞胺化前後未變化之 結構的質子作爲基準質子來決定，使用此質子之波峰積分 値與在9.5至10.0Ppm附近出現之源自醯胺酸之NH基之質子 積分値，以下述式求得。 醯亞胺化率（％) = (1 - a . x/y) X 1 00 上述式中’ x爲源自醯胺酸之NH基之質子波峰之積分 値，y爲基準質子之波峰之積分値，α爲基準質子相對於聚 醯胺酸（醯亞胺化率爲0% )時之醯胺酸之一個ΝΗ基質子 的個數比例。 -101 - 201217433 〈合成例ι&gt; 將 BODA ( 5.61g，22.4mmol) 、PCH7DAB ( 5.34g ’ 14.0mmol)及 p-PDA ( l522，14.0mm〇1)在1^1* ( 22·48 )中混合’以8 0 t反應5小時。然後’添加C B D A ( 1 . 1 0 g ’ 5.60mmol)與NMP ( l8.3g) ’以40 °C反應6小時’得到樹 脂固體成分濃度爲25.0質量％之聚醯胺酸溶液（A)。此聚 醯胺酸之數平均分子量爲27,400 ’重量平均分子量爲 79，100 ° &lt;合成例2 &gt; 在合成例1所得之樹脂固體成分濃度爲25.0質量％之聚 醯胺酸溶液（A ) ( 20.0g )中添加NMP，稀釋成6質量％後 ，添加作爲醯亞胺化觸媒之乙酸酐（2 · 5 1 g )及吡啶（ 1.90g )，以80°C反應3.5小時。此反應溶液投入甲醇（ 3 5 0ml )中’將所得之沈澱物過濾取得。此沈澱物以甲醇 洗淨’以1 00 °C下進行減壓乾燥，得到聚醯亞胺粉末（b ) 。此聚醯亞胺之醯亞胺化率爲52%，數平均分子量爲 23，100，重量平均分子量爲56,2〇〇。 &lt;合成例3 &gt; 將 BODA ( 5.72g，22.8mmol)、PBCH5DAB ( 3.71g， 8.57mmol )、及 D B A ( 3 〇 4 g2 〇 · 〇mm 〇 1 )在 N Μ P ( 2 2.4 g )中混合’以80°C反應5小時。然後，添加cbdA ( 1.12g， s -102- 201217433 5_74mmol )與NMP ( 1 8.3g )，以4 0 °C反應6小時，得到樹 脂固體成分濃度爲25.0質量％之聚醯胺酸溶液。 所得之聚醯胺酸溶液（20.2g)中添加NMP，稀釋成6 質量％後，添加作爲醯亞胺化觸媒之乙酸酐（4.5 5g)及吡 啶（3.30g)，以90°C反應3小時。此反應溶液投入甲醇（ 400ml )中，將所得之沈澱物過濾取得。此沈澱物以甲醇 洗淨，在1 〇〇 °C下進行減壓乾燥，得到聚醯亞胺粉末（C ) 。此聚醯亞胺之醯亞胺化率爲80%，數平均分子量爲 20,700 &gt;重量平均分子量爲5 1,300。 &lt;合成例4&gt; 將 BODA ( 5.87g，23.5mmol ) 、C ο 1D A B -1 ( 2.1 7 g， 4.40mmol )、及 DB A ( 3 ·79g，24· 9mmo 1 )在 NΜP ( 2 1 ·4g )中混合，以80°C反應4小時。然後，添加CBDA ( 1.15g， 5.80mmol )與NMP ( 17.5g )，以40°C反應5小時，得到樹 脂固體成分濃度爲25.0質量％之聚醯胺酸溶液。 所得之聚醯胺酸溶液（20.0g)中添加NMP，稀釋成6 質量％後，添加作爲醯亞胺化觸媒之乙酸酐（2.5 0g )及d比 啶（1.95g)，以80 °C反應4小時。此反應溶液投入甲醇（ 350ml)中’所得之沈澱物過濾取得。此沈澱物以甲醇洗 淨’在1 0 0 °C下減壓乾燥’得到聚醯亞胺粉末（d )。此聚 醯亞胺之醯亞胺化率爲54 %，數平均分子量爲21，500，重 量平均分子量爲54,5 00。 -103- 201217433 &lt;合成例5&gt; 將 TCA ( 4.1〇g，1 8.3mm〇l ) 、PCH7DAB ( 3.48g， 9.1 5mmο 1 )、及 p-PD A ( 0· 99g，9.1 5mmo 1 )在 NMP ( 25.7g)中混合’以40°C反應6小時’得到樹脂固體成分濃 度爲25.0質量％之聚醯胺酸溶液（E)。此醯胺酸之數平均 分子量爲28,900，重量平均分子量係79,200。 &lt;合成例6 &gt; 將 TCA ( 3 . 1 1 g ' 1 3.9mmol ) 、PBCH5DAB ( 1.80g， 4.1 7 m m ο 1 )、及 m - P D A ( 1 · 0 5 g，9.7 2 mm ο 1 )在 N Μ P ( 17.8g)中混合，以40°C反應6小時，得到樹脂固體成分濃 度爲25.0質量％之聚醯胺酸溶液。 所得之聚醯胺酸溶液（20.0g)中添加NMP，稀釋成6 質量％後，添加作爲醯亞胺化觸媒之乙酸酐（2.50g)及吡 啶（1.95g)，以80 °C反應4小時。此反應溶液投入甲醇（ 3 5 0ml )中，將所得之沈澱物過濾取得。此沈澱物以甲醇 洗淨，在1 〇〇°C下減壓乾燥得到聚醯亞胺粉末（F )。此聚 醯亞胺之醯亞胺化率爲55%，數平均分子量係1 9,500，重 量平均分子量爲50,3 00。 上述合成例所得之聚醯胺酸及聚醯亞胺如表3 3所示。 -104- 201217433 【表3 3】 樹脂成分 四羧酸二酐 二胺成分 特定側鏈型 二胺化線 其他二胺化合物 醞亞胺 化率(％) 合成例1 聚醯胺酸溶液(A) CBDA (1.10g, 5,61mmol) BODA (5.61g, 22,4mmot) PCH7DAB (5.34g, 14.0mmol) p-PDA (1.52g, M.Ommol) *1 合成例2 聚醯亞胺粉末(B) CBDA (1.10g, 5.61mmol) BODA (5.61g, 22.4mmol) PCH7DAB (5.34g, M.Ommol) p-PDA (1.52g, 14.0mmol) 52 合成例3 聚醯亞胺粉末(C) CBDA (1.12g, 5.71mmol) BODA (5.72g, 22.8mmol) PBCH5DAB (3.7Hg, 8.57mmol) DBA (3.04g, 20.0mmol) 80 合成例4 聚醯亞胺粉末(D) CBDA (1.15g, 5.86mmol) BODA (5.87g, 23.5mmol) OolDAB-1 (2.17g. 4.40mmol) DBA (3.79g, 24.9mmol) 54 合成例5 聚醯胺酸溶液(E) TCA (4.10g, 18.3mmol) PCH7DAB (3.48g, 9.14mmol) p-PDA (0.99g, 9.14mmol) *1 合成例6 聚醯嫌粉末(F) TCA (3.11g, 13.9mmol) PBCH5DAB (1.80g, 4.16mmol) m-PDA (1.05g, 9.71 mmol) 55 * 1 :聚醯胺酸。The S-100-201217433 compound (LiBr·H20) was 30 mmol/L, the phosphoric acid anhydrous crystal (〇-disc acid) was 30 mmol/L, and tetrahydrofuran (THF) was 10 ml/L). Flow rate: 1.0 ml/min Standard sample for calibration curve preparation: TSK standard Polyethylene oxide (molecular weight: about 900,000, 150,000, 100,000, 30,000) (manufactured by Tosoh Corporation) and polyethylene glycol (molecular weight of about 12,000, 4,000, 1) , 000) (manufactured by Polymer Libertry Co., Ltd.). (Measurement of ruthenium iodide ratio) The ruthenium imidization ratio of the polyimine in the synthesis example was measured as follows. 20 mg of polyimine powder was placed in an NMR sample tube (NMR sampling tube standard, φ5 (manufactured by Kusano Scientific Co., Ltd.)), and dimethylated dimethyl hydrazine (DM SO-d6, 0.05% by mass of TMS (tetramethyl) was added.矽 )) mixture) 〇 5 5 ml, completely dissolved by ultrasound. This solution was measured for proton NMR at 500 MHz using an NMR (nuclear magnetic resonance) measuring instrument (JNW-ECA500) (manufactured by JEOL DATUM Co., Ltd.). The ruthenium imidization rate is determined by using protons derived from structures that have not changed before and after imidization as a reference proton. The peak integral enthalpy of this proton is used and the NH group derived from proline is present near 9.5 to 10.0 Ppm. The proton integral 値 is obtained by the following formula.醯imination rate (%) = (1 - a . x / y) X 1 00 In the above formula, 'x is the integral 値 of the proton peak derived from the NH group of the proline, and y is the integral of the peak of the reference proton値, α is the ratio of the number of ruthenium protons of the proline to the protonic acid relative to the polyproline (0% imidization). -101 - 201217433 <Synthesis Example ι> BODA ( 5.61 g, 22.4 mmol), PCH7DAB ( 5.34 g '14.0 mmol) and p-PDA (l522, 14.0 mm 〇 1) in 1^1* (22·48) Mix 'react at 80 t for 5 hours. Then, C B D A (1.10 g ' 5.60 mmol) was added and NMP (l8.3 g)' was reacted at 40 ° C for 6 hours to obtain a polyamic acid solution (A) having a resin solid concentration of 25.0% by mass. The number average molecular weight of the polyamic acid was 27,400 'the weight average molecular weight was 79,100 ° &lt; Synthesis Example 2 &gt; The polyamic acid solution (A) having a resin solid content concentration of 25.0% by mass obtained in Synthesis Example 1 NMP was added to (20.0 g), and after diluting to 6 mass%, acetic anhydride (2 · 5 1 g) and pyridine ( 1.90 g) as a ruthenium catalyst were added, and the mixture was reacted at 80 ° C for 3.5 hours. This reaction solution was poured into methanol (305 ml), and the obtained precipitate was obtained by filtration. This precipitate was washed with methanol to dry under reduced pressure at 100 ° C to obtain a polyimine powder (b). The polyimine had a hydrazine imidation ratio of 52%, a number average molecular weight of 23,100, and a weight average molecular weight of 56,2 Å. &lt;Synthesis Example 3 &gt; BODA ( 5.72 g, 22.8 mmol), PBCH 5 DAB ( 3.71 g, 8.57 mmol), and DBA (3 〇 4 g 2 〇· 〇mm 〇 1 ) in N Μ P ( 2 2.4 g ) Mix 'react at 80 ° C for 5 hours. Then, cbdA (1.12 g, s -102 - 201217433 5_74 mmol) and NMP (1 8.3 g) were added, and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution having a resin solid concentration of 25.0% by mass. NMP was added to the obtained polyaminic acid solution (20.2 g), and after diluting to 6 mass%, acetic anhydride (4.55g) and pyridine (3.30g) which are a ruthenium-imidation catalyst were added, and it reacted at 90 degreeC. hour. This reaction solution was poured into methanol (400 ml), and the obtained precipitate was obtained by filtration. This precipitate was washed with methanol and dried under reduced pressure at 1 ° C to obtain a polyimine powder (C). The polyimine had an oxime imidization ratio of 80%, a number average molecular weight of 20,700 &gt; a weight average molecular weight of 5,300. &lt;Synthesis Example 4&gt; BODA (5.87 g, 23.5 mmol), C ο 1D AB -1 (2.17 g, 4.40 mmol), and DB A (3 · 79 g, 24·9 mmo 1 ) at NΜP ( 2 1 · 4 g) was mixed and reacted at 80 ° C for 4 hours. Then, CBDA (1.15 g, 5.80 mmol) and NMP (17.5 g) were added, and the mixture was reacted at 40 ° C for 5 hours to obtain a polyamic acid solution having a solid concentration of the resin of 25.0% by mass. After adding NMP to the obtained polyamidic acid solution (20.0 g), and diluting it to 6 mass%, acetic anhydride (2.50 g) and d-pyridyl (1.95 g) as a ruthenium catalyst were added at 80 ° C. Reaction for 4 hours. This reaction solution was poured into methanol (350 ml) to obtain a precipitate obtained by filtration. This precipitate was washed with methanol to dry under reduced pressure at 100 ° C to obtain a polyimine powder (d). The polyamidimide had a ruthenium iodide ratio of 54%, a number average molecular weight of 21,500, and a weight average molecular weight of 54,500. -103-201217433 &lt;Synthesis Example 5&gt; TCA (4.1〇g, 1 8.3mm〇l), PCH7DAB (3.48g, 9.1 5mmο 1 ), and p-PD A (0·99g, 9.1 5mmo 1 ) were used in NMP (25.7 g) was mixed and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution (E) having a resin solid content concentration of 25.0% by mass. The proline had a number average molecular weight of 28,900 and a weight average molecular weight of 79,200. &lt;Synthesis Example 6 &gt; TCA (3.11 g '1 3.9 mmol), PBCH5DAB (180 g, 4.1 7 mm ο 1 ), and m - PDA (1 · 0 5 g, 9.7 2 mm ο 1 ) The mixture was mixed with N Μ P (17. 8 g), and reacted at 40 ° C for 6 hours to obtain a polyaminic acid solution having a resin solid content concentration of 25.0% by mass. After adding NMP to the obtained polyamic acid solution (20.0 g), and diluting it to 6 mass%, acetic anhydride (2.50 g) and pyridine (1.95 g) as a ruthenium catalyst were added, and the reaction was carried out at 80 °C. hour. This reaction solution was poured into methanol (305 ml), and the obtained precipitate was obtained by filtration. This precipitate was washed with methanol and dried under reduced pressure at 1 ° C to obtain a polyimine powder (F). The polyimine was imidized at a rate of 55%, the number average molecular weight was 1,900, and the weight average molecular weight was 50,300. The polyamic acid and polyimine obtained in the above synthesis examples are shown in Table 33. -104- 201217433 [Table 3 3] Resin component tetracarboxylic dianhydride diamine component specific side chain type diamine line Other diamine compound oxime iodization ratio (%) Synthesis example 1 Polyamid acid solution (A) CBDA (1.10g, 5,61mmol) BODA (5.61g, 22,4mmot) PCH7DAB (5.34g, 14.0mmol) p-PDA (1.52g, M.Ommol) *1 Synthesis Example 2 Polyimine powder (B) CBDA (1.10g, 5.61mmol) BODA (5.61g, 22.4mmol) PCH7DAB (5.34g, M.Ommol) p-PDA (1.52g, 14.0mmol) 52 Synthesis Example 3 Polyimine powder (C) CBDA (1.12 g, 5.71 mmol) BODA (5.72 g, 22.8 mmol) PBCH5DAB (3.7Hg, 8.57 mmol) DBA (3.04 g, 20.0 mmol) 80 Synthesis Example 4 Polyimine powder (D) CBDA (1.15 g, 5.86 mmol) BODA (5.87g, 23.5mmol) OolDAB-1 (2.17g. 4.40mmol) DBA (3.79g, 24.9mmol) 54 Synthesis Example 5 Polyproline solution (E) TCA (4.10g, 18.3mmol) PCH7DAB (3.48g, 9.14 mmol) p-PDA (0.99 g, 9.14 mmol) *1 Synthesis Example 6 Polyfluorene powder (F) TCA (3.11 g, 13.9 mmol) PBCH5DAB (1.80 g, 4.16 mmol) m-PDA (1.05 g, 9.71 mmol) 55 * 1 : Polyglycine.

「液晶配向處理劑之製造J 實施例1〜6及比較例1〜4係記載評價用之液晶配向處理 劑之製造例。結果如表34及3 5所示。 「液晶配向膜之製作」、「摩擦處理耐性之評價」、 「液晶胞（通常也稱爲胞（cell ))之製作」、「液晶胞 (PSA胞）之製作」及「電特性之評價」係如下述。又， 實施例1〜6及比較例1〜4所得之各液晶配向處理劑之特性如 表36~3 8所示。表36係表示摩擦處理耐性之評價結果，表 3 7係表示使用通常液晶胞之電特性的評價結果，表38係表 示使用PSA液晶胞之電特性之評價結果。 「液晶配向膜之製作」 將液晶配向處理劑旋轉塗佈於30mmx40mm之附ITO電 極之基板的ITO面，在加熱板上以8CTC加熱處理5分鐘，在 熱循環型無塵烘箱中以22 0°C加熱處理30分鐘，得到附膜 厚lOOnm之聚醯亞胺液晶配向膜的基板。 -105- 201217433 「摩擦處理耐性之評價」 將上述「液晶配向膜之製作」所得之附液晶配向膜之 基板的塗膜面使用輥徑120mm之摩擦裝置’使用生絲布， 以輥轉數300rpm、輥移動速度20mm/sec、押入量0.4mm的 條件進行摩擦處理。將摩擦處理後之基板中心附近的液晶 配向膜表面以設定爲倍率1〇〇倍之雷射顯微鏡，任意觀察5 處，由觀察視野之約6.5mm四方之範圍所確認的摩擦傷、 及摩擦切削屑（附著物）量之平均値，評價摩擦處理耐性 。評價基準係如下述方式決定。 (評價基準） A:摩擦傷或摩擦切削屑爲20個以下 B:摩擦傷或摩擦切削屑爲20〜40個 C :摩擦傷或摩擦切削屑爲40~60個 D:摩擦傷或摩擦切削屑爲60個以上 「液晶胞（一般液晶胞）之製作」 將液晶配向處理劑旋轉塗佈於3〇mm x4 0 mm之附IT Ο電 極之基板的ITO面’在加熱板上以8〇°C加熱處理5分鐘，在 熱循環型無塵烘箱中以220 °C加熱處理30分鐘’得到附膜 厚lOOnm之聚醯亞胺液晶配向膜的IT Ο基板。將此IT Ο基板 的塗膜面使用輥徑1 2 〇mm之摩擦裝置’使用生絲布’以輥 轉數lOOOrpm、輥移動速度50mm/sec、押入量0.1mm的條 -106- 201217433 件進行摩擦處理。 準備2片所得之附液晶配向膜的ITO基板，使液晶配向 膜面爲內側，以夾著6μιη之隔離材來組合，使用密封劑黏 著周圍，製作空晶胞。於此空晶胞中，使用減壓注入法注 入液晶MLC-6608 ( Merck ·日本公司製），封閉注入口， 得到液晶胞（一般液晶胞）。 以偏光顯微鏡觀察實施例及比較例所得之液晶胞，確 認液晶之排列均句性。發現各液晶胞均無因摩擦處理所伴 隨之切削或配向不良，液晶係均勻排列。 「液晶胞（PSA胞）之製作」 將液晶配向處理劑旋轉塗佈於中心有lOmmxlOmm之 圖型間隔20μιη之ITO電極之基板與中心有10mmx40mm之 ITO電極之基板的ITO面，在加熱板上以8(TC加熱處理5分 鐘，在熱循環型無塵烘箱中以220°C加熱處理30分鐘，得 到附膜厚1 〇〇nm之聚醯亞胺塗膜。塗膜面以純水洗淨後， 熱循環型無塵烘箱中以1 〇〇°C加熱處理1 5分鐘，得到附液 晶配向膜的基板。 .將此附液晶配向膜的基板置於液晶配向膜的內面，以 夾著6μπι之隔離材來組合，使用密封劑黏著周圍，製作空 晶胞。於此空晶胞中，使用減壓注入法注入下述液晶，此 液晶係液晶MLC-6608 (Merck·日本公司製）中使下述式 表示之聚合性化合物（1 )相對於MLC-6608之100質量％， 混合有聚合性化合物0.3質量％的液晶，然後封閉注入口， -107- 201217433 得到液晶胞。 [化 47]"Production of liquid crystal alignment agent J" Examples 1 to 6 and Comparative Examples 1 to 4 describe the production examples of the liquid crystal alignment treatment agent for evaluation. The results are shown in Tables 34 and 35. "Production of Liquid Crystal Alignment Film", "Evaluation of friction treatment resistance", "production of liquid crystal cell (usually referred to as cell)", "production of liquid crystal cell (PSA cell)", and "evaluation of electrical characteristics" are as follows. Further, the characteristics of the respective liquid crystal alignment treatment agents obtained in Examples 1 to 6 and Comparative Examples 1 to 4 are shown in Tables 36 to 38. Table 36 shows the evaluation results of the rubbing treatment resistance, Table 3 7 shows the evaluation results using the electrical characteristics of the usual liquid crystal cells, and Table 38 shows the evaluation results of the electrical characteristics using the PSA liquid crystal cells. "Production of Liquid Crystal Alignment Film" The liquid crystal alignment agent was spin-coated on the ITO surface of a substrate of 30 mm x 40 mm with an ITO electrode, heat-treated at 8 CTC for 5 minutes on a hot plate, and 22 0 ° in a heat cycle type dust-free oven. C was heat-treated for 30 minutes to obtain a substrate having a polyimide film alignment film having a thickness of 100 nm. -105-201217433 "Evaluation of the resistance to the rubbing treatment" The coating surface of the substrate with the liquid crystal alignment film obtained by the above-mentioned "production of the liquid crystal alignment film" was made of a raw material using a friction device having a roll diameter of 120 mm, and the number of rolls was 300 rpm. The rubbing treatment was carried out under the conditions of a roll moving speed of 20 mm/sec and a pushing amount of 0.4 mm. The surface of the liquid crystal alignment film in the vicinity of the center of the substrate after the rubbing treatment was subjected to a laser microscope set at a magnification of 1 〇〇, and five points were observed arbitrarily, and the frictional damage and the frictional cutting confirmed by the range of about 6.5 mm of the observation field of view were observed. The average enthalpy of the amount of chips (attachment) was evaluated for the resistance to rubbing treatment. The evaluation criteria are determined as follows. (Evaluation Criteria) A: Friction or friction chips are 20 or less B: Friction or friction chips are 20 to 40 C: Friction or friction chips 40 to 60 D: Friction or friction chips For the production of more than 60 "liquid crystal cells (general liquid crystal cell)", the liquid crystal alignment agent was spin-coated on the ITO surface of the substrate of the IT Ο electrode of 3 mm × 4 0 mm on the hot plate at 8 ° C. The heat treatment was carried out for 5 minutes, and heat treatment was carried out at 220 ° C for 30 minutes in a heat cycle type dust-free oven to obtain an IT ruthenium substrate having a polyimide film alignment film having a thickness of 100 nm. The coating surface of the IT Ο substrate was rubbed using a friction device of a roll diameter of 1 2 〇 mm, using a raw silk cloth, with a number of rolls of 100 rpm, a roll moving speed of 50 mm/sec, and a pushing amount of 0.1 mm. deal with. Two sheets of the obtained ITO substrate with the liquid crystal alignment film were prepared, and the liquid crystal alignment film surface was placed inside, and the spacer was sandwiched between 6 μm, and the surrounding area was adhered with a sealant to prepare an empty cell. In this empty cell, liquid crystal MLC-6608 (manufactured by Merck Japan Co., Ltd.) was injected by a vacuum injection method, and the injection port was closed to obtain a liquid crystal cell (generally liquid crystal cell). The liquid crystal cells obtained in the examples and the comparative examples were observed under a polarizing microscope to confirm the alignment of the liquid crystals. It was found that each of the liquid crystal cells was not subjected to the rubbing treatment, and the cutting or alignment was poor, and the liquid crystal system was uniformly arranged. "Production of Liquid Crystal Cell (PSA Cell)" A liquid crystal alignment treatment agent was spin-coated on an ITO surface of a substrate having an ITO electrode having a pattern interval of 20 μm at a center of 10 mm×10 mm and an ITO electrode having a center of 10 mm×40 mm at the center. 8 (TC heat treatment for 5 minutes, heat treatment at 220 ° C for 30 minutes in a heat cycle type dust-free oven to obtain a polyimide film with a film thickness of 1 〇〇 nm. The film surface is washed with pure water. , heat-discharged in a non-dusting oven at 1 ° C for 15 minutes to obtain a substrate with a liquid crystal alignment film. The substrate with the liquid crystal alignment film is placed on the inner surface of the liquid crystal alignment film to sandwich 6 μm The spacers were combined and adhered to each other by using a sealant to form an empty cell. In the empty cell, the following liquid crystal was injected by a vacuum injection method, and the liquid crystal liquid crystal MLC-6608 (manufactured by Merck Japan Co., Ltd.) was used. The polymerizable compound (1) represented by the following formula is mixed with 100% by mass of the MLC-6608, and the liquid crystal is mixed with 0.3% by mass of the polymerizable compound, and then the injection port is closed, and -107-201217433 is obtained to obtain a liquid crystal cell.

對於所得之液晶胞外加交流5 V之電壓，同時使用照度 60mW之金屬鹵素燈，照射除去35〇nm以下之波長，並以 3 6 5nm換算爲20J/cm2之紫外線，得到液晶之配向方向被控 制之液晶胞（P S A胞）。對液晶胞照射紫外線時之照射装 置內的溫度爲5 0 °C。 測定此液晶胞之紫外線照射前與紫外線照射後之液晶 應答速度。應答速度係測定由透過率9 0 %至透過率1 0 %爲 止之T9 0 —T10。實施例及比較例所得之PSA胞，相較於紫 外線照射前之液晶胞時，紫外線照射後之液晶胞的應答速 度較快，因此確認液晶之配向方向被控制。 此外’偏光顯微鏡觀察各液晶胞，確認液晶均爲均勻 配向。 「電特性之評價」 對於上述「液晶胞（一般液晶胞）之製作」及「液晶 胞（PSA胞）之製作」所得的液晶胞，於8〇°C之溫度下， IV之電壓施加60μιη，測定16.67ms後之電壓及5 0ms後之電For the obtained liquid crystal, a voltage of 5 V was applied to the liquid crystal, and a metal halogen lamp having an illuminance of 60 mW was used, and the wavelength of 35 〇 nm or less was removed by irradiation, and the ultraviolet ray of 20 J/cm 2 was converted into 365 nm to obtain the alignment direction of the liquid crystal. Liquid crystal cell (PSA cell). The temperature in the irradiation device when the liquid crystal cell was irradiated with ultraviolet rays was 50 °C. The liquid crystal response speed of the liquid crystal cell before ultraviolet irradiation and after ultraviolet irradiation was measured. The response speed was measured from a transmittance of 90% to a transmittance of 10%, and T9 0 - T10. In the PSA cells obtained in the examples and the comparative examples, the response time of the liquid crystal cells after the ultraviolet irradiation was faster than that of the liquid crystal cells before the ultraviolet irradiation, and it was confirmed that the alignment direction of the liquid crystal was controlled. Further, each liquid crystal cell was observed by a polarizing microscope, and it was confirmed that the liquid crystals were uniformly aligned. "Evaluation of electric characteristics" For the liquid crystal cell obtained by the above-mentioned "production of liquid crystal cell (general liquid crystal cell)" and "production of liquid crystal cell (PSA cell)", 60 μm is applied to the voltage of IV at a temperature of 8 ° C. Measure the voltage after 16.67ms and the electricity after 50ms

S -108- 201217433 壓，測定電壓究竟保持至何種程度，以電壓保持率（ Voltage Holding Ratio)來計算。又，電壓保持率之測定 係使用VHR-1電壓保持率測定裝置（東陽科技公司製）， 並以 Voltage : ±1V、Pulse Width: 6 Ops、Flame Period: 16.67ms或50ms之設定來測定。S -108- 201217433 Pressure, to what extent the measured voltage is maintained, calculated by the Voltage Holding Ratio. Further, the voltage holding ratio was measured by using a VHR-1 voltage holding ratio measuring device (manufactured by Toyo Corporation) and measuring with a setting of Voltage : ±1 V, Pulse Width: 6 Ops, Flame Period: 16.67 ms or 50 ms.

對於電壓保持率之測定終了後的液晶胞，照射以 365nm換算爲50J/cm2之紫外線後，使用相同條件，測定 VHR。紫外線照射係使用桌上型UV硬化裝置（ HCT3B28HEX-1 ) ( Celite 公司製（SEN LIGHT CORPORATION ))。 〈實施例1&gt; 在合成例1所得之樹脂固體成分濃度25.0質量％之聚醯 胺酸溶液（A) (lO.Og)中添加NMP(5.83g) 、A-1之The liquid crystal cell after the measurement of the voltage holding ratio was irradiated with ultraviolet rays of 50 J/cm 2 in terms of 365 nm, and VHR was measured under the same conditions. For the ultraviolet irradiation, a desktop type UV curing device (HCT3B28HEX-1) (manufactured by Celite Co., Ltd. (SEN LIGHT CORPORATION)) was used. <Example 1> NMP (5.83 g) and A-1 were added to a polyaminic acid solution (A) (10.Og) having a resin solid content concentration of 25.0% by mass obtained in Synthesis Example 1.

NMP溶液（2.50g) ( A-1爲5.0質量％之NMP溶液）及BCS (23.5g)，以25°C攪拌2小時，得到液晶配向處理劑（1 ) 。確認此液晶配向處理劑中未發現混濁或析出等異常，爲 均勻的溶液。 使用製得之液晶配向處理劑（].)，以上述條件評價 摩擦處理耐性及一般液晶胞的電特性。 &lt;實施例2&gt; 在合成例2所得之聚醯亞胺粉末（B ) (2.51g)中添 加NMP ( 12.6g)，以70 °C攪拌24小時使溶解。此溶液中添 -109- 201217433 加A-l之NMP溶液（2.51g ) ( A-1爲5.0質量％之NMP溶液 )' NMP ( 7.27g)、及 BCS(19.7g)，以 50 °C 攪拌 15 小時 得到液晶配向處理劑（2 )。確認此液晶配向處理劑中未 發現混濁或析出等異常’爲均勻的溶液。 使用製得之液晶配向處理劑（2 )，以上述條件評價 摩擦處理耐性、一般液晶胞及P S A液晶胞的電特性。 &lt;實施例3&gt; 在合成例3所得之聚醯亞胺粉末（C) (2.48g)中添 加NMP ( 1 1 .8g )，以70 °C攪拌24小時使溶解。此溶液中添 加A-1之NMP溶液（3.47g ) ( A -1爲5 · 0質量％之Ν Μ P溶液 )、NMP ( 8.70g)、及 BCS(17.5g)，以 50°C 攪拌 15 小時 得到液晶配向處理劑（3 )。確認此液晶配向處理劑中未 發現混濁或析出等異常，爲均勻的溶液。 使用製得之液晶配向處理劑（3 )，以上述條件評價 摩擦處理耐性及一般液晶胞的電特性。 &lt;實施例4&gt; 在合成例4所得之聚醯亞胺粉末（D) (2.50g)中添 加NMP ( 14.2g)，以70 °C攪拌24小時使溶解。此溶液中添 加A-1之NMP溶液（2.50g ) ( A-1爲5.0質量％之NMP溶液 )' NMP ( 13.30g )、及 BCS ( 1 1 .8g )，以 50°C 攪拌 15小 時得到液晶配向處理劑（4 )。確認此液晶配向處理劑中 未發現混濁或析出等異常，爲均勻的溶液。 -110- 201217433 使用製得之液晶配向處理劑（4 ) ’以上述條件評價 摩擦處理耐性及一般液晶胞的電特性。 &lt;實施例5&gt; 在合成例5所得之樹脂固體成分濃度25.〇質量％之聚醯 胺酸溶液（E ) ( lO.Og )中添加NMP (7.73g) 、A-1之 NMP溶液（2.50g) (A-1爲5.0質量％之NMP溶液）、及 BCS ( 21.5g)，以2 5 °C攪拌2小時得到液晶配向處理劑（5 )。確認此液晶配向處理劑中未發現混濁或析出等異常’ 爲均勻的溶液。 使用製得之液晶配向處理劑（5 )，以上述條件評價 摩擦處理耐性及一般液晶胞的電特性。 &lt;實施例6&gt; 在合成例6所得之聚醯亞胺粉末（F ) ( 2.51g )中添 加NMP ( 16.7g )，以70°C攪拌24小時使溶解。此溶液中添 加A-1之NMP溶液（5.02g ) ( A-1爲5.0質量％之NMP溶液 )、NMP(8.28g)、及 BCS (11.8g)，以 50°C 攪拌 15 小時 得到液晶配向處理劑（6 )。確認此液晶配向處理劑中未 發現混濁或析出等異常，爲均勻的溶液。 使用製得之液晶配向處理劑（6 )，以上述條件評價 摩擦處理耐性及一般液晶胞的電特性。 &lt;比較例1 &gt; -111 - 201217433 在合成例1所得之樹脂固體成分濃度25.0質量％之聚醯 胺酸溶液（A) ( lO.Og)中添加 NMP ( 8.20g)、及 BCS ( 23.5g)，以25。&lt;：攪拌2小時得到液晶配向處理劑（7 )。確 認此液晶配向處理劑中未發現混濁或析出等異常’爲均勻 的溶液。 使用製得之液晶配向處理劑（7 ) ’以上述條件評價 摩擦處理耐性及一般液晶胞的電特性。 &lt;比較例2 &gt; 在合成例2所得之聚醯亞胺粉末（B) (2.5U)中添 加NMP ( 14.8g)，以70°C攪拌24小時使溶解。此溶液中添 加 NMP(7.40g)、及 BCS (19.6g) ’以 50 °C 攪拌 15小時得 到液晶配向處理劑（8 )。確認此液晶配向處理劑中未發 現混濁或析出等異常，爲均勻的溶液。 使用製得之液晶配向處理劑（8 ) ’以上述條件評價 摩擦處理耐性、一般液晶胞及P S A液晶胞的電特性。 &lt;比較例3 &gt; 在合成例1所得之樹脂固體成分濃度25.0質量％之聚醯 胺酸溶液（A) ( 10.5g)中添加 NMP ( 6.10g) 、：B-1 之NMP solution (2.50 g) (A-1 was 5.0 mass% of NMP solution) and BCS (23.5 g) were stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment treatment agent (1). It was confirmed that no abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was a uniform solution. Using the obtained liquid crystal alignment treatment agent (.), the rubbing treatment resistance and the electrical characteristics of the general liquid crystal cell were evaluated under the above conditions. &lt;Example 2&gt; NMP (1.26 g) was added to the polyimine powder (B) (2.51 g) obtained in Synthesis Example 2, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. Add -109-201217433 to this solution with Al's NMP solution (2.51g) (A-1 is 5.0% by mass of NMP solution) 'NMP (7.27g), and BCS (19.7g), stir at 50 °C for 15 hours A liquid crystal alignment treatment agent (2) was obtained. It was confirmed that no abnormality such as turbidity or precipitation was observed in the liquid crystal alignment treatment agent as a uniform solution. Using the obtained liquid crystal alignment treatment agent (2), the rubbing treatment resistance, the electrical properties of the general liquid crystal cell and the P S A liquid crystal cell were evaluated under the above conditions. &lt;Example 3&gt; NMP (1 1.8 g) was added to the polyimine powder (C) (2.48 g) obtained in Synthesis Example 3, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. To this solution was added A-1 NMP solution (3.47 g) (A-1 was 5% by mass of ΝP solution), NMP (8.70 g), and BCS (17.5 g), and stirred at 50 °C. The liquid crystal alignment treatment agent (3) was obtained in an hour. It was confirmed that no abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was a uniform solution. Using the obtained liquid crystal alignment treatment agent (3), the rubbing treatment resistance and the electrical characteristics of the general liquid crystal cell were evaluated under the above conditions. &lt;Example 4&gt; NMP (1.42 g) was added to the polyimine powder (D) (2.50 g) obtained in Synthesis Example 4, and the mixture was stirred at 70 ° C for 24 hours to dissolve. To this solution, a NMP solution of A-1 (2.50 g) (A-1 was 5.0% by mass of NMP solution) 'NMP (13.30 g) and BCS (1 1.8 g) were added, and the mixture was stirred at 50 ° C for 15 hours. Liquid crystal alignment treatment agent (4). It was confirmed that no abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was a uniform solution. -110-201217433 Using the obtained liquid crystal alignment treatment agent (4)', the friction treatment resistance and the electrical characteristics of the general liquid crystal cell were evaluated under the above conditions. &lt;Example 5&gt; NMP (7.73 g) and A-1 NMP solution were added to the polyamic acid solution (E) (10.Og) of the resin solid content concentration of 25.5% by mass obtained in Synthesis Example 5 ( 2.50 g) (A-1 is 5.0 mass% of NMP solution) and BCS (21.5 g), and stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment treatment agent (5). It was confirmed that no abnormality such as turbidity or precipitation was observed in the liquid crystal alignment treatment agent as a uniform solution. Using the obtained liquid crystal alignment treatment agent (5), the rubbing treatment resistance and the electrical characteristics of the general liquid crystal cell were evaluated under the above conditions. &lt;Example 6&gt; NMP (1,7 g) was added to the polyimine powder (F) (2.51 g) obtained in Synthesis Example 6, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. A solution of A-1 in NMP (5.02 g) (A-1 was 5.0% by mass of NMP solution), NMP (8.28 g), and BCS (11.8 g) were added to the solution, and the mixture was stirred at 50 ° C for 15 hours to obtain a liquid crystal alignment. Treatment agent (6). It was confirmed that no abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was a uniform solution. Using the obtained liquid crystal alignment treatment agent (6), the rubbing treatment resistance and the electrical characteristics of the general liquid crystal cell were evaluated under the above conditions. &lt;Comparative Example 1 &gt; -111 - 201217433 NMP (8.20 g) and BCS (23.5) were added to a polyamic acid solution (A) (10.Og) of a resin solid content concentration of 25.0% by mass obtained in Synthesis Example 1. g), to 25. &lt;: A liquid crystal alignment treatment agent (7) was obtained by stirring for 2 hours. It was confirmed that no abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent. Using the obtained liquid crystal alignment treatment agent (7)', the rubbing treatment resistance and the electrical characteristics of the general liquid crystal cell were evaluated under the above conditions. &lt;Comparative Example 2 &gt; NMP (14.8 g) was added to the polyimine powder (B) (2.5 U) obtained in Synthesis Example 2, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. To the solution, NMP (7.40 g) and BCS (19.6 g) were added and stirred at 50 ° C for 15 hours to obtain a liquid crystal alignment treatment agent (8). It was confirmed that no abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was a uniform solution. Using the obtained liquid crystal alignment treatment agent (8)', the rubbing treatment resistance, the general liquid crystal cell, and the electric properties of the P S A liquid crystal cell were evaluated under the above conditions. &lt;Comparative Example 3 &gt; NMP (6.10 g) and B-1 were added to the polyas amino acid solution (A) (10.5 g) having a resin solid content concentration of 25.0% by mass obtained in Synthesis Example 1.

NMP溶液（2.63g) (B-1爲5.0質量％之NMP溶液）及BCS (24.7g )，以2 5 °C攪拌2小時得到液晶配向處理劑（9 )。 確認此液晶配向處理劑中未發現混濁或析出等異常’爲均 勻的溶液。 -112- 201217433 使用製得之液晶配向處理劑（9 )，以上述條件評價 摩擦處理耐性及一般液晶胞的電特性。 &lt;比較例4 &gt; 在合成例2所得之聚醯亞胺粉末（b) (2.50g)中添 加NMP ( 13.2g )，以70°C攪拌24小時使溶解。此溶液中添 加B-1之NMP溶液（2.50g ) ( B-1爲5.0質量％之NMP溶液 )' NMP ( 6.58g )、及 BCS(19.6g)，以 50°C 攪拌 15 小時 得到液晶配向處理劑（1 0 )。確認此液晶配向處理劑中未 發現混濁或析出等異常，爲均勻的溶液。 使用製得之液晶配向處理劑（1 0 )，以上述條件評價 摩擦處理耐性、一般液晶胞及PSA液晶胞的電特性。 〔表 34〕 液晶配向處理劑 樹脂成分 特定胺化合物~~ 實施例1 液晶配向處理劑(1) 聚醯胺酸溶液(A) A-1 實施例2 液晶配向處理劑(2) 聚醯亞胺粉末(B) A-1 實施例3 液晶配向處理劑(3) 聚醯亞胺粉末(C) A-1 實施例4 液晶配向處理劑(4) 聚醯亞胺粉末(D) A-1 實施例5 液晶配向處理劑(5) 聚醯胺酸溶液(E) A-1 實施例6 液晶配向處理劑(6) 聚醯亞胺粉末(F) A-1 〔表 3 5〕 液晶配向處理劑 樹脂成分 胺化合物 比較例1 液晶配向處理劑(7) 聚醯胺酸溶液(A) 比較例2 液晶配向處理劑(8) 聚醯亞胺粉末(B) 比較例3 液晶配向處理劑(9) 聚醐安酸溶液(A) B-1 比較例4 液晶配向處理劑(10) 聚醯亞胺粉末(B) B-1 -113- 201217433 〔表 36〕A NMP solution (2.63 g) (B-1 was 5.0 mass% of NMP solution) and BCS (24.7 g) were stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment treatment agent (9). It was confirmed that no abnormality such as turbidity or precipitation was observed in the liquid crystal alignment treatment agent as a uniform solution. -112-201217433 Using the obtained liquid crystal alignment treatment agent (9), the friction treatment resistance and the electrical characteristics of the general liquid crystal cell were evaluated under the above conditions. &lt;Comparative Example 4 &gt; NMP (13. 2 g) was added to the polyimine powder (b) (2.50 g) obtained in Synthesis Example 2, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. To this solution, B-1 NMP solution (2.50 g) (B-1 was 5.0% by mass of NMP solution) 'NMP (6.58 g) and BCS (19.6 g) were added, and the mixture was stirred at 50 ° C for 15 hours to obtain a liquid crystal alignment. Treatment agent (10). It was confirmed that no abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was a uniform solution. Using the obtained liquid crystal alignment treatment agent (10), the rubbing treatment resistance, the electrical characteristics of the general liquid crystal cell and the PSA liquid crystal cell were evaluated under the above conditions. [Table 34] Liquid crystal alignment agent resin component specific amine compound ~~ Example 1 Liquid crystal alignment treatment agent (1) Polyamid acid solution (A) A-1 Example 2 Liquid crystal alignment treatment agent (2) Polyimine Powder (B) A-1 Example 3 Liquid crystal alignment treatment agent (3) Polyimine powder (C) A-1 Example 4 Liquid crystal alignment treatment agent (4) Polyimine powder (D) A-1 Example 5 Liquid crystal alignment treatment agent (5) Polylysine solution (E) A-1 Example 6 Liquid crystal alignment treatment agent (6) Polyimine powder (F) A-1 [Table 3 5] Liquid crystal alignment treatment agent Resin Component Amine Compound Comparative Example 1 Liquid Crystal Alignment Treatment Agent (7) Polyamide Acid Solution (A) Comparative Example 2 Liquid Crystal Alignment Treatment Agent (8) Polyimine Powder (B) Comparative Example 3 Liquid Crystal Alignment Treatment Agent (9) Polyanthraquinone acid solution (A) B-1 Comparative Example 4 Liquid crystal alignment treatment agent (10) Polyimine powder (B) B-1 -113- 201217433 [Table 36]

液晶配向處理劑 摩擦耐性 實施例1 液晶配向處理劑(1) A 實施例2 液晶配向處理劑(2) A 實施例3 液晶配向處理劑(3) A 實施例4 液晶配向處理劑(4) A 實施例5 液晶配向處理劑(5) A 實施例6 液晶配向處理劑(6) A 比較例1 液晶配向處理劑(7) D 比較例2 液晶配向處理劑(8) D 比較例3 液晶配向處理劑(9) D 比較例4 液晶配向處理劑(10) D 【表37】 液晶配向處理劑 電壓保持率(％) 液晶胞剛製作後 紫外線照射後 16.67ms 50ms 16.67ms 50ms 實施例1 液晶配向處理劑(1) 97.2 94.2 86.1 80.2 實施例2 液晶配向處理劑(2) 97.3 95.2 92.3 90.5 實施例3 液晶配向處理劑(3) 97.4 95.5 92.6 91.1 實施例4 液晶配向處理劑(4) 97.3 95.1 92.1 90.4 實施例5 液晶配向處理劑(5) 97.1 94.0 85.8 79.3 實施例6 液晶配向處理劑(6) 97.3 95.4 92.1 89.0 比較例1 液晶配向處理劑(7) 96.9 93.7 79.3 68.3 比較例2 液晶配向處理劑(8) 97.1 95.0 87.2 83.0 比較例3 液晶配向處理劑(9) 96.7 93.5 79.0 66.4 比較例4 液晶配向處理劑(10) 97.0 95.0 86.5 81.2 【表3 8】 液晶配向處理劑 電壓保持率(％) 液晶胞K ϋ製作後 紫外線照射後 16.67ms 50ms 16.67ms 50ms 實施例2 液晶配向處理劑(2) 96.9 94.7 91.2 90.0 比較例2 液晶配向處理劑(8) 96.3 93.6 86.0 81.9 比較例4 液晶配向處理劑(10) 96.0 93.5 85.2 80.6 由上述結果可知，由本發明之實施例之液晶配向處理Liquid crystal alignment treatment agent friction resistance Example 1 Liquid crystal alignment treatment agent (1) A Example 2 Liquid crystal alignment treatment agent (2) A Example 3 Liquid crystal alignment treatment agent (3) A Example 4 Liquid crystal alignment treatment agent (4) A Example 5 Liquid crystal alignment treatment agent (5) A Example 6 Liquid crystal alignment treatment agent (6) A Comparative example 1 Liquid crystal alignment treatment agent (7) D Comparative example 2 Liquid crystal alignment treatment agent (8) D Comparative example 3 Liquid crystal alignment treatment (9) D Comparative Example 4 Liquid crystal alignment treatment agent (10) D [Table 37] Liquid crystal alignment treatment agent voltage retention ratio (%) After the liquid crystal cell was fabricated, after ultraviolet irradiation 16.67 ms 50 ms 16.67 ms 50 ms Example 1 Liquid crystal alignment treatment Agent (1) 97.2 94.2 86.1 80.2 Example 2 Liquid crystal alignment treatment agent (2) 97.3 95.2 92.3 90.5 Example 3 Liquid crystal alignment treatment agent (3) 97.4 95.5 92.6 91.1 Example 4 Liquid crystal alignment treatment agent (4) 97.3 95.1 92.1 90.4 Example 5 Liquid Crystal Alignment Treatment Agent (5) 97.1 94.0 85.8 79.3 Example 6 Liquid Crystal Alignment Treatment Agent (6) 97.3 95.4 92.1 89.0 Comparative Example 1 Liquid Crystal Alignment Treatment Agent (7) 96.9 93.7 79.3 68.3 Comparative Example 2 Liquid Crystal Alignment Treatment Agent ( 8) 97.1 95.0 87.2 83.0 Comparative Example 3 Liquid crystal alignment treatment agent (9) 96.7 93.5 79.0 66.4 Comparative Example 4 Liquid crystal alignment treatment agent (10) 97.0 95.0 86.5 81.2 [Table 3 8] Liquid crystal alignment treatment agent voltage retention ratio (%) After liquid crystal cell K ϋ After ultraviolet irradiation 16.67 ms 50 ms 16.67 ms 50 ms Example 2 Liquid crystal alignment treatment agent (2) 96.9 94.7 91.2 90.0 Comparative Example 2 Liquid crystal alignment treatment agent (8) 96.3 93.6 86.0 81.9 Comparative Example 4 Liquid crystal alignment treatment agent (10) 96.0 93.5 85.2 80.6 From the above results, the liquid crystal alignment treatment by the embodiment of the present invention is known.

S -114- 201217433 劑所得之液晶配向膜，相較於由比較例之液晶配向處理劑 所得之液晶配向膜，因摩擦處理所造成之摩擦切削屑較少 ，且即使長時間暴露於紫外線後，電壓保持率之降低仍然 較少。 不含特定胺化合物之比較例1及比較例2與使用不含雙 鍵部位之胺化合物（B-1 )之比較例3及比較例4，因摩擦 處理所造成之摩擦切削屑多，且長時間暴露於紫外線後， 電壓保持率之大幅降低。 〔產業上之可利用性〕 本發明之液晶配向處理劑，可得到不易伴隨液晶顯示 元件之製造步驟中之摩擦處理所伴隨之聚合物被膜之切削 屑或伴隨摩擦處理產生傷痕，即使長時間受光照射，也可 抑制電壓保持率降低的液晶配向膜。具有由本發明之液晶 配向膜的液晶顯示元件係可靠性優異，適用於大畫面、高 精細的液晶電視，可用於TN元件、STN元件、TFT液晶元 件，特別是垂直配向型之液晶顯示元件等。 此外，由本發明之液晶配向處理劑所得之液晶配向膜 可用於製造具有對電極間外加電壓，同時照射紫外線之步 驟的液晶顯示元件。 在此引用2010年7月13日申請之日本專利申請案第 20 1 0- 1 58 783號之明細書、申請專利範圍及發明摘要的全 部內容，作爲本發明之說明書內容。 -115-The liquid crystal alignment film obtained by the S-114-201217433 agent has less friction chips due to the rubbing treatment than the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the comparative example, and even after prolonged exposure to ultraviolet rays, The reduction in voltage retention is still small. In Comparative Example 1 and Comparative Example 2 containing no specific amine compound and Comparative Example 3 and Comparative Example 4 using the amine compound (B-1) containing no double bond moiety, friction chips caused by friction treatment were numerous and long. After the time is exposed to ultraviolet light, the voltage retention rate is greatly reduced. [Industrial Applicability] The liquid crystal alignment agent of the present invention can obtain chips which are less likely to be accompanied by the rubbing treatment in the manufacturing process of the liquid crystal display element, or scratches accompanying the rubbing treatment, even if it is received for a long time. The irradiation can also suppress the liquid crystal alignment film having a lowered voltage holding ratio. The liquid crystal display element having the liquid crystal alignment film of the present invention is excellent in reliability and is suitable for a large-screen, high-definition liquid crystal television, and can be used for a TN element, an STN element, a TFT liquid crystal element, particularly a vertical alignment type liquid crystal display element. Further, the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention can be used for producing a liquid crystal display element having a step of applying a voltage between the electrodes while irradiating ultraviolet rays. The entire contents of the specification, the scope of the patent application, and the summary of the invention of the Japanese Patent Application No. 20 1 0-58 783, filed on Jul. 13, 2010, are hereby incorporated by reference. -115-

Claims (1)

201217433 七、申請專利範圍： 1 . 一種液晶配向處理劑，其特徵係含有下述成分（A )及成分（B )， 成分（A):下述式[1]表示之化合物， 成分（B):選自聚醯亞胺前驅物及聚醯亞胺所成群 之至少一種聚合物， [化1] Η〆1、/ ⑴ (式[1 ]中，X 1係由脂肪族烴基或非芳香族系環式烴 基所構成之2價有機基，X2係單鍵、-0-、-NH-、-S-、-S02-、-COO-、-OCO-、-CONH-、-NHCO-、-CO-、苯環或 環己烷環，X3係選自下述式[1-1]〜[1-6]之至少1種的基團 [化2]201217433 VII. Patent application scope: 1. A liquid crystal alignment treatment agent characterized by containing the following component (A) and component (B), component (A): a compound represented by the following formula [1], component (B) : at least one polymer selected from the group consisting of a polyimide precursor and a polyimine, [1] Η〆1, / (1) (In the formula [1], the X 1 is an aliphatic hydrocarbon group or a non-aromatic group. a divalent organic group consisting of a cyclic hydrocarbon group, X2 single bond, -0-, -NH-, -S-, -S02-, -COO-, -OCO-, -CONH-, -NHCO-, -CO-, a benzene ring or a cyclohexane ring, and X3 is a group selected from at least one of the following formulas [1-1] to [1-6] [Chemical 2] [1-4] (式[1-3]中，W1係表示氫原子或苯環，式[1-6]中， -116- 201217433 w2係選自苯環、環己烷環及雜環所成群之環狀基’ W3係 碳數1〜18之烷基、碳數1〜18之含氟烷基、碳數1~18之烷氧 基或碳數之含氟烷氧基）。 2.如申請專利範圍第1項之液晶配向處理劑’其中式 [1]之X1爲前述2價有機基所具有之與胺基鄰接之任意的-CH2-可被-0-、-COO-、-oco-、-CONH-、-NHCO-、-CO- 、-s-、-S ( 0) 2- ' -CF2- ' -c ( CF3 ) 2- ' -C ( CH3 ) 2- ' -Si ( CH3 ) 2- ' -OSi ( CH3 ) 2-、-si ( CH3 ) 2〇-、-OSi ( CH3 ) 20-、環狀烴基或雜環取代，與任意碳原子鍵結之氫 原子可被碳數卜2 0之直鏈狀烷基、碳數3 ~2 0之支鏈狀烷基 、碳數3~20之環狀烴基、碳數1~1〇之含氟烷基、雜環、氟 原子或羥基取代。 3 .如申請專利範圍第1或2項之液晶配向處理劑，其中 式[1]之X2爲單鍵、-OCO-、-NHC0-、苯環或環己烷環。 4.如申請專利範圍第1〜3項中任一項之液晶配向處理 劑，其中式[1]之X3爲式[1-2]、式[1-4]、式[1-5]或式[1-6] 表示之結構的基團。 5 .如申請專利範圍第1〜4項中任一項之液晶配向處理 劑，其中成分（B)爲選自使二胺成分與四羧酸二酐成分 反應所得之聚醯胺酸及使該聚醯胺酸進行脫水閉環所得之 聚醯亞胺所成群之至少一種聚合物。 6.如申請專利範圍第5項之液晶配向處理劑，其中二 胺成分爲下述式[2]表示之二胺化合物， -117- [2] 201217433 [化3][1-4] In the formula [1-3], W1 represents a hydrogen atom or a benzene ring, and in the formula [1-6], -116-201217433 w2 is selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring. The group of cyclic groups 'W3 is an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkoxy group having a carbon number). 2. The liquid crystal alignment treatment agent of claim 1, wherein X1 of the formula [1] is any of -CH2- which may be adjacent to the amine group of the above-mentioned divalent organic group may be -0-, -COO- , -oco-, -CONH-, -NHCO-, -CO-, -s-, -S ( 0) 2- ' -CF2- ' -c ( CF3 ) 2- ' -C ( CH3 ) 2- ' - Si ( CH3 ) 2- ' -OSi ( CH3 ) 2-, -si ( CH3 ) 2〇-, -OSi (CH3) 20-, cyclic hydrocarbyl or heterocyclic ring, hydrogen atom bonded to any carbon atom a linear alkyl group having a carbon number of 2, a branched alkyl group having 3 to 20 carbon atoms, a cyclic hydrocarbon group having 3 to 20 carbon atoms, a fluorine-containing alkyl group having 1 to 1 carbon number, and a heterocyclic ring , fluorine atom or hydroxyl substitution. 3. The liquid crystal alignment treatment agent according to claim 1 or 2, wherein X2 of the formula [1] is a single bond, -OCO-, -NHCO-, benzene ring or cyclohexane ring. 4. The liquid crystal alignment treatment agent according to any one of claims 1 to 3, wherein X3 of the formula [1] is a formula [1-2], a formula [1-4], a formula [1-5] or A group represented by the formula [1-6]. The liquid crystal alignment treatment agent according to any one of claims 1 to 4, wherein the component (B) is selected from the group consisting of polyamines obtained by reacting a diamine component with a tetracarboxylic dianhydride component, and The polyamic acid is subjected to at least one polymer of a group of polyimine obtained by dehydration ring closure. 6. The liquid crystal alignment treatment agent of claim 5, wherein the diamine component is a diamine compound represented by the following formula [2], -117- [2] 201217433 [Chemical 3] (式（2)中，Y1係單鍵、選自- (CH2) a-(a係1〜15 之整數）、-0-、-CH20-、-COO -或 OCO-，Y2 係單鍵或（ CH2)b-(b係1〜15之整數），Y3係單鍵、-(CHjc-Cc係 1〜15 之整數）、-0-、-CH20-、-C00 -或 0C0-，Y4係選自 苯環、環己烷環及雜環所成群之環狀基（此等之環狀基上 之任意的氫原子可被碳數1〜3之烷基、碳數1~3之烷氧基、 碳數1~3之含氟烷基、碳數1〜3之含氟烷氧基或氟原子取代 )、或具有類固醇骨架之碳數12 ~2 5之有機基之2價有機基 ，Y5係選自苯環、環己烷環及雜環所成群之環狀基（此等 之環狀基上之任意的氫原子可被碳數1〜3之烷基、碳數1〜3 之烷氧基、碳數1〜3之含氟烷基、碳數1〜3之含氟烷氧基或 氟原子取代），η係0〜4之整數，Y6係碳數1~1 8之烷基、碳 數1〜18之含氟烷基、碳數1〜18之烷氧基或碳數1〜18之含氟 烷氧基，m係1~4之整數）。 7 ·如申請專利範圍第6項之液晶配向處理劑，其中式 [2]表示之二胺化合物爲二胺成分中之5〜8 0莫耳％。 8 .如申請專利範圍第5〜7項中任一項之液晶配向處理 劑，其中四羧酸二酐爲下述式[3]表示之四羧酸二酐， S -118- 201217433 [化4](In the formula (2), Y1 is a single bond, selected from -(CH2) a- (a is an integer of 1 to 15), -0-, -CH20-, -COO- or OCO-, Y2 is a single bond or (CH2)b-(b is an integer from 1 to 15), Y3 is a single bond, -(CHjc-Cc is an integer from 1 to 15), -0-, -CH20-, -C00 - or 0C0-, Y4 is a system a cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring, and a heterocyclic ring (any hydrogen atom on the cyclic group may be an alkyl group having 1 to 3 carbon atoms and an alkyl group having 1 to 3 carbon atoms a divalent organic group having an oxy group, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom), or an organic group having a carbon number of 12 to 2 5 having a steroid skeleton Y5 is a cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring, and a heterocyclic ring (any hydrogen atom on the cyclic group may be an alkyl group having 1 to 3 carbon atoms, and a carbon number of 1 to 3 alkoxy group, fluorine-containing alkyl group having 1 to 3 carbon atoms, fluorine-containing alkoxy group having 1 to 3 carbon atoms or fluorine atom substituted), η-based integer of 0 to 4, and Y6-based carbon number 1 to 1 8 The alkyl group, the fluorine-containing alkyl group having 1 to 18 carbon atoms, the alkoxy group having 1 to 18 carbon atoms or the fluorine-containing alkoxy group having 1 to 18 carbon atoms, and m is an integer of 1 to 4). 7. The liquid crystal alignment treatment agent of claim 6, wherein the diamine compound represented by the formula [2] is 5 to 80% by mole of the diamine component. The liquid crystal alignment treatment agent according to any one of claims 5 to 7, wherein the tetracarboxylic dianhydride is a tetracarboxylic dianhydride represented by the following formula [3], S-118-201217433 [Chemical 4 ] (式[3]中，Z1係碳數4〜13之4價有機基，且含有碳數 4〜10之非芳香族環狀烴基）。 9.如申請專利範圍第8項之液晶配向處理劑，其中式 [3]中之Z1爲下述式[3a]〜式[3j]表示之結構， [化5](In the formula [3], Z1 is a tetravalent organic group having 4 to 13 carbon atoms and a non-aromatic cyclic hydrocarbon group having 4 to 10 carbon atoms). 9. The liquid crystal alignment treatment agent of claim 8, wherein Z1 in the formula [3] is a structure represented by the following formula [3a] to [3j], [Chemical 5] [3a] [3b] [3C] [3d][3a] [3b] [3C] [3d] DC ΏΣ [3f ] [3e]DC ΏΣ [3f ] [3e] (式[3 a]中，Z2〜Z5係氫原子、甲基、氯原子或苯環， -119- 201217433 各自可相同或相異，式[3 g]中，z6及Z7係氫原子或甲基， 各自可相同或相異）。 10.如申請專利範圍第1〜9項中任一項之液晶配向處理 劑’其中成分（B)之聚合物爲使聚醯胺酸進行脫水閉環 所得的聚醯亞胺。 1 1 ·如申請專利範圍第1〜1 0項中任一項之液晶配向處 理劑，其中相對於成分（B) 1〇〇質量份，成分（A)爲0.1 質量份~50質量份。 1 2 ·如申請專利範圍第1〜1 1項中任一項之液晶配向處 理劑，其中液晶配向處理劑含有有機溶劑，且含有有機溶 劑全體之5〜80質量％的弱溶劑。 1 3 . —種液晶配向膜，其特徵係使用如申請專利範圍 第1〜12項中任一項之液晶配向處理劑所得。 1 4. 一種液晶顯示元件，其特徵係具有如申請專利範 圍第13項之液晶配向膜。 1 5 .如申請專利範圍第1 3項之液晶配向膜，其係在具 備電極之一對基板間具有液晶層所成，且經由前述一對基 板間配置含有藉由活性能量線及熱之至少其一進行聚合之 聚合性化合物的液晶組成物，對前述電極間外加電壓，使 前述聚合性化合物聚合的步驟所製造。 1 6. —種液晶顯示元件，其特徵係在具備如申請專利 範圍第1 3項之液晶配向膜與電極之一對基板間具有液晶層 所成，且經由前述一對基板間配置含有藉由活性能量線及 熱之至少其一進行聚合之聚合性化合物的液晶組成物，對 -120- 201217433 前述電極間外加電壓，使前述聚合性化 製造。 1 7 ·如申請專利範圍第1 3項之液晶 下述液晶顯示元件，此液晶顯示元件係 基板間具有液晶層所成，且經由前述一 藉由活性能量線及熱之至少其一進行聚 的液晶配向膜，對前述電極間外加電壓 聚合的步驟所製造。 1 8 . —種液晶顯示元件，其特徵係 基板間具有液晶層所成，且經由前述一 藉由活性能量線及熱之至少其一進行聚 之如申請專利範圍第1 3項之液晶配向膜 加電壓，使前述聚合性基聚合的步驟所; 合物聚合的步驟所 配向膜，其係用於 在具備電極之一對 對基板間配置含有 合之含有聚合性基 ，使前述聚合性基 在具備電極之一對 對基板間配置含有 合之含有聚合性基 ，對前述電極間外 裂造。 121 - 201217433 (化2)(In the formula [3 a], Z2 to Z5 are a hydrogen atom, a methyl group, a chlorine atom or a benzene ring, and -119-201217433 may each be the same or different, and in the formula [3g], the z6 and Z7 hydrogen atoms or a Bases, each of which may be the same or different). 10. The liquid crystal alignment treatment agent according to any one of claims 1 to 9 wherein the polymer of the component (B) is a polyimine obtained by subjecting polylysine to dehydration ring closure. The liquid crystal alignment agent according to any one of the first to tenth aspects of the invention, wherein the component (A) is from 0.1 part by mass to 50 parts by mass based on 1 part by mass of the component (B). The liquid crystal alignment treatment agent according to any one of claims 1 to 1 wherein the liquid crystal alignment treatment agent contains an organic solvent and contains 5 to 80% by mass of a weak solvent of the entire organic solvent. A liquid crystal alignment film obtained by using a liquid crystal alignment treatment agent according to any one of claims 1 to 12. A liquid crystal display element characterized by having a liquid crystal alignment film according to item 13 of the patent application. The liquid crystal alignment film of claim 13, wherein the liquid crystal layer is formed between one of the electrodes and the substrate, and at least the active energy ray and the heat are disposed between the pair of substrates. The liquid crystal composition of the polymerizable compound which is polymerized is produced by applying a voltage between the electrodes to polymerize the polymerizable compound. (1) A liquid crystal display device comprising: a liquid crystal layer formed between a liquid crystal alignment film and an electrode of the first object of the third aspect of the patent application, and disposed between the pair of substrates; A liquid crystal composition of a polymerizable compound in which at least one of an active energy ray and a heat is polymerized, and a voltage is applied between the electrodes of -120 to 201217433 to produce the polymerizable product. 1 7 . The liquid crystal display element of the liquid crystal display device of claim 13 , wherein the liquid crystal display element has a liquid crystal layer between the substrates, and is polymerized by at least one of the active energy ray and the heat. The liquid crystal alignment film is produced by the step of applying voltage polymerization between the electrodes. a liquid crystal display device characterized in that a liquid crystal layer is formed between the substrates, and the liquid crystal alignment film is polymerized by the at least one of the active energy rays and the heat as described above. a step of polymerizing the polymerizable group; and a step of polymerizing the polymer to align the film, wherein the polymerizable group is disposed between the pair of substrates and the substrate; One of the electrodes is provided between the pair of substrates, and the polymerizable group is contained, and the electrode is externally cracked. 121 - 201217433 (化2) [1-4] (W1係表示氫原子或苯環。W2係選自苯環、環己烷 環及雜環所成群之環狀基，W3係碳數1~18之烷基、碳數 1〜18之含氟烷基、碳數1〜18之烷氧基或碳數1〜18之含氟烷 氧基）。 -2 - 201217433 四 指定代表®: (一） 本案指定代表圓為：無 (二） 本代表圖之元件符號簡單說明：無 五、本案若有化學式時，請揭示最能顯示發明特徵的化學 式：無[1-4] (W1 represents a hydrogen atom or a benzene ring. W2 is a cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring, and W3 is an alkyl group having 1 to 18 carbon atoms and a carbon number. a fluorine-containing alkyl group of 1 to 18, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkoxy group having 1 to 18 carbon atoms). -2 - 201217433 Four designated representatives®: (1) The designated representative circle in this case is: None (2) The symbol of the symbol of this representative is simple: No. 5. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: no
TW100124790A 2010-07-13 2011-07-13 Liquid crystal alignment film and a liquid crystal display element to the processing agent, with the liquid crystal TWI520984B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010158783 2010-07-13

Publications (2)

Publication Number Publication Date
TW201217433A true TW201217433A (en) 2012-05-01
TWI520984B TWI520984B (en) 2016-02-11

Family

ID=45469461

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100124790A TWI520984B (en) 2010-07-13 2011-07-13 Liquid crystal alignment film and a liquid crystal display element to the processing agent, with the liquid crystal

Country Status (5)

Country Link
JP (1) JP5900337B2 (en)
KR (1) KR101824283B1 (en)
CN (1) CN103097949B (en)
TW (1) TWI520984B (en)
WO (1) WO2012008464A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014084309A1 (en) * 2012-11-29 2014-06-05 日産化学工業株式会社 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
CN105339838A (en) * 2013-04-16 2016-02-17 日产化学工业株式会社 Liquid crystal display element, liquid crystal alignment film and liquid crystal aligning agent
TWI600750B (en) * 2011-03-17 2017-10-01 Jsr股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI609052B (en) * 2015-03-02 2017-12-21 日產化學工業股份有限公司 Liquid crystal display element
TWI649411B (en) * 2013-02-01 2019-02-01 日產化學工業股份有限公司 Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104203970B (en) * 2012-01-12 2016-08-17 和光纯药工业株式会社 Aligning agent for liquid crystal
CN105637410B (en) * 2013-08-14 2019-08-02 日产化学工业株式会社 Liquid crystal indicates element
KR102481772B1 (en) * 2014-08-28 2022-12-27 닛산 가가쿠 가부시키가이샤 Composition for forming cured film, alignment material, and retardation material

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06100755B2 (en) * 1986-06-18 1994-12-12 日産化学工業株式会社 Alignment treatment agent for liquid crystal cells
US6900271B2 (en) 2002-05-31 2005-05-31 Elsicon, Inc Hybrid polymer materials for liquid crystal alignment layers
JP4645823B2 (en) 2004-06-18 2011-03-09 Ｊｓｒ株式会社 Vertical liquid crystal aligning agent and vertical liquid crystal display element
CN101490188B (en) * 2006-07-18 2012-07-04 日产化学工业株式会社 Liquid crystal orienting agent and liquid crystal oriented film and liquid crystal display element using the same
TWI437045B (en) * 2006-07-28 2014-05-11 Nissan Chemical Ind Ltd A liquid crystal alignment agent and a liquid crystal display device using the liquid crystal display device
JP5035517B2 (en) * 2007-02-16 2012-09-26 日産化学工業株式会社 Liquid crystal aligning agent and liquid crystal display element using the same
JP4544432B2 (en) * 2007-02-21 2010-09-15 Ｊｓｒ株式会社 Method for producing diamine compound having cinnamoyl group
JP2008216671A (en) * 2007-03-05 2008-09-18 Jsr Corp Liquid crystal aligning agent and liquid crystal display element
JP5077048B2 (en) 2007-05-02 2012-11-21 Ｊｓｒ株式会社 Vertical alignment type liquid crystal alignment agent
WO2009154208A1 (en) 2008-06-17 2009-12-23 日産化学工業株式会社 Liquid-crystal alignment material, liquid-crystal display element employing same, and novel diamine
JP5614284B2 (en) 2008-10-29 2014-10-29 日産化学工業株式会社 Diamine, polyimide, liquid crystal aligning agent and liquid crystal aligning film
JP5304174B2 (en) 2008-10-29 2013-10-02 Ｊｎｃ株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI600750B (en) * 2011-03-17 2017-10-01 Jsr股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
WO2014084309A1 (en) * 2012-11-29 2014-06-05 日産化学工業株式会社 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
TWI635135B (en) * 2012-11-29 2018-09-11 日產化學工業股份有限公司 Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI649411B (en) * 2013-02-01 2019-02-01 日產化學工業股份有限公司 Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
CN105339838A (en) * 2013-04-16 2016-02-17 日产化学工业株式会社 Liquid crystal display element, liquid crystal alignment film and liquid crystal aligning agent
CN105339838B (en) * 2013-04-16 2019-06-07 日产化学工业株式会社 Liquid crystal indicates element, liquid crystal orientation film and aligning agent for liquid crystal
TWI609052B (en) * 2015-03-02 2017-12-21 日產化學工業股份有限公司 Liquid crystal display element
CN107533258A (en) * 2015-03-02 2018-01-02 日产化学工业株式会社 Liquid crystal represents element
CN107533258B (en) * 2015-03-02 2020-11-06 日产化学工业株式会社 Liquid crystal display element

Also Published As

Publication number Publication date
JPWO2012008464A1 (en) 2013-09-09
KR20130128367A (en) 2013-11-26
CN103097949B (en) 2015-06-17
KR101824283B1 (en) 2018-01-31
CN103097949A (en) 2013-05-08
TWI520984B (en) 2016-02-11
JP5900337B2 (en) 2016-04-06
WO2012008464A1 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
TWI447146B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW201217433A (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
TW201219451A (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
TWI586757B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element
TWI650345B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI637043B (en) Liquid crystal display element, liquid crystal alignment film, and liquid crystal alignment treatment agent
TWI547743B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display element
TW200948860A (en) Liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element
TWI564283B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
TW201343788A (en) Composition, liquid crystal aligninig agent, liquid crystal alighment film, and liquid crystal display element
TW201514248A (en) Liquid-crystal orientation treatment agent, liquid-crystal orientation film, and liquid-crystal display element
TWI545147B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI635135B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI633128B (en) Composition, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TW201219380A (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI638008B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TW201504282A (en) Liquid crystal display element, liquid crystal alignment film, and liquid crystal alignment treatment agent
TW201510078A (en) Liquid crystal display element, liquid crystal alignment film and liquid crystal aligning agent
TWI623518B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI649411B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
JP6183616B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TW201422677A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI575022B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI542633B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
TW201302855A (en) Composition, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element